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DEDICATION 
This thesis Is dedicated to my parents 
ABSTRACT 
Despite the body of information which has accumulated on the mechanisms of 
immunity to Schistosoma mansoni operating in the irradiated ccrcaria vaccine model, 
little is known about the antigens involved. Biosynthetic labelling of parasites with 31S_ 
methioninc, either prior to, or post ccrcarial transformation facilitated analysis of the 
kinetics of protein synthesis and release by schistosomula during in vitro culture. The 
proteins labelled during ccrcarial development in the snail were lost most rapidly within 
the fiTSt 3h after transformation to schistos. omula, and at a much diminished rate 
thereafter. Additionally, the proteins released by schistosomula during in vitro Culture 
were charactcrised. Two released proteins of M. 61 and 20 kDa were dominant on 
autoradiographs and corresponded to areas of proteolytic activity detected on gelatin 
substrate gels. The de novo synthesis of proteins after transformation followed a complex 
pattern, rising to a peak at day 8 before declining sharply. The highest rate of protein 
synthesis corresponded to the period in vivo when schistosomula are undergoing the 
adaptations necessary for migration through capillary beds. During development to the 
lung-stage, schistosomula labelled post-transformation released at least 15 proteins of 
diverse molecular weights. Among them, three of 61,45 and 20 kDa were especially 
prominent and appeared to be produced over the whole period. I believe that one or more 
of these proteins released in the skin-draining lymph nodes by irradiated parasites must 
serve as the inducers of the primary immune response, and released subsequently from 
challenge larvae in the lungs, as triggers of the effector response. 
The ability of various antigcnic fractions of Schistosoma mansoni, and in particular 
schistosomula-released proteins, to induce proliferation of lymph node cells, recovered 
from vaccinated mice, was tested in blastogenesis assays. Results from such experiments 
indicated that parasite-relcased proteins provided a good source of T cell immunogens, 
and reinforced their potential as vaccine candidates. 
The production of antisera against early- and latcr-stage released proteins facilitated 
investigation of the ability of such molecules to induce antibody production, a further 
indicator of their immunogenicity. In this respect, antigens of 45,20 and 12 kDa were 
rccognised strongly by both sera on Western blots of protein preparations of Schistosoma 
mansoni. The ability of these sera to transfer resistance against a cercarial challenge 
infection in mice was tested. Ile serum raised against later-stagc released proteins 
induced a moderate degree of immunity ranging from 19% to 29%, whereas the serum 
raised against early-stage released proteins conferred up to 51% resistance to mice when 
administered on days 4 and 7 post-challcngc. 
Subsequently, a unique cDNA library was generated with mRNA derived from 4 to 8 
day old schistosomula. Ile library was screened with serum raised against proteins 
released by in vitro-cultured schistosomula between day 4 and day 8 post- 
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transformation. Bacterial colonies expressing recombinant proteins, identified by such 
sera, were isolated and initial steps towards their characterisation taken. 
Finally, during the course of studying proteins released by schistosomula during in 
vitro culture, significant differences in the surface morphology of normal and irradiated 
larvae were observed. It is possible that such abnormalities could account for the ability 
of optimally-attenuatcd parasites to induce high levels of protective immunity against a 
ccrcarial challenge infection. 
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INTRODUCTION 
1.1 Background 
Schistosomiasis is a disease caused by infection with dioccious parasites belonging 
to the family Schistosomatidae. Of the genera within this family, 7 are confined to birds 
and 5 to mammals, but only the genus Schistosoma is associated with humans. Of the 
mammalian blood flukes, this genus has achieved the greatest geographical distribution 
and diversity of the definitive hosts parasitised. Species of schistosome infective to man 
are found in 76 of the world's tropical and sub-tropical countries (W. H. O., 1985) and in 
some, the disease is extremely prevalent; for example, approximately 72% of the 
Ghanaian population is estimated to be infected (Doumenge et al. 1987). Seven species of 
Schistosoma parasitise humans; the three most common, S. haematobium, S. japonicum 
and S. mansoni account for 78,69 and 57 million cases of schistosomiasis respectively, 
whilst the less common human parasites S. intercalatum, S. mattheei, S. mekongi and S. 
malayensis infcct thousands of people (Peters & Gilles, 1991). However, these may 
represent conservative estimates, since it has been reported for Schistosoma mansoni that 
faecal egg screening, the standard method for assessing, infection, usually underestimates 
the number of people carrying the disease (De Vlas & Gryseels, 1992). 
Due to the relative case in which the life-cycle of Schistosoma mansoni is 
maintained in the laboratory compared to other human schistosomes, this species has 
received the most attention. In York, the vast majority of research has centred upon this 
species using the murine host. Thus, the remainder of this thesis will refer, almost 
exclusively, to Schistosoma mansoni. 
1.2 Life-cyck of Schistosoma mansoni 
Schistosoma mansoni is transmitted via freshwater snails (including Biomphalaria 
glabrata) which are the intermediate hosts in the life-cycle, and in which asexual 
reproduction occurs. Owing to the losses of parasite numbers incurred during host 
location, a substantial amplification step occurs in the snail; penetration and development 
of only one miracidium leads to the production of several thousand cercariae (Theron, 
1986). Ile ccrcaria, consisting of a head and a bifurcated tail, develops in approximately 
1 week from the daughter sporocyst which is located in the digestive gland of the snail 
(Jourdane & Theron, 1987). Once mature, the cercaria leaves the snail in response to 
sunlight and then has between 5h and 8h, under optimal conditions, in which to find an 
appropriate host before its infectivity is impaired (Lawson & Wilson, 1983). The cercaria 
is covered by a carbohydrate-rich glycocalyx, which is thought to be anchored to the 
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underlying tegument via polypeptide chains (Marikovsky, Fishelson & Amon, 1988), and 
functions to waterproof the cercaria whilst in search of a susceptible host. Host location 
by the cercaria is incompletely understood, but its probability of success is thought to be 
greatly enhanced by changes in motility in response to water turbulence, shadows and 
skin substances, the stimuli usually presented by a passing human. When a host is 
located, skin penetration is thought to have 3 distinct phases; attachment, surface 
exploration and penetration of the epidermis. The first 2 phases can be triggered by 
thermal and chemical stimuli, the third by chemical stimuli alone (Haas & Schmidt, 
1982). Skin surface lipid has been shown to stimulate penetration (McKcrrow et A 
1983), and also to induce cicosanoid production in cercariac; these substances are 
immunosuppressants and may therefore play a role in immune evasion by the parasite 
(Salafsky & Fusco, 1987). The cercarial head contains 3 functionally and structurally 
discrete secretory glands, the head gland and the pre- and post-acetabular glands. 
Secretion from the post-acetabular gland precedes but overlaps that of the pre-acetabular 
gland; however, both release proteascs which facilitate skin penetration and possibly 
shedding of the glycocalyx (Marikovsky et aL 1988). Secretions from the head gland are 
thought to facilitate penetration of blood vessel walls in the dermis by parasites (Crabtree 
& Wilson, 1985). 
Various protease activities have been reported from different laboratories. 
Landsperger, Stircwalt & Dresden (1982) identified the major protcase species from a 
ccrcarial homogenate as a 25 kDa scrine protease with an isoelectric point (PI) of 6 and 
with properties similar to chymotrypsin. Amon and colleagues characterised two serine 
proteases secreted by transforming schistosomula. The major protcolytic activity was 
associated with a 28 kDa glycoprotein which had a pI of 11 and pH optimum of 9, whilst 
the minor activity was associated with a 60 kDa glycoprotein which had a pI of 9.2 
(Marikovsky et aL 1988). The 28 kDa protease was later localised to both the pre- and 
post-acetabular glands of cercariae (Marikovsky, Amon & Fishelson, 1990). McKerrow 
and colleagues have cloned a stage-specific proteinase which also facilitates infection of 
the host by cercariae (Newport et aL 1988). This serine proteinase of molecular weight 
(M) 30 kDa has a remarkably broad substrate specificity toward host tissue 
macromolecules, including keratin, fibronectin, laminin, type IV collagen and elastin 
(McKerrow et aL 1985). Despite the identification of different proteolytic species, which 
may be involved in skin penetration, recent structural analysis of the enzymes has shown 
that at least some of them are in fact post-translational derivatives of the same gene 
product (McKerrow, Newport & Fishelson, 1991). However, although evidence to date 
suggests that there is only a single serine protease gene in schistosomes, the origin of 
certain biochemical differences between the enzyme species remains obscure. 
Strong muscular contractions around the acetabular glands, initiated by skin lipids, 
results in the release of proteases which are packaged in vesicles so as to protect the 
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parasite from its own degradative enzymes. Ruptured vesicles were noted adjacent to 
degraded epidermal cells and along the surface of the penetrating larvae themselves 
(Fishclson et aL 1992). It was suggested that these observations were consistent with the 
dual role for the enzymes in tissue invasion and in release of the glycocalyx. In concert 
with the action of proteases, the cercaria utilises its head spines to burrow through the 
channel that is created ahead of it. Shortly after shedding of the glycocalyx, 
schistosomula express a scrine protease on their surface which appears to be identical, or 
very similar, to the secreted enzyme (McKerrow et aL 1991). This enzyme could degrade 
the complement components, C3, Ob, i0b and C9 (Parizide et aL 1990) suggesting that 
it may also function to protect the larva against immune damage by cleaving off any 
complement proteins that become attached to the parasite surface. Skin penetration is 
accompanied by transformation of cercariae into schistosomula, which are adapted to life 
in the mammalian host. 
For obvious reasons, the vast majority of information concerning the migratory 
pathway of Schistosoma mansoni and accompanying morphological and biochemical 
changes undergone by the parasite in the mammalian host comes from studies of infected 
rodents. Such adaptations will be described in more detail in section 1.5.1. The majority 
of schistosomula locate and penetrate a blood vessel and migrate via the lungs to the 
liver; this involves periods of active migration by schistosomula through capillary beds 
interspersed with passive carriage in the direction of blood flow. When the worms have 
paired, they begin to migrate up the hepatic vessels to the mesenteric veins, where the 
female commences egg-laying. Of the three most common schistosomes of humans, 
adult S. mansoni and S. japonicum inhabit the mesenteric vein and its tributaries. The 
eggs, after passing through the vessel walls to the lumen of the intestine are eventually 
voided in the faeces. In contrast, female adult worms of S. haematobium oviposit in the 
vcsical plexus of the bladder, and eggs are excreted in the urine. Tbc eggs hatch in 
freshwater releasing free-swimming miracidia which infect susceptible snails, and the 
life-cycle is perpetuated. 
In humans, schistosomiasis is a chronic disease which presents a broad spectrum of 
morbidity ranging from sub-clinical infection to severe splenomegaly and hepatomcgaly, 
which can be fatal. Worm pairs can persist within their host for many years causing only 
trivial direct pathology. The vast majority of damage is caused by the host's immune 
response to the eggs, of which approximately 300 are produced per day by an adult 
Schistosoma mansoni female. Unfortunately, roughly half of the eggs are washed into, 
and lodge in, the liver. The immune response to the trapped eggs results in granuloma 
formation around each egg, disruption of hepatic tissue organisation, portal hypertension 
and the development of porto-systemic anastomoses, which shunt a fraction of hepatic 
portal blood to the vena cava. Despite a low mortality rate from schistosomiasis of 
approximately 1%, an annual death toll of 2 million people has been recorded (Bergquist, 
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1987). As such, the disease is an important target for immune intervention. 
1.3 Control measures 
The requirement of a molluscan intermediate host for transmission of schistosomiasis 
to humans, means that the disease is centrcd around areas of freshwater, which can range 
from natural rivers and lakes to man-made dams and irrigation canals. Unfortunately, the 
latter two make a substantial contribution to the spread of schistosomiasis, for example in 
the Sudan, soon after 1 million acres of land was irrigated in 1963, the prevalence of 
Schistosoma mansoni infection reached 75% (Fenwick, 1987). 
Many measures have been used to try to prevent, or limit, the spread of 
schistosomiasis, including the provision of public health education in tandem with 
latrines and clean water for washing and drinking. Latrines could reduce faecal and 
urinary contamination of water, thus preventing contact of eggs, and therefore miracidia, 
with the intermediate snail host and so reduce transmission. However, Schistosoma spp. 
have reservoir hosts which contribute to transmission of the disease to man. In endemic 
areas, water exposure time has been shown to correlate strongly with presence of 
infection in humans. T'herefore, the existence of a clean water source could have a great 
impact on the level of parasite infection and transmission, simply by reducing the level of 
contact with 'contaminated' water. However, such measures require large amounts of 
money and a suitable water supply throughout the dry-season, both of which are difficult 
to obtain. Furthermore, a significant impact on transmission cannot be expected unless 
improvements in sanitation are also accompanied by changes in human behaviour. 
Unfortunately, it has been noted that even when better sanitation is available it is often 
not used (Caimcross, 1987). 
Molluscicides, such as niclosamide have been used with limited success to reduce 
the population of susceptible snails. Such measures are not only expensive and potentially 
damaging to the local environment but with time could lead to the evolution of resistant 
snails. Furthermore, the snail populations have an impressive potential for regeneration 
and rcinvasion, being able to rc-establish in a period of months. However, there have 
been some successes, for example in an area of Egypt, the prevalence of infection was 
reduced from 46% in 1968 to 10% in 1973 by molluscicide treatment combined with 
chemotherapy (Fenwick, 1987). Ibus, it has been suggested that there is still an important 
role to be played, by focal, rather than arca-wide molluscicide treatment to reduce the 
transmission of schistosomiasis, alongside other control measures (Klumpp & Chu, 
1987). 
The mass treatment of infected human populations with chemotherapeutic drugs has, 
on the whole been very effective in reducing the prevalence and incidence of the disease 
(Mahmoud et A 1983). Ilis approach was advanced further by the availability of the 
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drug praziquantel, which has few side-effects, is given as a single dose, is highly 
effective against all species of schistosome and is relatively cheap (W. H. O., 1985). 
Unfortunately, such treatment does not prevent the pathological damage caused to the 
host as a result of the presence of eggs, nor reinfection. Thus, many patients require 
treatment more than once, which increases the overall cost of chemotherapy and 
necessitates the presence of an organised screening programme. Additionally, there is the 
possibility, as with molluscicide treatment, that resistance to the chemical could evolve. 
A recent outbreak of schistosomiasis has occurred in Northern Senegal, five years after 
two dams were completed on the Senegal river (W. H. O., 1992). Stool examinations of 
over 400 people showed >90% to be infected, of whom 41% had over 1000 eggs per 
gram of faeces, indicating intense infection. This previously "schistosome-naive" 
population showed a very low cure rate of 18% after praziquantel treatment compared to 
the 70-85% normally expected. Additionally, the drug caused severe although transient 
side-cffects. Despite doubts that the results were due to praziquantcl resistance, there is 
cause for concern. 
For these and additional reasons, a single-shot vaccine would be a major step 
forward to relieve the suffering of many people who, without such treatment, will 
inevitably become infected with schistosomes. A vaccine, probably composed of 
recombinant protein(s) or synthetic peptides, presented in the appropriate manner should 
provide long-lived immunity, be cheap to manufacture and easy to transport and 
administer to people in endemic areas. Additionally, if given before natural exposure to 
the parasite, vaccination would have the added advantage over chemotherapy of 
preventing cgg-induced pathology and reinfection, thus negating the need for further 
treatment. To date, no live or dead vaccine has been able to induce 100% immunity in 
laboratory rodent or primate hosts. Although sterile immunity is a goal to aim for, unlike 
malarial infections, schistosomes do not multiply within the definitive host and so a 
vaccine which induced >50% resistance is likely to be of benefit. Since only the most 
heavily infected individuals develop hepatosplenornegaly, which can be fatal, a 
substantial decrease in the level of infection would limit the number of people in this 
category and dramatically reduce the mortality rate, as well as decreasing the level of 
transmission. 
Two other avenues of research arc being pursued to try to prevent infection, or limit 
the pathology associated with the disease. One approach is to design compounds which 
will inhibit the action of the cercarial penetration enzyme, which is essential for skin 
invasion and therefore initiation of infection. Hotcz et al. (1985) showed that dogs which 
were refractory to reinfection with another skin-invasive parasite, the hookworm, had 
high circulating titres of anti-elastasc antibody and suggested the use of the enzyme as a 
protective vaccine. In schistosomiasis research, McKerrow and colleagues (Pino-Heiss et 
al. 1986) showed that monoclonal antibodies directed against the ccrcarial clastasc could 
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kill transforming cercariae in vitro. Additionally, an inhibitor of the enzyme has been 
developed which, when applied to the surface of human skin inhibited cercarial invasion 
by 85% (Cohen et al. 1991). A different approach is to design an anti-fecundity vaccine 
which would act by reducing the number of eggs produced by adult female worms in an 
infected patient, and therefore decrease the level of pathology and transmission of the 
disease. The promising vaccine candidate glutathione S-transferase (Sm28GST; see 
section 1.9.4.1) not only protects various rodent and primate hosts through a reduction in 
worm burden but has also been shown to reduce female worm fecundity (Boulanger et al. 
1991; Xu et al. 1993). 
Additional research aimed at deciphering the complex interplay between the parasite 
and the host's immune system will undoubtedly yield more important information. Once 
understood, it may be possible to influence the outcome of infection, or at least limit the 
degree of pathology, by manipulating the immunological environment within the host. 
One way to achieve this could be through the addition or neutralisation of particular 
cytokines. 
Along with the large body of evidence for acquired human resistance to 
schistosomiasis (Butterworth & Hagan, 1987; Hagan et aL 1991; Hagan, 1993) and the 
major advances in recombinant DNA technology, differentiation of T cells into 
functionally discrete sets and sub-sets, identification of cytokines and their functions and 
advances in the presentation and delivery of antigens, a vaccine against schistosomiasis is 
looking more promising. 
1.4 Experimental models of schistosomiasis 
Various animal models are available for the study of schistosomiasis in the 
laboratory. The most widely used are rats and mice and, to a lesser extent Guinca-pigs 
and non-human primates. These animals differ in their ability to support or, perhaps 
more correctly, inability to reject, a primary infection. Each has features which are 
analogous to human scbistosomiasis. The chimpanzee develops disease most analogous 
to man and is the best model of pipestem fibrosis (Phillips et A 1977). Moreover, 
resistance is minimal and develops very slowly; additionally spontaneous cure does not 
occur. Rhesus monkeys develop more dramatic resistance than chimpanzees and also 
demonstrate spontaneous cure. Obvious logistic and ethical problems exist in studying 
these animals. The mouse is the most highly studied susceptible rodent host and displays 
many similarities to human schistosomiasis in that liver pathology occurs, spontaneous 
cure does not, and resistance develops slowly. Furthermore, the existence of a wide range 
of inbred strains of mice has allowed dissection of the immunological interplay between 
the parasite and the host. Recent technological breakthroughs have permitted the 
development of transgcnic (or knockout) mice in which a specific gene, for example one 
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which codes for a cytokine, can be made non-functional. This should allow further 
elucidation of the immune response to the parasite. 
Unlike mice, rats are semi-permissive hosts which, although susceptible to infection, 
manifest a spontaneous and dramatic reduction in worm burden approximately 28 days 
after initial exposure (Stircwalt, Kuntz & Evans, 1951; Smithers & Terry, 1964). The 
elucidation of this mechanism of parasite elimination is of interest and is being actively 
researched; however, the rat model of schistosomiasis is perhaps the least analogous to 
that in humans (Phillips et aL 1977). Despite these facts, extrapolations of results 
achieved in a single animal model to the human disease are made with care. It is likely 
that all model systems will provide important information which will help in the 
development of a protective vaccine. 
1.5 The normal infection in laboratory mice 
1.5.1 Migration and development 
Upon penetration of mouse skin, the cercarial tail is lost and the parasite commences 
its transformation into the next larval stage, the schistosomulum. The adaptations 
occurring at this stage include a change from cyanide-sensitive to cyanide-insensitive 
metabolism and intolerance to water. Parasites successfully penetrating the skin, reach the 
base of the epidermis within 30 min but then seem to be impeded by the epidermal 
basement membrane (Wilson & Lawson, 1980). On average, the skin phase of migration 
in the mouse takes approximately 88h (Miller & Wilson, 1978). During the first 3h post- 
transformation, membraneous vesicles pass from subtegumental cells to the tegument via 
cytoplasmic connections where they participate in the formation of the characteristic 
heptalamminate membrane of the schistosomulum (Hockley & McLaren, 1973). 
Additionally, the mid-body spines are progressively lost and have completely 
disappeared by day 3 post-transformation; this is thought to facilitate migration through 
the vascular system (Crabtree & Wilson, 1980). The loss of mid-body spines is 
accompanied by an increase in tegumental pits which are responsible for adding 
membrane to the surface of the schistosomulum (Hockley & McLaren, 1973; Wilson & 
Barnes, 1974) and result in an increase in surface area. The schistosomulum continues 
skin migration until it locates and penetrates a post-capillary venule in the dcrmis, a 
process which takes approximately 8h and may be facilitated by lytic secretions from the 
head gland (Crabtree & Wilson, 1985). Exit from the skin is not exclusively via the blood 
vessels, approximately 10-20% penetrate a lymphatic vessel (Miller & Wilson, 1978; 
Wheatcr & Wilson, 1979); this may be a chance event, simply reflecting the relative 
proportion of blood vessels to lymphatic vessels present in the dcrmis. 17his small 
percentage of parasites may have an important role to play in the induction of immunity 
in the irradiated ccrcaria vaccine model (see section 1.7.6). 
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The majority of parasites migrate in the direction of blood flow via the pulmonary 
artery to the lungs, the peak accumulation occurring at 6-7 days post-infection (Miller & 
Wilson, 1980; Mountford, Coulson & Wilson, 1988). There is a growth period of at least 
72h in the lungs, and an increase in maximum length to 4 times that of skin worms 
(Wilson et al. 1978) implying synthesis of tegument membranes, and a concomitant 
decrease in diameter. A new inclusion body is seen at the lung-stage, the homogeneous 
body which may provide a lubricant for the surface of the schistosomulum (Crabtree & 
Wilson, 1986a). These changes are believed to facilitate the migration of larvae along the 
narrow pulmonary capillaries. Parasites which successfully migrate through the lungs, 
leave via the pulmonary vein and pass via the left side of the heart to be distributed, in the 
same proportion as cardiac output, to the systemic organs of the body. Wilson & Coulson 
(1986) speculated that 3 circuits of parasites around the pulmonary-systemic vasculature 
was required to recruit the entire hepatic portal population, which reaches a plateau by 
day 21. The high nutrient content of the hepatic portal system, low blood pressure or 
oxygen tension may be the triggers for parasite shortening, which probably terminates 
any further migration (Wilson et al. 1978). However, trapping of schistosomula in the 
liver is not completely efficient, and in a previously uninfected mouse, an estimated 14- 
30% may return to the lungs (Wilson, Coulson & Dixon, 1986). 
Between days 28 and 35 after penetration, the parasites begin to pair and migrate up 
the hepatic vessels to the mesenteric veins where egg production commences 
approximately 5-6 weeks after infection (Warren & Peters, 1967). Some of the 
intravascularly released eggs fail to move on through tissues of the gut lumen. Tbcse ova 
arc then carried by portal blood flow and can become trapped in the liver. Soluble egg 
antigens (SEA), secreted by the miracidiurn within the cgg, induces aT ccll-mediated 
granulomatous inflammatory response eventually resulting in tissue fibrosis and 
disruption of the hepatic architecture. The intensity of the granulomatous response is 
maximal during the acute stage (8-10 weeks post-cxposurc) of infection, and is 
accompanied by a strong T-helper (rh) cell activity (Doughty & Phillips, 1982a; 1982b) 
manifested by proliferation and inflammatory cytokine production (Chensuc, Boros & 
David, 1980; Raghcb & Boros, 1989). As the infection progresses into the chronic stage 
(16-20 weeks post-cxposurc), the granulornatous response is spontaneously down- 
modulated resulting in diminished proliferation and cytokinc production by lymphocytes 
(Chcnsue et al. 1980; Raghcb & Boros, 1989). 
1.5.2 Maturation ofparasites 
Of the parasites which penetrate the skin of mice, between 50% and 70% fail to 
mature. Initial experiments, using techniques of tissue mincing and incubation to extract 
schistosomula suggested that the bulk of non-maturing parasites died in the skin soon 
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after penetration (Clegg & Smithers, 1968; Smithcrs & Gammage, 1980). Indeed, in 
some studies it was observed that an average of 30% of the schistosomula that could be 
recovered from the skin within 1h of penetration failed to exclude a dye, indicating that 
the parasites were not viable (Clegg & Smithers, 1968; Ghandour & Webbe, 1973). 
However, histological methods failed to detect significant numbers of dead or damaged 
schistosomula in this site (Stircwalt, 1959; Von Lichtenberg et al. 1976; Von 
Lichtenberg, Correa-Oliveira & Sher, 1985; Wheater & Wilson, 1979; Mastin, Bickle & 
Wilson, 1983). Additionally, 63% of parasites which penetrated the skin were detected in 
the lungs by quantitative histology 6-7 days after infection (Mastin et al. 1983). 
However, to determine the fate of non-maturing parasites, the techniques of mincing and 
incubation and quantitative histology have their disadvantages. The former suffers from 
the unknown efficiency of extraction (Miller & Wilson, 1978; 1980) whilst the latter is 
difficult to quantify, tedious and only a small number of samples can be processed 
(Wheater & Wilson, 1979; Mastin et al. 1983; Von Lichtenberg et al. 1985). Tlicse 
problems were overcome by the advent of the technique of compressed organ 
autoradiography (Georgi, 1982) in which isotopically labelled parasites can be tracked 
throughout the body of the host. This technique allowed essentially all of the organs of 
the mouse to be analysed and therefore did not suffer from the problem of lack of 
detection because of parasite migration to an unsampled organ. 
Autoradiographic tracking studies of labelled parasites detected up to 78% of skin 
penetrants in the lungs of mice on day 7 (Mangold & Dean, 1983) and 92% in the lungs 
of rats on day 5 (Knopf et al. 1986). Additionally, Wilson et al. (1986) demonstrated that 
by day 14 post-infcction, greater than 90% of parasites, detected in the skin on day 0, 
were present in other sites, although a small number lingered in the infection site as late 
as 35 days post-infection. Tbus, it appears that only a minority of parasites are eliminated 
at the skin-stage of migration. The high degree of accuracy achieved by Wilson et al. 
(1986), which allowed the detection of parasites with only a low level of associated 
radioactivity, enabled them to predict that a reduction of parasite number did not occur 
until day 14 post-infection. 
That the parasites experience difficulties in migrating through the pulmonary 
vasculature is suggested by the transit time through the lungs, which is considerably 
longer than through other organs (Wilson & Coulson, 1986). This inference was 
supported by ultrastructural studies (Crabtree & Wilson, 1986a) in which lung-stage 
parasites located in pulmonary capillaries were often seen to cause considerable 
distension of the vessels. From day 11 post-infection, it was found that an increasing 
proportion of schistosomula present in the lungs had been diverted into alveoli (Crabtree 
& Wilson, 1986b). Indeed by day 20,80% of parasites present in the lungs were detected 
in alveoli. Whilst no cellular reactions were observed around intravascular parasites, large 
foci consisting initially of 50% polymorphonuclear cells and 50% mononuclear cells 
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were observed around alveolar parasites. However, if removed from their position in the 
lungs by mincing and incubation on days 7,12 or 17 after infection and transferred to the 
hepatic portal system via the superior mcscntcric vein, schistosomula were equally 
capable of maturing, irrespective of age (Coulson & Wilson, 1988). This suggests that 
parasites were not damaged in a manner which affected their maturation. However, 7 day 
old schistosomula delivered via the trachea to the alveoli had a limited capacity to reentcr 
tissues and mature, since only 15% could be recovered by hepatic portal perfusion 
(Coulson & Wilson, 1988). Thus despite adaptive changes, it would appear that during 
parasite migration through the pulmonary capillaries, a large proportion of schistosomula 
rupture the narrow blood-air barrier and find themselves trapped in alveoli. From such a 
position, the majority of schistosomula, arc unable to reenter tissues and therefore will 
ultimately starve to death. Thus, these results do not support a direct cytotoxic 
mechanism of parasite elimination. 
1.6 77te concomitant immunity model 
Chronically infected mice are extremely resistant (up to 100%) to secondary 
cercarial challenge infection (reviewed by Dean, 1983). The elimination mechanism in 
such mice appears to be directed against the migrating larvae of the challenge infection, 
whilst the adult worms from the primary exposure remain unharmed. The term 
'concomitant immunity'was coined to describe this situation (Smithers & Terry, 1969). 
The immunological nature of this mechanism was supported by the fact that T cell- 
deficient mice failed to develop concomitant immunity (Doenhoff & Long, 1979). 
Additionally, a role for macrophagcs in the resistance of infected mice to a subsequent 
infection was postulated (James et al. 1983). Furthermore, a proportion of immunity 
could be passively transferred to naive animals with chronic mouse sera, although the 
degree of resistance achieved rarely exceeded 50% of the resistance attained by the serum 
donor animals (Sher, Smithers & Mackenzie, 1975). However, mice that had been 
partially. u-supprcsscd developed a degree of resistance to challenge infection 
comparable to that of intact mice (Maddison et al. 1981) suggesting no role for antibody- 
mediated effector mechanisms. 
Despite these results, the absolute role of the immune system in precipitating parasite 
attrition was called into question when it was found that the level of host resistance to a 
secondary challenge infection, correlated with the animal's pre-cxisting egg burden 
(Wilson, Coulson & McHugh, 1983 and reviewed by Wilson, 1990). Further evidence for 
the role of eggs in concomitant immunity was suggested by the failure of single-sex and 
mixed-sex infections, which were drug-terminated before oviposition, to induce 
immunity. It was found that when 7 day old schistosomula were injected into the hepatic 
portal vein of chronically infected mice, a significantly higher proportion could be 
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recovered from the lungs compared to uninfected control mice, suggesting a reduced 
trapping, or increased 'leakiness', in the liver. The chronically infected mice possessed 
well developed porto-caval anastomoses whereas the control mice did not. Ile greatly 
elevated leakiness of the liver in chronically infected mice caused many of the worms 
from the secondary infection to be redirected back to the circulation from which they 
could eventually reach the lungs. Since lung-stage schistosomula find this organ difficult 
to traverse, it is likely that the much larger liver worms would have a greater problem. 
Additionally, liver worms regain some mid-body spines which could cause further 
damage to the pulmonary capillaries. Taken together, these factors arc likely to cause 
diverted liver worms to burst into alveoli, from which they are unlikely to be able to 
escape. Immune responses may enhance the observed resistance in chronically infected 
mice, but it is difficult to dissect their importance compared to the non-specific effector 
mechanisms caused by the presence of eggs. Further evidence of this non-specificity 
comes from observations that mice with chronic infections are protected against a 
hcterologous challenge infection (Dean, 1983). 
1.7 The irradiated cercaria vaccine model 
One of the most promising breakthroughs towards the development of a vaccine 
against schistosomiasis occurred when Villella, Gomberg & Gould (1961) discovered 
that ccrcariae attenuated by gamma-irradiation, did not mature and hence produced no 
liver pathology, but were capable of inducing resistance in mice. Following this 
discovery, a series of experiments were performed to optimise the conditions required for 
the expression of resistance (Minard et aL 1978; Bickle et aL 1979a). Several other 
methods have been used to attenuate parasite migration and induce resistance in 
laboratory hosts. These include the use of chemicals (Bickle & Andrews, 1985) 
ultraviolet light (Dean, 1983) and X-rays (Hsu, Hsu & Burmeister, 1981). However, the 
use of gamma radiation is most widespread. 
1.7.1 Identification of the optimal conditionsfor the induction ofprotective immunity 
It was found that both the extent of migration and, the level of protection induced by 
attenuated larvae, were strongly influenced by the dose of radiation. Bickle, Dobinson & 
James (1979b) noted that while attenuation of cercariae with 2.3 krad. of radiation 
allowed a small number of intra-muscularly injected schistosomula to reach the liver, the 
majority of female worms were sterile. A dose of 2.3-10 krad. resulted in decreased 
worm recoveries from the lungs while 20 krad. caused a much reduced and 40 krad. a 
virtual absence of parasites in the lungs. Concomitantly, Bickle et aL (1979a) 
demonstrated that parasites irradiated with 20 krad. induced consistently greater levels of 
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protection (approximately 60%) than higher or lower doses of radiation. Conversely, in 
the U. S., a radiation dose of 50 krad. was found to induce the highest levels of resistance 
(Minard et A 1978; Mangold & Dean, 1984). This discrepancy was thought to reflect 
differences in parasite maintenance and/or irradiation conditions Qamcs & Dobinson, 
1985). However, a recent report by Reynolds & Harn (1992) compared 15- and 50- 
krad. doses of gamma radiation and found that the former induced higher levels of 
protective immunity. 
At York, the optimal iffacliation dose was found to be 20 krad. (Coulson, 
unpublished observations); this consistently induces between 60-70% resistance to a 
cercarial challenge infection. Mastin et A (1983) found that such optimal ly-attcnuated 
parasites migrated to the lungs, persisted for at least 2 weeks and considerable numbers of 
larvae died there. Thus, in the majority of cases, the highest level of resistance induced by 
a vaccinating infection correlates with the radiation dose which causes premature 
termination of parasite migration in the lungs. 
Optimal levels of protective immunity can be achieved with as few as 50 attenuated 
cercariae (Dean, 1983) and, there is no indication that resistance can be enhanced by 
increasing the numbers of vaccinating parasites above this dose (Minard et A 1978; 
Bickle et A 1979b). In the majority of cases, vaccine-induced resistance in mice appears 
to have a ceiling of approximately 70%. It is not known why the level of protection 
cannot be raised above this. It is possible that challenge parasites which arrive in the 
lungs and elongate more rapidly than other parasites, are able to negotiate the lungs 
before the effector mechanism has time to act. 
1.7.2 Effects of radiation on schistosomula and their ability to migrate 
Few studies which have analysed either directly or indirectly the effect irradiation 
has on the parasite, have noted any biochemical or morphological changes which could 
account for the ability to induce high levels of immunity. However, attenuated parasites 
were shown to migrate more slowly through the murine host. Mountford et aL (1988) 
demonstrated that by day 5 only 13% of applied parasites remained in the skin of mice 
infected with normal parasites while 43.4% were present in the skin of vaccinated mice. 
Normal parasites also migrated through the skin-draining lymph nodes more rapidly; less 
than 3% of applied parasites remained by day 7 compared with 10.4% of irradiated 
schistosomula. As mentioned previously, Mastin et aL (1983) showed that the migration 
of optimal ly-attenuated parasites was terminated in the lungs of vaccinated mice. 
Subsequently, an ultrastructural study on 20 krad. radiation-attenuated parasites fixed in 
situ in the lungs was performed (Mastin, Bickle & Wilson, 1985). It appeared that such 
parasites had undergone the normal developmental changes associated with the lung- 
stage of migration, including elongation of the body and loss of mid-body spines. No 
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evidence was found to suggest why migration was terminated in the lungs. 
Biochemical observations (Simpson et al. 1985) have demonstrated that the same set 
of antigens, identified by serum from mice vaccinated with irradiated cercariae, were 
present on the surface of both normal and attenuated 3h schistosomula. Thus, at this early 
stage of development, irradiation seemed to have no effect on the expression of antigenic 
parasite surface proteins. Additionally, Vieira et al. (1987) showed that there was no 
difference in the ability of newly-transformed or 24h old, normal or irradiated, live or 
fixed schistosomula to induce proliferation of peripheral blood mononuclear cells from 
patients with chronic intestinal schistosomiasis. Tbus, optimal levels of irradiation 
appears to have a subtle effect on the parasite, but one which can profoundly influence 
the induction of resistance. More recent studies have demonstrated some differences 
between normal and irradiated parasites. Wales et al. (1993) found that UN. irradiation 
caused a pronounced modification of carbohydrate antigens expressed at the surface of 
cercariae and newly-transformed schistosomula. This could result in enhanced exposure 
of parasite surface proteins to the host's immune system. Additionally, it was 
demonstrated that protein synthesis was inhibited relative to normal larvae in the first 24h 
after irradiation but nevertheless recovered by 7.2h (Wales, Kusel & Jones, 1992). 
Whether the same results would be obtained with gamma-irradiatcd parasites is not 
known. Furthermore, recent morphological observations of in vivo and in vitro-cultured 
schistosomula (Harrop & Wilson, 1993; see appendix one) provide an alternative 
explanation for the premature termination of migration by gamma-iffadiated parasites. 
1.7.3 The immunological nature of resistance 
Parasite attrition in the concomitant immunity model correlates with the host's pre- 
existing egg burden and crosses the species barrier. Conversely, there is much evidence to 
suggest that rc , sistancc 
in the irradiated cercaria vaccine model, which in most cases is 
only effective against homologous challenge (Cheever et aL 1983; Bickle et aL 1985), is 
the result of a specific immune response. For example, the immunity generated in 
vaccinated mice, but not those with chronic infections, was transferred to naive animals 
across a parabiotic union (Dean, Bukowski & Clark, 1981a) which suggested a role for 
circulating factors. Additionally, vaccination failed to protect congenitally athymic 
(nu/nu; nude) mice (Sher et aL 1982) whilst nude mice receiving thymus grafts became 
resistant. Although resistance was also abrogated by depletion of B cells with anti-It 
chain serum (Sher et aL 1982) this result was subsequently invalidated by the discovery 
that the ablation also suppressed T helper cell function (Kim et aL 1984). Further support 
for the importance of T cells in the expression of resistance came from the discovery that 
the P/N strain of mouse developed poor resistance to a challenge infection, despite 
normal antibody levels and isotypes Qames & Sher, 1983). Such mice were found to be 
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abnormal in their ability to activate macrophages due to a defect in T cell function which 
prevented the production of interferon gamma (IFNg; James et al. 1986). Subsequently, a 
pivotal role for IFNg, and therefore the Thl cells that produce it, was demonstrated by 
Smythies, Coulson & Wilson (1992). Administration of a monoclonal antibody to IFNg 
on days 4,8,12 and 16 post-challcnge gave an average 89.5% abrogation of protective 
immunity. This occurred in the presence of greatly elevated eosinophil levels suggesting 
no major role for these cells in this vaccine model. Indeed, it has been demonstrated 
previously that the ablation of eosinophils or strong depression of the IgE response, by 
treatment with monoclonal antibodies against IL-5 and IL-4 respectively, failed to 
influence the level of resistance attaincd (Sher et A 1990). The evidence suggests that 
the ability to reject a challenge infection correlates with the induction of a dclayed-type 
hypersensitivity (DTH) response. 
1.7.4 Immunological events accompanying vaccination 
1.7.4.1 Yhe skin and draining lymph nodes 
Following vaccination, 10-15% of attenuated larvae enter and persist in the skin- 
draining lymph nodes (inguinal and axillary) where they release substantial quantities of 
antigen (Mountford et al. 1988). The presence of antigenic material caused an increase in 
cell number which reached a peak on day 14 post-vaccination in the axillary lymph 
nodes, 13.5-fold higher than on day 0 (Constant, Mountford & Wilson, 1990). 
Additionally, the proportion of proliferating cells, determined by the incorporation of the 
thymidinc analogue 5-bromo-. 1-deoxyuridine (BrdUrd) into axillary lymph node cells 
and detection by flow cytometry, increased reaching a peak on day 14,3.4-fold higher 
than on day 0 (Constant & Wilson, 1992). Taking into account the elevated cell number, 
a 22.2-fold increase in BrdUrd" cells was detected on day 14 post-vaccination. The 
increase in cell number was accounted for by a significant change in both T- and 13- 
cells, the former usually being the most common but the latter showing a greater 
proportional increase (Constant et aL 1990). However, the proportion of B cells which 
proliferated in the axillary lymph nodes was much smaller compared to the proportion of 
T cells (Constant & Wilson, 1992). It was suggested by these authors that after 
vaccination, T cells leave the skin-draining lymph nodes to enter the circulation, whilst 
the majority of B cells arc retained. The reason for this retention has not been explained. 
However, it was postulated that B cells may have an important function in their role as 
antigcn-presenting cells (APQ in the lymph nodes. In fact, Janeway, Ron & Katz (1987) 
postulated that B lymphocytes are the main type of APC in peripheral lymph nodes. 
Furthermore, it was suggested that B cells preferentially present antigen to DTH- 
inducing cells (Bottomly & Jancway, 1989). 
T-helper (CD4") cells have been divided into two subsets which appear to be 
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phenotypically identical but differ in the profile of cytokines they secrete (Mosmarm & 
Coffman, 1989). Thl cells arc charactcrised by their production of the cytokines IL-2 
and IFNg whereas Th2 cells produce IL-4 and IL-5. The former mediates DTH, while 
only Th2 cells can act as helper cells for IgE production. Analysis of the cytokines 
produced by lymph node cells (Pemberton et al. 1991; Mountford et al. 1992) or spleen 
cells (Pearcc-et al. 1991; Caulada-Bcnedetti et al. 1991) of mice following vaccination 
with attenuated ccrcariae, was consistent with the prevalence of a Thl-type response. In 
comparison to a normal infection, vaccination caused a small increase in the number of 
cells in the skin- and lung-draining lymph nodes, yet the level of proliferation by both 
sets of lymph node cells was similar in both regimes (Pemberton et al. 1991). However, 
there was a substantial difference in the ability of lymph node cells from vaccinated mice 
to produce IFNg. It was calculated that on day 22 post-exposure, 24-fold more IFNg was 
produced per pair of axillary lymph nodes from mice receiving attenuated rather than 
normal parasites (Pemberton et al. 1991). This provides further evidence that the ability 
of Thl cells from mice to produce IFNg after parasite antigen stimulation may correlate 
with the subsequent expression of protective immunity. 
Following vaccination, schistosomc-specific T cells traffic from the lymph nodes to 
the circulation where they can be detected by their ability to induce DTH as measured by 
the footpad assay (Ratcliffe & Wilson, 1991). The maximum degree of swelling occurred 
on day 10 post-vaccination in response to live lung-stage schistosomula and on day 17 
to a soluble adult worm antigen preparation. This response could be completely abrogated 
by treatment of mice with an anti-CD4 antibody. 
1.7.4.2 Events in the lungs and their draining lymph node 
In an ultrastructural examination of the migration of attenuated parasites, Mastin et 
aL (1985) observed no host inflammatory reaction around schistosomula on day 7. By 
day 13, inflammation was noticeable but it was suggested that this was as a result of 
pulmonary tissue damage rather than the presence of parasites. Ile composition of cells, 
recruited to the lungs in response to the presence of vaccinating parasites, has been 
sampled by bronchoalveolar lavage (BAL). This provides cellular populations which 
reside in the respiratory airways but are free of contaminating leukocytcs from the blood 
or the intcrstitium, and thus allows characterisation of the cells present in the lungs during 
the induction and effector phases of immunity. In mice exposed to 500 normal or 
irradiated (20 krad. ) cercariac, no difference in the number of cells recovered by BAL 
was detectable at 2 weeks post-cxposure (Aitken, Coulson & Wilson, 1988). However, 
by week 5, the numbers of leukocytcs washed from the lungs of vaccinated mice was 
substantially greater than that from infected mice, and remained elevated beyond 10 
weeks post-exposure. The sustained response may correlate with the long-term nature of 
immunity in this model, which can persist undiminished beyond 15 weeks (Corrca- 
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Oliveira, Sher & James, 1984; Smith & Clegg, 1984). 
While infected mice showed a small but significant increase in the number of 
monocytes recovered by BAL at week 5, vaccinated mice showed a 5-fold increase in 
monocytcs and polymorphonuclear cells and a 15-fold increase in lymphocytes. Within 
this pool of lymphocytes, the percentage of CD41 (Th) cells did not differ significantly 
from the equivalent cell population of mice infected with normal parasites, however the 
absolute number did. Furthermore, it has been shown that a greater proportion of Th cells 
recovered from the airways responded more rapidly to mitogen stimulation by up- 
regulating the p55 subunit of the IL-2 receptor than did splenocytes from the same 
animal (Coulson & Wilson, 1993). This is indicative that many more previously- 
activated cells were present in the airways than the spleen. That this elevated proportion 
of sensitiscd cells was due to schistosome-spccific lymphocytes was demonstrated by 
their 4-fold higher response to schistosome antigen. The majority of Th cells expressed 
high levels of the surface markers CD44 and low levels of the B isoform, of CD45, 
compared to Th cells from the lymph nodes or the circulation, such phenotypes being 
characteristic of short-term effector/memory cells (Coulson & Wilson, 1993). 
Additionally, flow cytometric analysis of BAL cells recovered from vaccinated mice 
was used to quantify the proportion of macrophagcs displaying specific surface markers 
(Menson & Wilson, 1990). The proportion of la" macrophages increased 5-fold over 
days 14-28 post-vaccination whilst there was a sharp decrease in F4/80 expression 
between days 14-21. These phenotypic changes are characteristic of activated 
macrophages and coincide with the production of IFNg, which can activate macrophages, 
by Th cells in the mediastinal lymph node, which drains the lungs. 
Following the arrival of schistosomula in the lungs, small quantities of parasite- 
released material could be detected in the mediastinal lymph node, as judged by the 
presence of radio-labelled proteins after either infection or vaccination of mice with 
'Se-labelled parasites (Mountford et al. 1988). However, the method used in this study, 
only allowed detection of material that was synthesised and therefore labelled prior to 
cercarial transformation. By the lung-stage of development much of this labelled 
material has been lost. Therefore, this result is likely to provide an underestimate of the 
amount of parasite-derived protein present in the mediastinal lymph node. In response to 
this parasite material, changes in the cellular composition of the mediastinal lymph node 
could be observed (Constant et aL 1990). The peak percentage of BrdUrdI cells detected 
in the mediastinal lymph node occurred on day 14, with the greatest absolute number of 
proliferating cells occurring on day 21, a value 10.3-fold higher than from naive mice 
(Constant & Wilson, 1992). This enhanced level of proliferation persisted beyond day 35 
post-vaccination. 
Restimulation of mediastinal lymph node cells, recovered from vaccinated mice, in 
vitro with a soluble schistosomula preparation resulted in a peak of proliferation by 
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approximately 18 days post-exposure, while T-cell growth factor production peaked on 
day 18 and IFNg was first detected on day 15 and was still increasing by day 22 
(Pemberton et al. 1991). Mediastinal lymph node cells recovered from vaccinated mice 
showed a 3- to 6-fold increase in their ability to produce IFNg after in vitro 
restimulation compared to equivalent cells from infected mice. 
Both the increases in lymph node cell number (Constant et al. 1990) and degree of 
proliferation after rcstimulation in vitro (Lewis & Wilson, 1982a; Pemberton et al. 1991) 
reflected the kinetics of parasite migration. Thus, axillary lymph node cells, recovered 
from vaccinated mice, showed a peak responsiveness to a soluble schistosome antigen 
preparation on day 5 whereas schistosome-specific proliferation by cells from the 
mediastinal lymph node was not detected until at least day 10 post-vaccination. 
A significant increase in cell number was detected in the spleen only at days 14 and 
21 post-vaccination, the maximum at day 14 representing a 1.7-fold increase over day 0, 
thus indicating that vaccination with attenuated parasites causes marked localised rather 
than systemic responses. The limited splenic response is not surprising as no parasites 
and little of their released antigens were found in this site after vaccination (Mountford et 
al. 1988). 
1.7.5 Source of antigens and exposure time essentialfor the induction of immunity 
Since irradiated cercariae are capable of inducing consistently high levels of 
resistance to a challenge infection, it is pertinent to ask what is the nature of the 
immunogens responsible for immunity? It has proved extremely difficult to pinpoint both 
the stage of parasite and the relevant antigen(s), derived from such larvae, that are 
responsible for the induction of protective immunity. 
Antigens unique to the cercaria can be excluded, since it has been demonstrated that 
mice receiving an intra-dcrmal immunisation of 8 day old lung-stage schistosomula, 
derived from irradiated cercariae, were as resistant to a challenge infection as mice 
vaccinated percutancously with irradiated cercariae (Coulson & Mountford, 1989). 
Conversely, irradiated 3-4 week old schistosomula were much less effective inducers of 
resistance than skin- or lung-stage larvae (Dean, Cioli & Bukowski, 1981b; Sher & 
Benno, 1982). Ibis would seem to indicate that larval antigens expressed within the first 
1-2 weeks after penetration are crucial for the induction of protection. However, the 
latter experiments used 3-4 week old schistosomula irradiated at the time of recovery, 
rather than as cercariae. Since this may have altered their migratory potential and 
possibly their antigcnic profile, interpretation of the results is complicated. 
Certain schistosomulicidal drugs, which rapidly kill parasites in vivo, have been used 
to determine the period of contact between host and attenuated parasites required before 
resistance is induced against a subsequent challenge infection. Utilising this approach, 
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Bickle (1982) concluded that at least 1-2 weeks contact was required to elicit a protective 
response. Subsequently, a refined study (Bickle & Andrews 1985) using the drug R011- 
3128 showed that only when the drug was administered 8 days after vaccination, was the 
level of resistance relatively unaffected compared with vaccinated control animals. 
Additionally, by varying the time between vaccination and challenge, Ratcliffe & Wilson 
(1992) showed a gap of not more than 10 days was required to induce near optimal levels 
of resistance. However, it must be remembered that challenge elimination does not occur 
immediately and therefore the induction phase could be prolonged beyond day 10 post- 
vaccination. Ratcliffe & Wilson (1992) suggested that the protective mechanism 
operating in the lungs of vaccinated mice developed primarily between days 11 and 20. 
The surgical removal of the site of immunisation at times post-vaccination has also 
been used to assess the timing of the induction mechanism. Excision of the exposure site 
at 24h prevented the development of resistance, yet if delayed until day 7 or 14 partial 
immunity developed (Bickle, 1982). In a similar study, Mangold & Dean (1984) showed 
that removal of the tail exposure site on days 2 and 4 blocked the induction of resistance 
whereas excision on days 5 and 6 had less effect, and by day 8 resistance levels were 
comparable to vaccinated control mice. Between days 5 and 8, an increasing proportion 
of applied parasites would have migrated to post-skin sites, especially the lungs, 
suggesting that antigen presentation at, and/or cell recruitment to, such sites could be 
important to the induction process Alternatively, it was possible that the induction 
proccss was compIcte by day 8. 
1.7.6 Site requirements for the induction of immunity 
To investigate any site requirements for the induction of immunity, the vaccinating 
parasites can be delivered via various routes so as to by-pass an organ, or the organ 
(specifically lymph nodes) can simply be removed by surgery. These methods were used 
by various researchers to investigate any such requirements. Dean et aL (1981b) found 
little difference in the ability of day 6 schistosomula, irradiated at the time of recovery, to 
induce resistance when delivered intravenously, intra-muscularly or intra-pcritoneally. 
Nevertheless, percutaneous vaccination with irradiated ccrcariae, a proportion of which 
migrate through the skin-draining lymph nodes, was found to induce similar or higher 
levels of resistance. Coulson & Mountford (1989) found that intra-dermal administration 
of attenuated 3h or 8 day old schistosomula, a proportion of which migrate to the draining 
lymph nodes and lungs, induced high levels of protection comparable to pcrcutancous 
vaccination. Intermediate levels were elicited by delivery of parasites via intra-peritoneal 
or intra-tracheal routes, whilst intravenous injection yielded little or no resistance. The 
latter result was corroborated by a recent paper from the same group (Mountford et aL 
1992). Thus, the induction of optimal levels of resistance appears to require that some 
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attenuated parasites migrate to, and are sequestered in, lymph nodes draining the 
vaccination site. Since lymph nodes are potent sites for antigen processing and 
presentation, their importance is perhaps not surprising. 
Removal of the skin-draining lymph nodes provided more direct evidence of their 
role in the expression of resistance (Mountford & Wilson, 1990). Surgical excision of the 
axillary and inguinal lymph nodes, which drain the skin exposure site, five days prior to 
vaccination, reduced the level of resistance by two-thirds following challenge infection, 
compared to sham-operated controls. Since abrogation was not complete suggests that 
priming of schistosome-specific lymphocytes may also occur at other sites, for example 
in the mediastinal lymph node. Additionally, removal of the skin-draining lymph nodes 
on days 5,10,15 or 20 post-vaccination resulted in progressively smaller reductions in 
immunity. Presumably this is as a result of the removal of primed lymphocytes resident in 
the skin-draining lymph nodes. The later the excision time, the more cells will have left 
the node and entered the circulation from which they may be recruited to sites of 
antigenic challenge, for example the lungs. Removal of lymph nodes not draining the site 
of vaccination had no effect on the induction of resistance, indicating that a major 
fraction of the proliferative responses relevant to protection occurs in the lymph nodes 
draining the skin-exposure site. 
Nevertheless, the sensitisation of schistosome-specific T cells in the skin-draining 
lymph nodes may not be the only requirement for the induction of immunity, since 
parasites attenuated with 80 krad. radiation which fail to migrate beyond the skin but 
promote changes in lymph node cell number, fail to induce resistance (Constant et aL 
1990; Mountford et aL 1992). However, vaccination of mice with 80 krad. irradiated 
cercariae followed 8 days later by intravenous injection of attenuated lung-stagc 
schistosomula resulted in the recruitment of IFNg-secreting cells to the lungs and 
significant levels of resistance following challenge infection (Mountford et aL 1992). 
1.8 Challenge infection of vaccinated mice 
1.8.1 Immunological events accompanying challenge infection 
Exposure of vaccinated mice to a ccrcarial challenge provokes a classical anamncstic 
immune response in the skin-draining lymph nodes, which is both more rapid in 
appearance and of greater magnitude than following primary exposure (Correa-Olivcira 
et aL 1984). Similarly, an anamnestic response was noted in the lungs following 
challenge infection, as judged by increase in cell number (Aitken et aL 1988). Changes in 
macrophage phenotype were also observed, though these were slight compared to the 
responses detected after vaccination (Menson & Wilson, 1990). Aitken et aL (1988) 
observed a strong association between pulmonary leukocytic responses and the 
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elimination of challenge infections by vaccinated mice. However, in the same study, mice 
vaccinated with irradiated cercariae of Schistosoma mansoni and challenged with 
Schistosoma margrebowiei failed to show a pulmonary anamnestic response, and were 
not protected. Thus, it appeared that the population of cells sensitised by the vaccinating 
parasites failed to react to the antigens presented by a heterologous challenge. 
Despite the observed correlation between the occurrence of an anamnestic response 
and resulting protection, it has been shown that the effector mechanism operative against 
challenge schistosomula is radiation-resistant (Aitken et aL 1987; Vignali, Bickle & 
Taylor, 1988). Whole-body irradiation of vaccinated mice prior to challenge infection 
causes a dramatic decrease in the number of blood leukocytes but has no effect on the 
level of resistance induced, or the number of cells recoverable by BAL. Thus, it appears 
that the cells which are recruited to the lungs after vaccination are responsible for 
challenge parasite elimination, suggesting that further expansion of the cellular 
population as a result of the challenge infection is not required. 
1.8.2 Target and site of challenge elimination 
The parasite stage which is the target of immune elimination and the site at which it 
occurs, are in many respects intimately intcrlinked. However, experimental analysis of 
either has proved to be a controversial subject for many years. Investigations by some 
groups suggested early parasite death in the skin (Miller & Smithcrs, 1980; Hsu et al. 
1983; Kamiya, Smithers & McLaren, 1987; Li Hsu et A 1990), whereas, Mastin et al. 
(1983), using histologic techniques concluded that challenge schistosomula were 
eliminated during, or after their migration through the lungs. Since 1983, this finding has 
been corroborated by several workers (Dean et aL 1984; Von Lichtenberg et A 1985) 
despite the detection of intense eosinophil-enriched inflammatory responses in the skin 
of vaccinated and challenged micc. Thus, although immune responses do occur in the 
skin, their relevance to immunity in this vaccine model is questionable. Autoradiographic 
tracking of challenge parasites has confirmed that the bulk of elimination occurs in the 
lungs of mice vaccinated against the York isolate of Schistosoma mansoni (Wilson et aL 
1986). There is now overwhelming evidence to suggest that tKe "lung-stage" parasite is 
the major target of immune elimination. However, the site of lung-stage parasite attrition 
remains unresolved, being reported to occur either in the lungs or the skin (see Wilson & 
Coulson, 1989 or McLaren & Smitbers, 1988; McLarcn, 1989 respectively). 
Further support for the importance of post-skin sites in the elimination of parasites 
has come from passive transfer studies with various protective sera. Several groups have 
found that the highest level of protection was achieved when the serum was transferred at 
a time coincidental with parasite residence in the lungs of mice (Mangold & Dean 1986; 
and see section 4.3.6) or rats (Ford et A 1984). Furthermore, the ablation of IFNg, 
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described in section 1.7.3 provided additional evidence for the importance of post-skin 
sites. In this study, treatment was not started until day 4, by which time most parasites are 
en route to the lungs, yet resistance to a cercarial challenge was reduced by 89.5%. 
As far as parasite attrition is concerned, the lungs may represent a unique site for 
various reasons. Firstly, parasites obviously find this a difficult organ to migrate through, 
since a large percentage of schistosomula from a primary infection fail to migrate beyond 
the lungs (see section 1.5.2). Also, the adaptive changes required to facilitate migration 
through this site necessitates that the parasite is a stationary target for several days, which 
may allow the immune response time to act. Secondly, following vaccination, the lungs 
contain a reservoir of schistosome-specific cells, which have been said to arm the lungs 
against a subsequent challenge infection. Finally, if parasite killing is the result of a non- 
specific blocking mechanism (see section 1.8.3) rather than direct cytotoxic action, it is 
more likely to be effective in the lungs than for example the skin. Parasite migration 
through the lungs is essentially unidirectional, any obstacle which manifests itself in front 
of the migrating larvae can retard or prevent onward migration. Rupturing of the narrow 
blood vessel walls may result in diversion into alveoli which trap the parasite. Conversely 
in the skin, parasites can migrate in any direction and there is no trap such as that 
provided by the alveoli in the lungs. 
1.8.3 Role of cell-mediated mechanisms in challenge elimination ofparasites 
Two main mechanisms of cell-mcdiated elimination of challenge parasites have 
been proposed, which differ only in their specific mode of killing. Both rely on the 
recruitment of schistosomc-specific Th cells to the lungs of vaccinated mice and the 
formation of cellular foci rich in mononuclear cells, including Th cells, around challenge 
parasites. These responses are characteristic of a DTH mechanism. Wilson and colleagues 
believe that the vast majority of parasite attrition is the result of a non-specific blocking 
effect caused by the compact cellular foci which form around the challenge parasite. In 
contradiction to this hypothesis, the ablation of IFNg during challenge infection caused 
larger pulmonary foci around parasites compared to untreated mice, yet immunity was 
almost totally abrogated. However, the foci were less compact and of different cellular 
composition, containing increased numbers of eosinophils and multinucleated giant cells 
(Smythies et aL 1992). It was postulated that the looser foci were not capable of 
preventing parasite migration through the pulmonary vasculature, accounting for the 
observed abrogation of immunity. Furthermore, despite the presence of extensive cellular 
infiltrates in the lungs of vaccinated mice, ultrastructural studies detected no dead or 
obviously damaged schistosomula (Crabtree & Wilson, 1986b). Indeed, the recovery of 
parasites from the lungs on days 7,12 or 17 post-challenge, and their injection into the 
superior mesenteric vein resulted in an equal maturation rate irrespective of age. Many of 
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these parasites would not have matured if left in situ. This suggests that the parasites were 
not suffering any cytotoxic damage that would affect their ability to mature. 
Conversely, James and colleagues believe that macrophages recruited to the lungs 
following vaccination have a direct cytotoxic effect on the challenge larvae. Macrophages 
obtained from normal humans and activated with recombinant human IFNg (Cottrcl, Pye 
& Butterworth, 1989), or recovered from the peritoneal cavity of mice infected with 
Schistosoma mansoni (James et aL 1983), are very efficient effector cells in in vitro 
killing assays against newly-transformed schistosomula. The process can occur 
independently of antibody but is very slow; by 48h targetted parasites displayed massive 
internal disruption but the tegument remained intact. Ultrastructural studies of the 
interaction between macrophage and parasite in vitro showed contact to occur only 
transiently yet changes in the sub-tegumental mitochondria and muscle cells were 
observed (McLaren & James, 1985). Tbus, unlike granulocyte-mediated killing, 
macrophage-mediated cytotoxicity did not appear to be directed against the surface 
tissues of the parasite. The mechanism of macrophage killing is not clear. However, the 
macrophage cell line, IC-. 11 can kill schistosomula in vitro despite its inability to 
produce oxygen products associated with the respiratory burst (McLarcn & James, 1985). 
Thus it may be assumed that toxic oxygen radicals and/or H202 are not responsible for 
the manifestations of damage observed. Instead, the role of nitric oxides has been 
postulated, since treatment of macrophages with arginase, which inhibits nitrogen oxide 
(NO) synthesis, decreased in vitro killing of schistosomula. NO is thought to diffuse 
through the membrane and act on enzymes, probably in the mitochondria. 
By using a nonliving vaccine to induce substantial levels of resistance to reinfection 
(see section 1.9.1), James (1986) demonstrated that sensitisation for ccll-mediated 
immune responses, including lymphokine production and macrophage activation, 
correlated with induction of resistance to Schistosoma mansoni in this model. However, 
despite this correlation, using in vitro assays Pearce & James (1986) showed that 3h 
schistosomula and 2 and 3 week old worms were susceptible to macrophage-mediatcd 
killing yet 7-10 day old lung-stage larvae, the postulated targets of the effector 
mechanism, were not. It has been suggested that schistosomula which persist in the lungs 
for 2 weeks or more could become susceptible to direct cytotoxic killing. A situation can 
be envisaged in which parasites which are impeded by the cellular foci in the lungs and 
have not died from starvation in alveoli, become targets of direct cytotoxic mechanisms. 
1.8.4 Role of humoral mechanisms in challenge elimination ofparasites 
Many studies have described the ability of various sources of antibodies to kill 
schistosomula in vitro in combination with cosinophils, macrophagcs or platelets 
(reviewed by Capron et al. 1982); these have been termed antibody-dcpcndcnt cellular 
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cytotoxicity (ADCC) mechanisms. It appears that only young schistosomula are 
susceptible to this killing mechanism since later-stage parasites fail to bind antibodies to 
their surface. Various mechanisms were proposed to explain this, including the action of 
parasite proteases against bound immunoglobulins, rapid surface membrane turnover, the 
inert nature of the secreted outer bilayer of the tegument and the acquisition of host 
molecules to mask parasite proteins. The latter explanation is unlikely since parasites 
cultured in vitro in a defined medium also became refractory to the effector response 
(Dean, 1977; Samuelson, Sher & Caulfield, 1980; Desscin et al. 1981). 
An in vivo role for antibodies in parasite elimination was suggested by the ability of 
some sera to confer protective immunity upon passive transfer to naive recipients. 
However, despite singly-vaccinated mice being highly protected against a challenge 
infection, and serum (vaccinated mouse serum; VMS) from such mice being able to 
recognise parasite surface proteins (Simpson et al. 1985), the passive transfer of VMS to 
naive mice has failed to confer any protection (Bickle et al. 1985; Mangold & Dean, 
1986). Conversely, serum from multiply-vaccinated mice was capable of transferring a 
degree of resistance, although this was never as great as that shown by the donors 
(Mangold & Dean, 1986; Jwo & LoVerde, 1989). Multiple vaccination has been shown 
to predispose towards a Th2-type response compared with single vaccination which 
induces a 111-type response (Caulada-Benedetti et al. 1991). Thus, multiple vaccination 
is likely to result in both quantitative and qualitative differences in antibody titrc. Indeed, 
Dalton & Strand (1987) showed that while antibodies from VMS were directed against 
glycoproteins ranging in M, from >300 to < 10 kDa, antibodies from mice vaccinated 
twice were directed predominantly towards high M, glycoproteins. Such differences may 
account for the ability of multiply-vaccinated sera to transfer resistance. 
The failure of serum from singly-vaccinated mice to transfer resistance could be 
viewed as circumstantial evidence for the importance of cell-mediated immunity in this 
model. Unfortunately, adoptive transfers of lymphoid cells from vaccinated donors 
(Bickle et al. 1985) or of Thl cell clones (Pemberton et al. 1993) have failed to transfer 
resistance. There are various possible explanations for these failures. However, after 
prolonged culture in vitro, a Sm28GST-specific T cell line containing primarily Th cells 
secreting IFNg and IL-2, conferred approximately 50% protection to recipient mice 
(Wolowczuk et al. 1989). 
It is possible that two different effector mechanisms occur in singly- and in 
multiply- vaccinated mice, a DTH response predominantly in the former and an 
antibody-mediated response in the latter. Supportive evidence for such ideas has been 
provided by CD41 T cell depletion experiments. As mentioned previously, depletion of 
this T cell sub-set can reduce immunity in singly-vaccinated mice by up to 100%. 
However, in multiply- vaccinated mice one study demonstrated that resistance was 
unaffected following CD4* T cell depletion (Kelly & Colley, 1988) whilst another 
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(Vignali et A 1989), reported up to 70% abrogation of resistance. 
1.8.5 A summary of the induction and effector phases of immunity, and implications for 
the nature of the relevant antigens 
Optimally-attcnuated parasites perform two key roles which facilitates their ability 
to induce protective immunity. Firstly, through their persistence in the skin-draining 
lymph nodes, a site of active antigen processing and presentation, they release 
proportionally greater amounts of material than normal parasites and stimulate a 
preferential proliferation of T lymphocytes. Secondly, their migration to, and eventual 
death in, the lungs recruits a population of schistosome-spccific T cells which arms this 
organ against a subsequent challenge infection. 
When normal schistosomula of a challenge infection reach the lungs of vaccinated 
mice, they provoke focal inflammatory responses rich in mononuclear cells, including 
CD4" T cells characteristic of DTH. The inflammation appears to function by blocking 
the migration of challenge parasites and, IFNg plays a key role via its capacity to act as 
an inflammatory cytokinc. 
The antigens involved in the induction phase of immunity which promote expansion 
of the T cell population are likely to be released from the viable vaccinating parasite, 
although it is possible that dead or dying schistosomula also prime immune cells. 
However, since the pulmonary effector mechanism in singly-vaccinatcd mice is T cell- 
mediated, it must be triggered by antigen(s) released from intact challenge schistosomula 
during the course of their migration. The released antigen(s) must then be processed by 
accessory cells and presented in association with MHC class II to the pulmonary T cells 
to initiate formation of an effector focus. 
1.9 Identification of candidate vaccine antigens 
Although live attenuated parasites consistently induce high levels of resistance against 
a ccrcarial challenge infection in micc, rats and primates, their use as a vaccine in humans 
is considered to be too risky for several reasons. Firstly, it would be essential that each 
vaccinating parasite was irradiated to such a degree as to prevent egg production. Failure 
to achieve this with essentially 100% of the parasites could lead to infection rather than 
immunisation. Secondly, there arc recurring reports of an association of spinal cord 
complications associated with acute schistosomiasis (Neves et aL 1973). For these and 
additional reasons, attempts have been made to induce resistance by using non-living 
parasite preparations. 
In the search for a vaccine against schistosomiasis, a vast number of antigens have 
been described and to list them all would be beyond the scope of this thesis. Therefore, I 
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shall try to concentrate on antigens which have received most attention. Initially, crude 
mixtures of parasite antigens from various stages of the life-cycle were tested for their 
ability to induce resistance, with moderate success. More recently, as research has 
progressed, defined antigens which have been cloned and sequenced have been used; 
these will be described later in section 1.9.4. 
1.9.1 Induction of resistance by complex non -living parasite preparations 
One of the highest protection results achieved with a crude antigen preparation 
utilised a cercarial sonicate (Horowitz, Smolarsky & Amon, 1982). Small quantities of 
this complex antigen preparation (0.2, ug - 2. Opg) adsorbed on alum were able to induce 
between 34% and 91% protection in mice against a subsequent challenge infection. The 
choice of mouse strain, adjuvant and immunisation protocol (two boosts on days 28 and 
70 post-primary immunisation) were chosen to yield high specific IgE levels, a hallmark 
of infection by helminth parasites. IgE has been postulated to play a role in resistance to 
schistosomiasis, although depletion of IgE appeared to have no effect on the level of 
immunity in the irradiated cercaria vaccine model (Sher et A 1990). The use of complete 
Freund's adjuvant instead of alum produced a higher titrc of total anti-ccrcarial 
antibodies but low levels of anti-parasite IgE and provided no significant protection to 
the mice. In contrast to this encouraging result, immunisation of mice with a cercarial 
glycocalyx preparation actually caused a significant increase in the adult worm burden 
recovered after challenge infection (Ham, Cianci & Caulfield, 1989). 
James and colleagues developed a vaccination regime specifically aimed at 
stimulating the cellular arm of the immune response. Either freezc-thawed larvae or 
soluble parasite preparations in combination with the adjuvant BCG injected intra- 
dermally into mice resulted in significant levels of protection, with a mean of 51% after a 
single immunisation (James, 1985). This has probably become the most consistent 
method for inducing significant levels of resistance using a non-living vaccine. Further 
characterisation of the immune response following this vaccination regime led to the 
identification of the protein paramyosin as an important inducer of the effector response 
(see section 1.9.4). 
1.9.2 Parasite surface proteins 
Since the tegument is in direct contact with the potentially hostile environment of the 
host, antigens expressed on the surface of the parasite have been extensively studied. 
Furthermore, many immune responses act at the surface of pathogens via antibodies. 
These include ADCC mechanisms which have been implicated in parasite killing. Thus, 
much time has been invested in the characterisation of tegumental proteins. Two major 
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approaches have been taken to analyse such proteins. One method involves the labelling 
of surface molecules using extrinsic non-pcrmeant probes, followed by membrane 
isolation, gel electrophoresis and autoradiography. The immunogenicity of such labelled 
surface proteins can be assessed by immunoprecipitation with various sera from 
vaccinated or infected hosts. In the second approach, the target antigens of monoclonal or 
polyclonal antibodies which bind to the parasite surface have been identified by 
immunoprccipitation, affinity chromatography or Western blotting. 
The two main surface labelling techniques which have been used by researchers are 
the lactoperoxidasc (Dissous, Dissous & Capron, 1981) and the lodogen methods (Knight 
et aL 1984). Both techniques demonstrated that 6 major polypcptidc surface antigens of 
Schistosoma mansoni could be precipitated by human or animal infection sera. These 
were of M, 92,38,32,20,17 and 15 kDa (Simpson & Smithers, 1985; Payares et aL 
1985). However, many more surface proteins have been described. Wilson (1987) 
compiled a table of 17 proteins which are expressed on the surface of 3h schistosomula 
and have been reported more than once in the literature. Such proteins ranged in M. from 
>150 to <20 kDa. Taylor & Wells (1984) detected at least 35 labelled surface 
polypeptides of schistosomula after 2-D SDS-PAGE. Of these, not all were precipitated 
by a pool of human infection serum, and there was a marked heterogeneity in the 
antibody response of infected individuals to the tegument preparation. Additionally, 2-D 
SDS-PAGE of 1211-labelled surface proteins resolved 23 polypeptides of which 14 could 
be immunoprecipitated by either chronic mouse serum or vaccinated mouse serum. 
Proteins of M. 32-38 kDa and 20 kDa could be precipitated by either sera (Kelly et aL 
1985). Thus, the schistosomulum appears to display a diverse range of surface proteins, 
which is unusual for a parasite which is in direct contact with an immunologically hostile 
environment. 
Evidence that schistosomula surface antigens play a role in immunity is provided by 
a number of studies which have shown that monoclonal antibodies which rccognise such 
antigens can often be used to transfer passive immunity. Grzych et aL (1982) produced a 
rat monoclonal IgG2a antibody which transferred significant levels of immunity to rats 
(53-61"lo) and which immunoprecipitated surface antigens of M, 200 and 38 kDa. Zodda 
& Phillips (1982) described a mouse monoclonal antibody which conferred 48% 
resistance to mice and recognised two proteins of M, 160 and 130 kDa. More recently, 
the antibody was shown to bind to schistosomulum surface antigens of 200,38,17 kDa 
and weakly to the 20 kDa antigen (Kelly et aL 1986). This poly-specific recognition was 
due to the presence of a common carbohydrate cpitopc. Ham et aL (1985) produced a 
protective monoclonal antibody following immunisation of mice with membrane- 
enriched extracts of mechanical ly-transformed schistosomula, which later lead to the 
identification of the vaccine candidate triose-phosphate isomcrase (see section 1.9.4). 
Bickle, Andrews & Taylor (1986) identified two monoclonal antibodies against surface 
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antigens present on schistosomula which reacted with proteins of 32 kDa and 16 kDa and 
which conferred significant protection to mice of between 28-70% and 14-58%, 
respectively. Furthermore, Smith & Clegg (1985) used two surface antigens of M, 155 
and 53 kDa, isolated from young or adult schistosomes, to vaccinate mice. Following 
challenge infection small yet statistically significant reductions in mean worm burdens 
were observed compared to challenge control mice. Such results would seem to suggest 
that this line of research is valid. Indeed, most of the promising vaccine candidates 
described in section 1.9.4 have been shown to be expressed, at least transiently, on the 
surface of the parasite. 
1.9.3 Parasite released proteins 
Released (i. e. secreted, excreted or shed) proteins of Schistosoma mansoni have 
received most attention for their potential as immunodiagnostic markers of infection, 
rather than vaccine candidates. In this respect, the majority of work has focused on 
proteins released by adult worms, since antigens of the adult worm digestive tract are 
recognised by the immune system of the host early after infection. Five proteins 
associated with the worm gut have been identified, some or all are thought to be 
components of the mucin-like layer shielding the gastrodcrmal syncitiurn from low pH 
and immune attack (Chappel et aL 1990). Of these antigens, two have reccived most 
attention, circulating cathodic antigen (CCA) and circulating anodic antigen (CAA). Both 
show a large molecular weight range of approximately 50 kDa to >300 kDa and partition 
in the TCA soluble fraction of adult worms (Declder et aL 1980). Their presence could be 
demonstrated in the vomitus and excretory/secretory antigens of adult worms. Using an 
IgG1 monoclonal antibody against CAA in a sandwich ELISA, the level of antigen in 
serum of infected patients was found to correlate with faccal egg output (DecIder et al. 
1989). Additionally, the lower detection level corresponded to approximately 10 eggs per 
gram of facces. Thus, such antigens are proving valuable in immunodiagnosis of 
schistosomiasis. 
Much less attention has focused on released proteins, of surface or other origin, as 
potential vaccine candidates. Of the few studies which have taken this approach, 
vaccination of mice with proteins released by parasites during in vitro culture has met 
with limited success. Muffel & Clay (1972) used a complex multiple vaccination regime 
to deliver proteins released by adult worms, and achieved 40% resistance. However, the 
culture conditions are unlikely to have been satisfactory for normal parasite maintenance 
and therefore the released proteins may have been contaminated with a large proportion 
of somatic proteins. Conversely, no protection was achieved by immunising mice with 
secretions derived from ccrcariae (Minard, Murrel & Stirewalt, 1977). 
However, studies from Capron's group on proteins released from newly-transformed 
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schistosomula during 16h of in vitro culture were more promising. Rat IgE directed 
against such schistosomula-relcased proteins (SRP) were cytotoxic for larvae in vitro in 
the presence of macrophages, eosinophils or platelets (Auriault et aL 1984a) and 
recognised two surface proteins of Mr 26 and'212 kDa. Additionally, a large number of 
SRP with a wide M. range was recogniscd by infected rat and human sera (Verwacrde et 
aL 1985). IgG antibodies obtained by immunisation of rats with SRP reacted with 3 
major schistosomula surface proteins of M. 38,32 and 21 kDa. These antibodies 
facilitated killing of schistosomula in vitro in the presence of complement or eosinophils. 
Active immunisation of rats with SRP achieved between 46% and 83% resistance, whilst 
passive transfer of anti-SRP antisera conferred up to 83% protection (Damonnevillc et 
aL 1986). An important role for IgE in parasite attrition was suggested by the significant 
reduction in immunity following IgE depletion of the antiscrum. Subsequently, the 26 
kDa antigen was found to be the main target of the cytotoxic IgE response. Additionally, 
T cell lines specific for SRP passively transferred to naive rats induced an increase in the 
IgE response and conferred 46-66% resistance to a challenge infection (Damonneville et 
aL 1987). 
1.9.4 Vaccine candidates 
In 1991, a World Health Organisation report stated that a limited number of vaccine 
candidates bad reached the stage at which development, with the objective of trials in 
humans, might be considered. These included glutathionc S-transferasc, paramyosin and 
triosc-pbosphatc isomcrase. It was noted that many additional proteins of potential utility 
had been described but were not as well defined as the aforementioned antigens. Table 
1.1 lists some of the protection data achieved with these and other promising vaccine 
candidates. 
1.9.4.1 Glutathione S-transferase (SM28GST) 
In terms of vaccine production, glutathione S-transferase (Sm28GST) is the most 
advanced, since it has been cloned, sequenced, crystallised and tested for protective 
immunity in various animal models. This antigen was first described by Balloul et aL 
(1985). Constituents of adult worms were fractionated by SDS-PAGE, and proteins 
electroeluted from the gel used to immunise Fischer rats. Three antisera were obtained, 
one of which recognised a 28 kDa protein. This antigen could be detected among the in 
vitro translation products from adult worm mRNA and among 1211 surface antigens of 
schistosomula. Furthermore, the antiserum could mediate antibody-dependent cellular 
cytotoxicity (ADCQ of schistosomula in vitro in the presence of cosinophils. By 1987, 
active immunisation of Fischer rats or BALB/c mice with the purified antigen resulted in 
significant levels of resistance (Balloul et aL 1987a). Additionally, antiserum raised 
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against this antigen conferred passive protection upon recipient rats. In the same year the 
anti-28 kDa antiscrum was used to screen an adult worm cDNA library. A positive clone 
was purified to homogeneity and found to code for a 25 kDa recombinant protein 
(Balloul et at. 1987b). Serum from rats immuniscd with this fusion protein was capable 
of inducing up to 80% cytotoxicity of schistosomula in an in vitro ADCC assay in the 
presence of normal rat eosinophils. This cytotoxicity could be reduced to 35% by heat- 
inactivation or IgE depletion. 
Subsequently, the recombinant protein was found to possess glutathione 
S-transferase activity (Taylor et aL 1988). This enzyme is ubiquitous amongst eukaryotic 
organisms and performs a series of reactions which are essential in protecting cell 
constituents from oxidative attack by oxygen and oxygen-free radicals. The enzyme was 
found to be present in the tegument, protonephridial and subtegumental cells. 
Additionally, no significant immunological cross-reactivity between parasite and human 
and rat GST was observed, an important consideration for vaccine development. 
T cells from mice immunised with recombinant Sm28GST (rSm28GST) proliferated 
in response to schistosomc antigens from different developmental parasite stages, and to 
3 rSm28GST-derived synthetic peptides, of which the most significant response occurred 
to amino acid residues 24-43 (Wolowczuk et aL 1989). Sm28GST specific Th cell lines 
maintained in culture for two months and containing predominantly IL-2 and IFNg 
secreting cells (Thl), passively transferred 50% protection to mice. Subsequently, a 
peptide (115-13 1) derived from Sm28GST was shown to have both T and B cell epitopcs 
and, when delivered as an octameric construction in conjunction with CIA, resulted in 
40-50% protection in rats (Wolowczuk et aL 1991). Immunisation of baboons with 
rSm28GST in alum resulted in a significant but very variable level of protection 
(Boulanger et aL 1991). In addition to the decrease of worm burden, immunisation could 
reduce female worm fecundity by 33% and faecal egg output by 66%. 
A monoclonal antibody raised against Sm. 28GST and which inhibited its enzymatic 
activity was shown to recognise the carboxyl terminal amino acids 190-211 and to a 
lesser extent the amino terminus residual 10-43. Active immunisation of mice with 
amino acid residues 190-211 decreased the worm burden and also tissue egg deposition 
and egg hatching. It was postulated that by using both the amino acid residues 115-131 
and the N- and C-terminal peptides, a peptidic construction could be produced which 
decreased both worm burden and female worm fecundity (Xu et aL 1993). Recently, 
vaccination of Zebu cattle with Schistosoma bovis GST was shown to have a small effect 
on the worm burden following challenge infection, but decreased faccal egg counts by 
56-82% (Bushara et aL 1993). 
1.9.4.2 Paramyosin (SM97) 
In 1986, Pearce et aL reported that mice protected against a challenge infection by 
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intra-dermal vaccination with a nonliving antigen preparation in conjunction with BCG, 
produced antibodies against a single antigen of 97 kDa present in soluble adult worm 
preparations. Hybridomas, prepared from such mice, produced antibodies which 
recognised the 97 kDa protein on Western blots. Furthermore, the antibodies bound to 
regions just below the tegumental and gut syncitia on transverse sections of adult worms. 
The purified antigen could elicit DTH in intra-dermally vaccinated mice indicating that it 
was also capable of evoking cell-mediated responses. Subsequently, antibodies were 
used to isolate a clone from an adult worm lambda gt11 cDNA library. Following 
purification and sequence analysis, the protein was found to have homology to 
paramyosin, a myofibrillar muscle protein (Lanar et A 1986). 
The internal location of this protein made it distinct from other vaccine candidates 
which are expressed, at least transiently, on the surface of the parasite. As such, this 
protein would not be available for direct attack by antibodies. It was postulated that the 
ccll-mediated response could be stimulated by Sm97 molecules released from parasites 
as a consequence of normal protein metabolism. Subsequently, when administered at 4- 
40, ug per mouse, both the native molecule and a recombinant expression product 
conferred resistance against a challenge infection (Pearce et aL 1988). Additionally, 
lymphocytes recovered from mice vaccinated with Sm97 produced IFNg in response to 
living schistosomula suggesting that this protein is released from live parasites. 
1.9.4.3 Triose -phosphate isomerase 
This protein was defined following the preparation of monoclonal antibodies from 
mice vaccinated with detergent extracts of living mcchanically-transformcd 
schistosomula (Ham et aL 1985). The monoclonal antibody M. 1 was found to recognise a 
28 kDa antigen in all stages of the parasite, and transiently bound to the surface of 
newly-transformed schistosomula, therefore it was tested for its ability to transfer 
resistance to mice. When administered intra-peritoneally 3-4h prior to challenge 
infection, the monoclonal antibody conferred 41-49% protection to mice (Ham et aL 
1992). By immunofluorescence on transverse sections of adult worms, the antigen was 
found in all cells. Amino terminus sequences of tryptic peptidcs of the 28 kDa. antigen 
had high (79-87%) sequence homology with the mammalian glycolytic/gluconcogenic 
enzyme triose-phosphate isomerase. Subsequently, the complete coding DNA for 
Schistosoma mansoni TPI was isolated (Shoemaker et aL 1992) and confirmed that this 
cDNA encoded the 28 kDa antigen Tecognised by the monoclonal antibody M. 1. The 
purified native enzyme was shown to function enzymatically in a manner similar to yeast 
and mammalian TPI. Addition of the monoclonal antibody to the reaction altered the 
catalytic activity of the schistosome TPI. The monoclonal antibody M. 1 was found to be 
immunologically specific for the schistosomc enzyme. 
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1.9.4.4 Glyceraldehyde 3-phosphate dehydrogenase (G3PDH) 
In a hyper-endcmic area for Schistosoma mansoni in Brazil, the ability of 
adolescents to resist reinfection, following parasitologic cure with oxamniquine, was 
assessed. Subsequently, the subjects were grouped into those with either a low or high 
susceptibility to reinfection. The ability of the most resistant group to specifically detect 
any parasite antigen was determined (Desscin et A 1988). It was found that IgG 
antibodies from those subjects with a low susceptibility to reinfection preferentially 
reacted with a 37 kDa larval surface antigen. Subsequently, this 37 kDa antigen was 
cloned and the encoded polypeptide found to have a high amino acid sequence homology 
with chicken and human G3PDH (Goudot-Crozel et aL 1989). This protein is highly 
conserved, therefore regions of low conservation need to be identified for use as a 
vaccine in humans. 
1.9.4.5 Other vaccine candidates 
Strand and colleagues identified potentially protective antigens by comparing the 
recognition of proteins by sera from protectively vaccinated mice to that of patently- 
infected mice (Strand, Dalton & Tom, 1987). Sera from mice vaccinated with irradiated 
cercariae recogniscd antigens present in schistosomula and adult worms, among them, an 
antigen of 200 kDa. A cDNA clone encoding a 62 kDa protein of this antigen was 
sequenced and found to have homology with myosins of other species (Amory Soisson et 
al. 1992). The recombinant protein presented to mice in the form of proteosome 
complexes, with or without the outer membrane protein of meningococcus, resulted in 
impressive levels of protection. 
A further protective glycoprotein antigen of 68 kDa was isolated from adult worms 
by immunoaffinity chromatography using a protective monoclonal antibody. 
Immunisation of mice with this antigen induced 30-66% resistance against a challenge 
infection without the use of adjuvant (King et aL 1987). Additionally, in a group of 
chronically infected Egyptian patients, the antibody response to this antigen showed a 
significant negative correlation with intensity of infection (King et aL 1989). 
Subsequently, a monoclonal antibody against this protein conferred partial protection to 
mice (Blanton et aL 1991) and, by immunoelcctron microscopy, was found to bind within 
the head and preacctabular glands of cercariae and schistosomula. In adult worms the 
protein was found to be widely distributed, being most visible in the gut and tegument. 
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1.10 Aims ofthis study 
From the preceding introduction, it should be clear that T cells play a pivotal role in 
the expression of resistance in mice vaccinated with irradiated ccrcariae of Schistosoma 
mansoni. Since the pulmonary effector mechanism is T cell-mediatcd, it must be 
triggered by antigcn(s) released from intact challenge schistosomula during the course of 
their normal biological activities in order to initiate an effector focus. The released 
antigen(s) must be processed by accessory cells before presentation, in association with 
MHC class II, to the pulmonary T cells. Thus, parasite-released proteins are a source of 
potential vaccine candidates. 
A large body of information is available about tcgumental proteins of schistosomula 
and adult worms. Conversely, much less is known about proteins released by 
Schistosoma mansoni during maturation in the mammalian host. Although proteins 
released by newly-transformed schistosomula have been described previously, most 
work examined the secreted proteases, which facilitate skin penetration by ccrcariae, to 
the exclusion of other proteins. No study has analysed the proteins released by 
schistosomula up to the lung-stage of development. It is during this period that the 
induction and effector mechanisms of immunity occur in the irradiated cercaria vaccine 
model. Therefore, the main aim of this study was to characterise such released proteins. 
Initial work, prior to that described in chapter two, led to the development of a 
suitable culture system which supported parasite development to the lung-stage and, 
maintained a high level of viability. Once this was achieved, several biochemical 
parameters of parasite metabolism were measured. The biosynthctic labelling of parasites 
either prior to or post-cercarial transformation, facilitated analysis of the kinetics of 
protein synthesis and loss during in vitro culture. Additionally, the proteins released into 
the culture medium over a period of 7 days were characterised following SDS-PAGE 
plus autoradiography. 
Chapter three describes an in vitro T cell blastogenesis assay which was used to 
assess the ability of such schistosomula-rclcased proteins to induce a proliferative 
response by lymph node cells recovered from vaccinated mice. A comparative analysis 
was carried out in which the proliferative responses induced by soluble, particulate and 
released proteins of Schistosoma mansoni and by live schistosomula were tested. It was 
hoped that such a study would provide an indication of the potency of released proteins as 
T cell immunogens, and hence their potential as vaccine candidates. 
Chapter 4 describes the production of two sera, 0-3hS and D4-D8S, raised in rabbits 
against proteins released by schistosomula during the first 3h and between day 4 and day 
8 post-transformation respectively. The D4-D8S was produced primarily to screen a 
cDNA library. However, both sera were tested for their ability to transfer passive 
protection to mice and were also used to identify antigenic moieties in various protein 
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fractions of Schistosoma mansoni. 
The final aim of the project was to characterise further the proteins released by lung- 
stage schistosomula. Since only tiny quantities of such molecules are available, chapter 5 
describes the generation and screening of a cDNA library with the D4-D8S. Tbc 
identification of recombinant proteins and, initial steps taken towards their 
characterisation are described. 
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SUMMARY 
The lung schistosomulum of Schistosoma mansoni is the target of protective immunity in mice singly vaccinated with 
irradiated cercariae. Since the effector responses are T cell-mediated, their initiation requires the release of antigens from 
the intact parasite. We have used the technique of biosynthetic labelling with ["S]methionine, before and after trans- 
formation of the cercariae, to analyse the kinetics of protein synthesis and release by the schistosomulum. In addition, the 
proteins present in the soluble fraction of the parasite and those released during in vitro culture have been characterized. 
During a 7-day culture period schistosomula derived from labelled cercariae lost proteins most rapidly within the first 3h 
after transformation. Two proteins of molecular weight 61 and 20 kDa were dominant and may correspond to areas of 
proteolytic activity. Analysis of the rate of protein synthesis of schistosomula labelled after transformation revealed four 
different phases, which may relate to the developmental processes occurring in vivo. During the first 24 h, synthesis was 
very low, increasing to a plateau and then rising to a peak at day 8; thereafter the rate declined rapidly. Whilst some stage- 
specific synthesis of proteins was detected in the soluble fractions of the parasite bodies, the pattern of proteins released 
by cultured larvae was remarkably uniform. At least IS proteins were detected by autoradiography with bands at 61,45 
and 20 kDa being particularly prominent. These proteins merit further study as potential mediators of the protective 
immune response. 
Key words: Schistosoma mansoni, protein synthesis, schistosomulum, protective immune response. 
INTRODUCTION 
Vaccination of C57131/6 mice with optimally irradi- 
ated cercariae of Schistosoma mansoni remains the 
most consistent method of inducing a high level of 
protective immunity. However, it is still not com- 
pletely understood why this vaccination regime is so 
successful. Irradiated larvae persist in the skin and 
draining lymph nodes for longer than their normal 
counterparts, and migrate no further than the lungs 
where they die (Mangold & Dean, 1984; Mountford, 
Coulson & Wilson, 1988). Priming of schistosome- 
specific lymphocytes with Thl characteristics takes 
place in the skin-draining lymph nodes (Pemberton 
et al. 1991; Mountford et al. 1992). The recruitment 
of these cells to the lungs, in response to the arrival 
and sequestration of vaccinating parasites, is thought 
to be an essential feature of immunity in this model 
(Wilson & Coulson, 1989; Mountford et al. 1992). 
It has proved difficult to pinpoint the precise 
developmental stage of the parasite which induces 
protective immunity. When irradiated day 8 lung 
schistosomula are administered intradermally, they 
prove to be at least as immunogenic as irradiated 
cercariae (Coulson & Mountford, 1989), implying 
that secretions unique to the latter are not the 
relevant immunogens. Conversely, irradiated 3 to 4- 
week-old schistosomula are much less effective than 
skin- or lung-stage larvae (Dean, Cioli & Bukowski, 
1981; Sher & Benno, 1982). These observations 
indicate that larval antigens expressed within the 
first 1-2 weeks after penetration are crucial for the 
induction of protection. This conclusion is sup- 
ported by experiments in which the time of excision 
of skin-exposure sites or draining lymph nodes was 
varied (Mangold & Dean, 1984; Mountford & 
Wilson, 1990), or the period between vaccination 
and challenge altered (Ratcliffe & Wilson, 1992). 
Tracking studies have revealed that the majority of 
challenge parasites are eliminated in the lungs of 
once-vaccinated mice (Wilson, Coulson & Dixon, 
1986), following stimulation of a focal delayed-type 
hypersensitivity (DTH) response which blocks on- 
ward migration (Crabtree & Wilson, 1986; Smythies, 
Coulson & Wilson, 1992). Each focal response to a 
challenge larva appears to be an independent event. 
Since immunity in these mice is cell-mediated, the 
antigens must be processed by accessory cells and 
presented in the context of MHC class 11, to be 
recognized by the antigen receptors on reactive 
CD4'1 T cells. Triggering of an effector response in 
the lungs will therefore require the release of antigens 
from intact challenge schistosomula. It is also 
implicit that the vaccinating parasites must release 
an identical set of antigens to prime T cells in the 
lymph nodes. 
The loss of significant quantities of material from 
labelled schistosomula in vivo has been noted 
Parasitology (1993), 107,26S-274 Copyright C 1993 Cambridge University Press 
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(Wilson & Coulson, 1986; Mountford et al. 1988), 
yet no study has characterized the proteins released 
from schistosomula during the period corresponding 
to migration from the skin to the lungs. Proteolytic 
enzymes released from cercariae upon transform- 
ation have been described previously (see review by 
McKerrow & Doenhoff, 1988), and the proteins 
released by adult worms during in vitro culture have 
recently been studied by Lewis & Strand (1991). 
The formulation of an efficient medium for the 
in vitro culture of schistosomula (Basch, 1981) has 
allowed the analysis of many biochemical parameters 
which would be impossible to study in vivo. This 
culture system is capable of supporting worm growth 
and development up to the stage of pairing, and 
electron microscope studies have detected no obvious 
morphological differences between in vivo and 
in vitro cultured worms (Basch & Basch, 1982). 
Using this system, we have investigated the 
kinetics of protein synthesis and loss during in vitro 
culture of schistosomula up to the lung-stage of 
development. For this purpose, two different pools 
of proteins were labelled, those synthesized by the 
developing cercariae in the snail, and those synthe- 
sized by the schistosomula after transformation. The 
pattern of proteins labelled in the soluble fraction of 
parasites prior to and post-transformation has been 
determined. In addition, the subset of proteins 
released into the culture medium between trans- 
formation and day 7 has been characterized. The 
dominant released proteins which may mediate lung- 
phase immunity are highlighted. 
MATERIALS AND METHODS 
Preparation of parasite material 
A Puerto Rican isolate of Schistosoma mansoni was 
maintained by routine passage through albino 
Biomphalaria glabrata and LACA mice. Snails 
harbouring a patent infection were induced to shed 
cercariae by exposure to bright light. The cercariae 
were pooled, concentrated on ice by sedimentation 
and mechanically transformed as described by 
Ramalho-Pinto et al. (1974). Cercarial heads were 
isolated from tails by centrifugation on a discon- 
tinuous Percoll gradient (Lazdins et al. 1982). 
Parasite culture system 
Medium 169 (M 169) as defined by Basch (198 1) was 
used throughout for the culture of schistosomula, 
without the addition of human serum or red blood 
cells; the absence of the latter prevents transform- 
ation of parasites to the liver stage of development. 
Medium 169 containing 300 U/ml penicillin, 
300, ug/ml streptomycin and 160, ug/ml gentamicin 
(Sigma) was used as a wash medium (M I 69W). This 
was supplemented with I% foetal calf serum 
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(M169S; Globepharm) or 20, ug/ml bovine serum 
albumin (M169A; Sigma), depending on the ex- 
perimental protocol followed. MI 69S was used when 
culture supernatants were not to be collected, as the 
excess of proteins contributed by the serum sup- 
plement caused distortions on gels. Isolated cercarial 
heads were washed 4 times in 10 ml of MI 69W, and 
cultured in either M169S or X1169A (2000-3000 
parasites/ml) in 24-well plates (Corning) at 37*C 
in 5% CO, 
Assessment of parasite viability and maturation 
The viability of schistosomula throughout the cul- 
ture period was assessed by scoring the percentage 
which were motile, and by means of a Trypan blue 
dye exclusion test. Viability on day 3 and day 7 was 
also tested by culturing 3 different aliquots of 
schistosomula for 4-5,9 or 20 h in 10 ml of M1 69A 
containing 100. uCi ["'S]methionine. Subsequently, 
the TCA-precipitable cpm/parasite were deter- 
mined. A linear increase in the incorporation of 
isotope into proteins with time indicated that there 
was no downturn in metabolism. The ability of 
in vitro-cultured schistosomula to mature in vivo was 
determined by their surgical transfer to the superior 
mesenteric vein of naive mice (Coulson & Wilson, 
1988). The experiment was performed with hand- 
counted day 7 and day 12 schistosomula and 
aliquotted samples of day 7 larvae. Five weeks later, 
adult worms were recovered by perfusion of the 
hepatic-portal system and counted to determine the 
percentage maturation. 
Radio-isotope labelling of parasites 
In order to identify proteins synthesized by the 
developing cercariae prior to transformation, snails 
previously screened for their ability to yield a large 
number of parasites were labelled with ["S]methio- 
nine (20, uCi/snail; NEN; specific activity 
1186, uCi/mmol) in I ml of pond water/snail for 5 h, 
according to the method of Wilson & Coulson 
(1986). Labelled cercariae were obtained 5 and 7 days 
later (shed I and 11 respectively), transformed, and 
cultured as described in the experimental design. 
Following centrifugation at ISO Z for 60 a, parasite- 
free culture supernatants were collected at pre- 
determined times. 
To label those proteins synthesized after trans- 
formation, schistosomula were first cultured in 
MI 69S for defined times, washed 4 times to remove 
any dead parasites and serum proteins, and cultured 
in approximately 10ml of M169A containing 
200, uCi ["'S]methionine for a defined period, as 
described in the experimental design. Schistosomula 
were then washed and chase-cultured in MI 69A, or 
pelleted and used to obtain a soluble protein fraction. 
Culture supernatants were collected at various times 
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and then passed through aI ODG desalting column 
(Bio-Rad) to remove any unincorporated ["'S]methi- 
onine. 
Preparation of culture supernatants and 
schistosomula for analysis by SDS-PA GE and 
autoradiography 
Culture supernatants were concentrated to 500#1 in 
a stirred ultrafiltration cell containing a3 kDa cut-off 
Diaflo membrane (Amicon), under N2 at a pressure 
of 40 psi, and stored at - 80 *C. Soluble proteins 
were released from larval bodies by sonication 
(21 kHz at 6-5 pm amplitude) for 90 a. Soluble and 
particulate material was partitioned by centri- 
fugation for Ih at 105 000 g and 4 *C. The soluble 
sonicate was recovered and stored at - 80 *C. Most 
of the secretory proteins should be a subset of the 
soluble fraction, although proteins of membrane 
origin may be absent. Conversely, many soluble 
proteins, for example cytoplasmic enzymes will not 
be secreted and their appearance in the culture 
medium would be an indication of leakage from dead 
or dying parasites. 
Proteins in the culture supernatants and soluble 
fractions were separated under reducing conditions 
by SDS-PAGE on 6-16% density gradient gels. 
Gels were fixed, stained with Coomassie R-250, 
impregnated with the fluorographic reagent Amplify 
(Amersham) and then dried. Labelled proteins were 
visualized by autoradiography following exposure of 
gels to Hyperfilm-, 8 max (Amersham) for 4-6 weeks. 
Analysis of samples by substrate gel electrophoresis 
Substrate gel electrophoresis was carried out 
essentially as described by Lockwood et al. (1987). 
Briefly, culture supernatants and soluble protein 
fractions were diluted in sample buffer without 
dithiothreitol and loaded, without prior boiling, onto 
9% acrylamide gels impregnated with gelatin to a 
final concentration of 0-2 %. After electrophoretic 
separation, the gels were washed briefly in distilled 
water and then for 2x 30 min in 2-5 % Triton X-1 00. 
Gels were incubated for 48 h at 37 *C in 0- 1m 
glycine-NaOH, 5 mm CaCl, pH 9, stained in Coo- 
massie blue and then destained to allow visualization 
of areas of proteolytic activity. 
Experimental design 
Pre-transformation labelling. The loss of ["'S]methi- 
onine labelled material from schistosomula was 
monitored throughout the 7-day culture period. 
Replicates of 10 cercariae, cercarial tails, or schisto- 
somula (0 h, 3 h, 24 h and day 7) and 5#1 aliquots of 
the corresponding culture supernatants, were 
applied to glass microfibre filters (Whatman). These 
were dried and, after addition of scintillant, counted 
in a liquid scintillation analyser (Packard). 
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In order to obtain proteins for analysis by 
SDS-PAGE and autoradiography, schistosomula 
derived from shed I of the labelled snails were 
cultured for 7 days in MI 69A. At 3h and 24 h, 
parasite-free culture supernatants were removed, the 
schistosomula resuspended and cultured in fresh 
medium. On day 7, the culture supernatant was 
removed and then the 0-3 h, 3-24 h and 24 h-day 7 
supernatants, concentrated as described previously. 
The schistosomula were used to yield a day 7 soluble 
fraction. Cultures of parasites from shed 11 were 
terminated at 24 h to yield a soluble protein fraction. 
Post- transformation labelling. (i) Kinetics of protein 
synthesis during development. Separate aliquots of 
newly-transformed schistosomula, derived from a 
single pool of cercariae, were pulsed with ["S]methi- 
onine for 24 h on consecutive days (up to day 10). At 
the end of the 24 h pulse-period, schistosomula were 
washed 6 times in 10ml of M169W to remove 
unincorporated isotope. The incorporation of 
["S]methionine into proteins of schistosomula was 
assessed by measuring the TCA-precipitable cpm. 
Replicate samples of 50 washed schistosomula in 
200jul of N1169W were lysed by sonication, and 
protein precipitated by the addition of 600 #1 of 15 O/o 
TCA. After 15 min on ice, the lysates were applied 
to individual glass microfibre filters (Whatman), 
washed with IS % TCA, dried and counted. The 
background radioactivity from 200jul of the final 
wash medium was determined and subtracted from 
the value of the parasite lysates. (ii) Analysis of 
released and soluble proteins. Schistosomula derived 
from a single pool were divided into 7 or 8 equal 
aliquots and cultured in NI I 69S for periods ranging 
from 0 to 7 days, after which they were washed 4 
times and pulsed with [s'S]methionine in MI 69A for 
24 h. The culture supernatant was removed after 
centrifugation, and the number of parasites in each 
culture determined. Soluble proteins were prepared 
from the larval bodies, whilst culture supernatants 
were treated to remove unincorporated isotope (as 
described above), and then concentrated. All samples 
were analysed by SDS-PAGE and autoradiography. 
(iii) Continuous 7-day labelling. A single pool of 
schistosomula was cultured in approximately 10 ml 
of MI 69A containing [3S]methionine for 7 days. At 
the end of this period, the culture supernatant was 
removed and treated as described previously. The 
number of parasites in the culture was determined 
and the larval bodies used to yield a soluble protein 
fraction for analysis by SDS-PAGE and auto- 
radiography, in comparison with the culture super- 
natant. (iv) Pulse-chase labelling. In order to in- 
vestigate the kinetics of labelled protein loss, schisto- 
somula derived from a single pool of cercariae were 
divided into 3 equal aliquots, and cultured in At I 69S 
prior to labelling. Each culture was pulsed with 
[31 S]methionine in M169A for 24 h on days 3,6 or 
10. The pulse supernatant was then recovered, the 
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parasites washed extensively to remove any un- 
incorporated label, and chase-cultured for 4 days in 
M169A. An aliquot of approximately 500 schisto- 
somuIa was taken immediately after the 24 h pulse 
period and 2 and 4 days later and the TCA- 
precipitable cpm/parasite determined. 
RESULTS 
Viability and maturation of schistosomula throughout 
the culture period 
To ensure that the proteins detected in the culture 
medium were products released from live schisto- 
somula and not material leaked by dead or dying 
parasites, viability was monitored by several 
methods. Following a 7-day continuous culture 
period in M169S (without any washes), approxi- 
mately 95% of parasites were motile and excluded 
Trypan blue. Viability was slightly lower in MI 69A, 
and therefore M169S was used in preference, except 
where the presence of serum would interfere with 
analysis of proteins by SDS-PAGE. Most deaths 
occurred during the first 2-4 days when the parasites 
were much less motile, less elongate and more fragile 
upon centrifugation than at later times. From day 5 
onwards, the schistosomula began to elongate and 
became much more motile. When schistosomula 
were cultured for 7 days and then pulsed for 4-5,9 
and 20h, they incorporated 2-8±0-15,5-89±0-26 
and 13-62±0-66cpm/parasite respectively, i. e. a 
linear increase with time (data not shown). An 
identical experiment using day 3 schistosomula 
produced a similar linear increase but with a lower 
level of incorporation. 
When hand-counted schistosomula were trans- 
ferred to naive mice after 7 or 12 days of in vitro 
culture, 70-3 and 86-6 % respectively were recovered 
as adult worms by perfusion 5 weeks later. When day 
7 larvae were aliquotted for transfer, to avoid a 
biased selection, 74-2 % matured in vivo. 
Pre- transformation labelling 
Kinetics of protein release during development. The 
rate of labelled protein loss, determined over a 7-day 
period, is illustrated in Fig. 1. Upon transformation, 
32 % of the total cercarial cpm were lost with the tail, 
whilst a further 16 % was released into the medium 
over the first 3h of culture. During this period, the 
mean rate of labelled protein loss was 5-4 % of the 
total cercarial cpm/h. This rate decreased markedly 
to 0-2%/h between 3 and 24h, and to 0-077%/h 
between 24 h and day 7. Only 29 % of the total 
cercarial counts remained associated with the 
schistosomula by day 7. This compares to a figure of 
16 % for day 7 ex vivo schistosomula (data not 
shown). At each sampling time, the sum of the 
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Fig. 1. Analysis of the distribution of labelled proteins, 
in the cercaria, larval body (M), tail (jj) or culture 
supernatant (0) derived from schistosomula during 
in vitro culture. The results are expressed as a mean 
percentage of the cercarial CpM±S. E. The values are 
from 10 experiments for cercariae, 0h body, tail, 3h 
body and 0-3 h supernatant, 5 experiments for 24 h 
body and 3-24 h supernatant, and 3 experiments for the 
7-d body and 24 h-day 7 supernatant. 
supernatant and larval body counts is approximately 
equal to the body counts of the previous sampling 
time indicating the accuracy of the balance sheet. 
Analysis of soluble and released proteins. The pattern 
of labelled proteins in the soluble and released 
fractions was analysed by electrophoresis followed 
by autoradiography; a representative example is 
shown in Fig. 2. The proteins released between 
0-3 h and 3-24 h showed qualitatively similar band- 
ing patterns. Two proteins of M, 61 and 20 kDa 
were the most dominant, and could be detected 
within 2 min of transformation (data not shown). 
Unique to the first 24 h, were 2 proteins of Al, 47 and 
43 kDa, while minor proteins of M, 90,88,70,38 
and 28 kDa (arrowed) were released only after 24 h. 
Many proteins with M, similar to those in the 
culture supernatants were also detectable in the 24 h 
or day 7 soluble fractions. However, the 61 and 
20 kDa proteins were enriched in all 3 culture 
supernatants; indeed, by day 7 the 20 kDa protein 
was barely detectable in the soluble fraction. A 
number of proteins in both the 24 h and day 7 
soluble fractions, most of which were < 20 kDa, 
were not released during the 7-day culture period. 
Proteolytic activity in the soluble and released 
protein fractions was analysed on gelatin substrate 
gels (data not shown). In both 0-3 h and 3-24 h 
culture supernatants areas of proteolytic activity in 
the region of 61 and 20 kDa were visible, yet only a 
low level of activity was present in the 24 h soluble 
fraction. No proteolytic activity could be detected 
when 24 h-day 7 supernatants were analysed, despite 
two proteins of M, 61 and 20 kDa remaining domi- 
nant on SDS-PAGE gels throughout this period. 
Post-transformation labelling 
Kinetics of protein synthesis during development. The 
rate of ["'S]methionine incorporation into TCA- 
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Fig. 2. Autoradiograph of elect rophoretically separated 
soluble (S) and released (R) proteins, derived from 
schistosomula labelled prior to transformation. The 
equivalent of 10000 cpm was run down each lane of the 
gel. The autoradiograph was developed after 4 %%eeks 
exposure to the gel. 
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Fig. 3. Rate of protein synthesis bv schistosomula 
pulsed for 24 h with ["S]methionine at 24 h intervals. 
Values represent the mean cpm/schistosomulum/h + S. E. 
precipitable material of schistosomula, following a 
24 h pulse on consecutive days, was determined over 
an 11-day period (Fig. 3). An initial lag phase of 
approximately 24 h occurred during which there was 
only a low level of protein synthesis. There was then 
a rise to a plateau phase which lasted for 2-3 davs, 
followed by a further increase in the rate of synthesis 
which reached a peak on day 8. The rate then 
declined rapidly so that by day 10, the level was 
similar to that seen between days 2 and 4. The peak 
M, 
(kDa) 
200- 
116- 
97- 
66- 
45 
31- 
-Z=; - 
M in 9 
21 - 
14- 
45678 
Day 
Fig. 4. Autoradiograph of elect rophoretical ly separated 
proteins of the soluble fraction of in vitro-cultured 
schistosomula follow ing a 24 h pulse on successive da% s. 
The equivalent soluble protein from 4000 schistosomula 
was run down each lane of the gel. The autoradiograph 
was developed after 4 weeks exposure to the gel. 
rate of protein synthesis %vas 11-5 times greater than 
within the first 24 h after transformation. A similar 
profile of the rate of protein synthesis was seen in 
repeat experiments (n = 3). However, the timing of 
the peak and subsequent rapid decline of synthesis 
varied by 24 h either side of the result sho" n here. 
Analývsis of soluble proteins. A one-dimensional 
separation of labelled proteins present in the soluble 
fraction of schistosomula pulsed for 24 h on suc- 
cessive days, is shown in Fig. 4. The intensity of the 
banding patterns of this subset of parasite proteins to 
a degree mirrored the observed rate of protein 
synthesis (cf. Fig. 3). Few proteins were synthesized 
during the first 24 h, yet the two most dominant, of 
M, 28 and 20 kDa, were synthesized at a higher rate 
during this period than at subsequent times. Several 
minor proteins were only synthesized within the first 
24 h, while other proteins of Al, 130,110,97,70,43, 
42,38 and 32 kDa (arrowed) showed stage-specific 
synthesis at later times. The most prominent of these 
were of Al, 97 and 38 kDa, the former of which was 
synthesized predominantly on days 6 and 7, and the 
latter only between days 3 and 6. 
Anaývsis of released proteins. Schisto-omula of' dif- 
ferent ages released a complex mixture of proteins 
into the culture medium during a 24 h pulse (Fig. 5). 
As would be predicted from the rate of isotope 
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Fig. 5. Autoradiograph of electrophoretically separated 
proteins released bý in vitro-cultured schistosomula 
during a 24 h pulse. The equiN alent protein released 
from 6000 schistosomula was run down each lane of the 
gel. The autoradiograph was developed after 4 x%eeks 
exposure to the gel. 
incorporation (Fig. 3), feý% newly synthesized pro- 
teins were detectable in the culture supernatant 
within the first 24 h. At later times, more than 15 
proteins v, -ere released into the culture medium, 
ranging in Al, from < 20 to > 100 kDa, the t\% o 
most dominant being 45 kDa and 20 kDa. During 
this latter period, there were few qualitative differ- 
ences in the banding patterns, -with the exception of 
two minor proteins of high M, and one of 23 kDa, 
which were not released until day 3. 
Anal 
- vsis of soluble and released proteins 
following a 
continuous labelling for 7 da 
- vs. 
The cumulative re- 
leased and soluble proteins derived from schisto- 
somula continuously labelled for 7 days are shown 
in Fig. 6. There were marked differences between 
the banding patterns of proteins in the soluble 
fraction and in the culture supernatant. The most 
dominant proteins in the latter had ' Wr of 61 and 
20 kDa. The 61 kDa protein was not detectable in 
the soluble fraction, and the 20 kDa protein was 
highly enriched in the culture supernatant, compared 
to the soluble fraction. 
Pulse-chase labelling of parasites. Schistosomula were 
pulse-labelled on davs chosen to correspond to 
different phases of protein svnthesis. The loss of 
parasi te- associated labelled protein was then fol- 
lowed over a 4-day chase period (Fig. 7). As predicted 
from the results in Fig. 3, there was differential 
incorporation of isotope into TCA-precipitable 
material of parasites at each time point (i. e. the 
parasites pulsed on day 6 incorporated more isotope 
than those pulsed on days 3 and 10). Ho, ývever, the 
percentage loss of cpm showed little difference. In 
each case, more than 50'), ) of the cpm, associated 
M, 
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Fig. 6. Autoradiograph of elect roph oretical Iý separated 
soluble (S) and released (R) proteins of schistosornula 
folloxNing a continuous 7-d labelling. The equivalent 
protein from 10000 schistosornula %%as loaded onto gels 
and separated bv SDS-PAGE. The autorachograph %%as 
developed after 4 weeks exposure to the gel. 
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Fig. 7. Rate of loss of parasite- assoc iat ed labelled 
protein following a 24 h pulse on claý 3,6, or 10 and a 
subsequent 4-d chase. Results are expressed as a mean 
percentage (n = 3) of the cpm/parasite immediatelý after 
the 24 h pu]SC+S. F,. 
%vith the parasite immediately after the pulse, N%as 
lost during the chase period. 
When the pulse and chase supernatants xNere 
compared bv SDS-PAGE and autoracliographý 
(data not shown), essentially the same pattern of 
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proteins was seen in each. The most dominant 
proteins were of M, 61,45 and 20kDa, the latter 
becoming less prominent with time. 
DISCUSSION 
In order to characterize proteins released by 
developing schistosomula in vitro, it is obviously 
important that essentially 100% of parasites are 
viable and develop normally. Several criteria were 
used to confirm that the culture system was capable 
of supporting a high level of parasite viability and 
did not impair maturation. The linear increase in the 
incorporation of ["S]methionine into schistosomula 
proteins was a good indication that there was little, if 
any, parasite death or loss of anabolic activity 
throughout the pulse period. Additionally, surgical 
transfer of day 7 or day 12 in vitro-cultured worms to 
naive mice resulted in maturation rates comparable 
to, or better than, those reported by Coulson & 
Wilson (1988) for ex vivo worms of identical ages. 
Randomly chosen (aliquotted) day 7 worms were 
equally as capable of maturing as hand-picked 
schistosomula indicating that our results were not 
biased by the selection procedure. Thus, we con- 
clude, that 12 days of in vitro culture have no effect 
on the ability of larvae to mature in vivo. 
Cercariae, labelled during development in the 
snail, lost 32 % of their total cpm with the tail upon 
transformation, a value identical to that reported by 
Wilson & Coulson (1986). These workers also found 
that during development of labelled parasites in vivo, 
89 % of the total cercarial cpm had been lost by day 7, 
compared to the value we report of 71 % after 7 days 
of in vitro culture. There are a number of possible 
explanations for this disparity. Firstly, development 
is known to occur slightly faster in vivo than in vitro 
(Basch, 1981). Secondly, the environment in vivo is 
probably more hostile than that in vitro, and a higher 
rate of protein turnover is likely, due to repair 
processes. Thirdly, secretion of some proteins may 
require a stimulus such as a change in 0,, tension or 
nutrient levels, or the physical pressure of squeezing 
along a blood vessel; these stimuli may not be 
present in vitro. Finally, this study used ["S]methi- 
onine to label parasites whereas Wilson & Coulson 
(1986) used ["Selmethionine. However, after 7 days 
of in vivo culture [35 S]methionine-labelled parasites 
lost 84 % of the total cercarial cpm compared to the 
89% reported by Wilson & Coulson (1986). This 
suggests that the use of different isotopes does not 
account for the disparity of labelled protein losses 
in vitro and in vivo. 
The most rapid release of proteins, labelled in the 
developing cercariae, occurred during the first 3h of 
culture. The cercarial glycocalyx, shed at this time, 
is composed of glycoprotein (M, 5xlO"kDa; 
Caulfield et al. 1987) too large to enter electro- 
phoretic gels. However, it is possible that some of the 
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macromolecules detected in the 0-3 h culture super- 
natants are derived from it. During the 0-3 h period, 
the most dominant polypeptides on SDS-PAGE 
reduced gels were of M, 61 and 20 kDa. Two bands 
of proteolytic activity against gelatin, had similar 
molecular weights but it is not possible to confirm if 
they are identical because of the different electro- 
phoretic conditions. Marikovsky, Fishelson & Arnon 
(1988) described two serine proteases of M, 60 and 
28 kDa which were secreted by transforming cer- 
cariae, predominantly within the first 30 min. They 
showed that these enzymes play an important role in 
skin penetration and shedding of the cercarial 
glycocalyx. Other secreted proteases of Mr 25 kDa 
(Landsperger, Stirewalt & Dresden, 1982), 30 kDa 
(McKerrow et al. 1985) and 47 kDa (Chavez- 
OIortegui, Resende & Tavares, 1992) have been 
described, and may be involved in skin penetration 
and transformation. Proteins of Mr 61 and 20 kDa 
were also prominent in the 24 h-day 7 culture 
supernatant, yet no proteolytic activity could be 
detected. This suggests that there is more than one 
protein migrating to the same position in the gel or, 
less likely, that some developmental regulation of the 
proteases is occurring. Keene et al. (1983) noted the 
absence of proteolytic activity after 24 h and showed 
that secretion of enzymes from the preacetabular 
glands was complete by this time. Furthermore, 
Cousin, Stirewalt & Dorsey (198 1) described empty 
and shrunken acetabular gland cells and ducts of 
schistosomula within 1h of skin penetration, 
although artificially transformed cercariae were 
found to release their contents more slowly. It is 
possible that secretion occurs more slowly in vitro 
due to the absence of short-chain fatty acids which 
are found on the skin, and are known to stimulate 
release of proteases from the acetabular glands 
(McKerrow et al. 1983). Most of the proteins 
released within the first 3h of culture are also 
detectable in subsequent culture supernatants. How- 
ever, there appears to be some stage-specific release 
of proteins over the 24 h-7-day period. These 
proteins may originate in the head gland, a structure 
which persists from the cercariae, and the secretions 
of which facilitate penetration of blood vessel walls 
by schistosomula (Crabtree & Wilson, 1985). 
Protein synthesis after transformation was meas- 
ured in vitro by pulsing cultures with ["S]methi- 
onine for 24 h periods. This pulse duration was 
chosen as a compromise between incorporating 
enough label into proteins to allow their detection by 
autoradiography, whilst minimizing the potential 
catabolism of the proteins within parasite tissues. 
The procedure under-estimates the rate of synthesis 
because some proteins are released from the body 
during the pulse period. However, our methods 
permitted these secreted proteins to be characterized. 
The rate of protein synthesis can be divided into four 
different phases over an II -day period. During the 
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first 24 h after cercarial transformation, a very low 
rate of protein synthesis was measured; a result 
which has been reported previously (Nagai et al. 
1977; Yuckenburg, Poupin & Mansour, 1987; 
Blanton & Licate, 1992), and presumably occurs 
because the parasite utilizes proteins pre-synthesized 
in the cercariae for the transformation process 
(Hockley & McLaren, 1973). Blanton & Licate 
(1992) noted that this lag phase was due, not to a 
paucity of mRNA, but to a post-transcriptional 
block on translation. This block was reversed over 
time and allowed the expression of available mRNA 
species. Heat-shock proteins are produced during 
the first 6-8 h of transformation (Yuckenburg et al. 
1987; Blanton & Licate, 1992) and could prevent 
protein synthesis; as their expression decreases the 
block on synthesis would be reversed. The increasing 
rate of synthesis up to day 8 corresponds to the 
period over which parasites reach the lungs and 
undergo the adaptive changes necessary for intra- 
vascular migration (Wilson et al. 1978). The 
subsequent decline in synthesis to the level seen 
between days 2 and 4 may represent a quiescent 
phase in development. Such a phase was postulated 
by Lawson & Wilson (1980) on the basis of 
biochemical analysis, and may indicate that the 
parasite has acquired all the adaptations necessary 
for migration to the portal system. 
Autoradiographic analysis of labelled proteins 
present in the soluble fraction of the larval body 
revealed some stage-specific synthesis, which may 
correspond to the physiological changes occurring 
during schistosomulurn development. One such 
change is the appearance of homogeneous bodies, 
which are specific to the lung-stage (McLaren et al. 
1978); their secretions may help to minimize friction 
between parasite tegument and pulmonary endo- 
theliurn (Crabtree & Wilson, 1986). Other workers 
have shown stage-specific synthesis of proteins, 
employing a very similar labelling protocol to our 
own but fractionating an homogenate of the whole 
worm body using 2-D SDS-PAGE (Yuckenburg 
et al. 1987). 
During development to the lung-stage, schisto- 
somula, labelled after transformation, released at 
least 15 proteins of diverse M, The distinct banding 
pattern of the soluble fraction compared with the 
culture supernatant, derived from schistosomula 
continuously labelled for 7 days, provides strong 
evidence that the proteins in the latter are true 
secretions, not molecules leaked from dying para- 
sites. Among the proteins released within most 
culture periods, three of M, 61,45 and 20 kDa are 
dominant (the 61 kDa protein is often poorly 
visualized due to the ballooning effect caused by the 
BSA additive in the culture medium). Since all three 
bands are present in the sequential 24 h pulse 
supernatants from day I to day 7, we conclude that 
these proteins are synthesized and released over 
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most of the developmental period. The bands at 61 
and 20 kDa coincide with major proteins released 
from the cercariae during transformation. However, 
unlike the latter they do not correspond to regions of 
proteolytic activity and may therefore represent 
completely different proteins. We are currently 
attempting to address this question using 2-D 
SDS-PAGE, but are limited by the amount of 
labelled secretion available for analysis. 
This is the first report to characterize proteins 
synthesized and released by schistosomula during 
development to the lung-stage. Many proteins of 
diverse molecular weight were identified in the 
culture supernatants. These molecules released 
within the lymph nodes draining the vaccination site 
must serve as inducers of the primary protective 
response, and in the lungs of vaccinated mice as 
initiators of the cell-mediated effector mechanism 
elicited by challenge larvae. The ability of these 
released proteins to stimulate proliferation by lymph 
node cells recovered from protectively vaccinated 
mice, will be reported in a later publication. In order 
to make further progress in understanding their 
biological role for the parasite, and their interaction 
with the host immune system, an abundant supply of 
purified proteins is required. With this in mind, we 
are currently screening a larval cDNA library, 
constructed in the lambda ZAP vector to identify 
recombinants coding for released proteins. 
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CHAPTERTHREE 
The proliferative responses of lymph node cells to 
antigenic fractions of larval Schistosoma mansoni, 
and to live schistosomula. 
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3.1 Introduction 
The importance of skin-draining lymph nodes, in the induction of resistance against 
Schistosoma mansoni, has been demonstrated previously by their excision prior to 
vaccination or by administering irradiated parasites intravenously, thus by-passing this 
site; in both cases immunity to a challenge infection was greatly reduced (Mountford & 
Wilson, 1990; Coulson & Mountford, 1989 respectively). It is likely that the skin- 
draining lymph nodes are the main site for the priming of schistosome-specific T cells, 
an event which is essential to the induction of protective immunity (Constant et al. 1990). 
Since lymphocytes are important for the development of resistance in the irradiated 
ccrcaria vaccine model, it is pertinent to ask whether their degree of proliferation in 
response to parasite antigen(s) correlates with the immune status of the host. Proliferation 
of lymphocytes in vitro in response to the presence of protein confirms two related facts, 
firstly that the macromolecule is immunogenic and secondly that lymphocytes have been 
sensitised to it previously. Several studies have used mouse strains which develop 
differential levels of resistance after vaccination, and tested the ability of lymphocytes 
recovered from lymph nodes or spleens of such animals to proliferate in response to 
crude antigen preparations (James, Labine & Sher, 1981; Lewis & Wilson, 1982b). No 
correlation was found between the immune status of the animal and its ability to respond 
to the antigen preparation. Similarly, Colley et al. (1977) found no statistical correlation 
between the intensity of schistosome infection in human patients (determined by eggs per 
grain of facccs) and the degree of cell-mediated reactivity, assessed by lymphocyte 
proliferation, to soluble preparations of either eggs, cercariac or adult worms. However, 
interpretation of such studies can be hindered by the complex nature of the antigen 
preparation. For example, it has been reported that schistosomcs contain material which 
can non-sPecifically inhibit (Dessaint et al. 1977; Camus et al. 1981) or promote 
(Auriault et al. 1984b) lymphocyte proliferation. 
Furthermore, certain experimental parameters can complicate results. James (1981) 
used lymph node cells recovered from mice with chronic infections. Such mice would 
have been exposed to three different life-cycle stages of the parasite, therefore 
lymphocytes derived from them would display a broad cross-reacting spectrum of 
antigen recognition. Vieira et al. (1987) analysed the proliferative response of peripheral 
blood mononuclcar cells, from patients with chronic intestinal schistosomiasis, to live 
schistosomula. Unfortunately, by the end of the culture period most of the parasites had 
died, therefore the proliferative response could not be assigned exclusively to parasite- 
released proteins. The use of an isolated protein, or at least a defined preparation with a 
restricted number of molecules would allow easier interpretation of results from such 
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experiments. 
There is a large body of information available on the antibody responses of 
vaccinated mice to specific parasite proteins fractionated from complex antigcnic 
mixtures, utilising SDS-PAGE and immunoprccipitation or Western blotting (Simpson, 
James & Sher, 1983; Simpson et al. 1984; Simpson et al. 1985; Richter & Ham, 1993). 
Similar techniques have also been applied using serum from human patients (Taylor & 
Wells, 1984; Roberts et al. 1987; Dessein et al. 1988). However, there are relatively few 
reports which describe T cell responses to fractionated parasite proteins. The specificity 
of an animal's T-cell repertoire can be investigated by clectrophorctic separation of 
complex antigenic mixtures and subsequent transfer to nitrocellulose. This circumvents 
the need to purify each polypeptide species (Lamb, Ohehir & Young, 1988). Despite the 
usefulness of this technique, technical problems such as the difficulty of transferring 
sufficient quantities of antigen to the solid support can result in failure to identify 
potentially important proteins (Rothbard & Lamb, 1990). Alternatively, Mountford & 
Wilson (1993) separated antigenic mixtures by high performance electrophoretic 
chromatography (HPEC) prior to analysis in T cell proliferation assays. Utilising this 
approach, they were able to fractionate relatively crude parasite protein mixtures into 
samples of limited antigenic composition. Each sample was then analysed for its ability 
to induce proliferation of, and cytokine production by, lymph node cells recovered from 
vaccinated mice. This allows both the immunogenic potential of the small number of 
proteins present in each fraction to be assessed, and their ability to induce a Tbl or T12 
type response, important considerations for vaccine design against schistosomiasis. 
As detailed in section 1.7.5, comparable levels of immunity can be achieved 
following either percutaneous (p. c. ) vaccination of C57BU6 mice with irradiated 
cercariae, or by intra-dermal (i. d. ) vaccination with day 8 schistosomula derived from 
irradiated cercariae (Coulson & Mountford, 1989). By using p. c. or i. d. vaccination 
protocols and lymphocytes extracted from the main skin-draining lymph nodes (axillary 
and cervical respectively) on day 5 post-vaccination, an attempt has been made to 
simplify the experimental design to facilitate easier interpretation of the results. In the 
previous chapter, the proteins present in the soluble fraction of, and those released by, 
schistosomula up to the lung-stage of development were analysed. Since we believe 
released proteins, whatever their origin, to be important in both induction and effector 
phases of immunity, the aim of this work was to examine the ability of this sub-set of 
parasite proteins to induce proliferative responses in lymphocytes recovered from 
protectively vaccinated mice. In addition, the responses to soluble and particulate parasite 
protein fractions and live schistosomula were analysed. The soluble preparation was used 
because many secretory molecules are likely to constitute a sub-set of this fraction, 
whereas shed proteins, such as membrane fragments, are more likely to be present in the 
particulate fraction. 
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3.2 Materials and methods 
3.2.1 Parasite culture medium 
Two media were used consecutively for the cultivation of parasites. Medium 169 
defined by Basch (1981) and adapted by Harrop & Wilson (1993) was used because of its 
ability to support a high level of parasite viability. This medium was supplemented with 
antibiotics alone (M169W) or with foetal calf serum (1%; M169S) to serve as a wash 
medium or parasite culture medium respectively. For the final 24h of culture, parasites 
were transferred to RPMI (RPMI-1640; Flow laboratories) containing 1% foetal calf 
serum (FCS; Globepharin IAd, Esher, Surrey, U. K. ), penicillin (20OU/ml), streptomycin 
(100pg/ml) and 2mM L-glutamine (designated RPMI/1). Over a 24h period, this medium 
maintained a high level of parasite viability (>959o'). 
3.2.2 Preparation ofparasite material 
A Puerto-Rican isolate of Schistosoma mansoni was maintained by routine passage 
through LACA mice and albino Biomphalaria glabrata. Snails, harbouring a patent 
infection, were induced to shed cercariae, the parasites concentrated by sedimentation at 
4*C and then mechanically transformed as described by Ramalho-Pinto et al. (1974). 
Resulting schistosomula were isolated by centrifugation on a discontinuous 40-70% 
Percoll gradient (Lazdins et aL 1982; SIGMA) and washed 4 times in 10ml M169W. 
They were then resuspended in M169S and cultured in 24-well plates (Coming) for 
defined periods of time at 37*C, 6% CO 2* Such parasites were used either directly in 
lymphocyte blastogenesis assays or to yield culture supernatants, soluble and particulate 
fractions. In order to obtain these samples, schistosomula, derived from a single pool of 
cercariae, were divided into 7 equal aliquots and cultured in M169S for periods ranging 
from 0 to 6 days (see Fig. 3.1), after which they were then washed 6 times and cultured 
for 24h in RPMI/1. At the end of this period, the parasite suspension was centrifuged 
(150g for 60s), the culture supernatant removed and the number of parasites in each 
culture determined. Culture supernatants were concentrated to 1ml in a stirred 
ultrafiltration cell, containing a3 kDa cut-off Diaflo membrane (Amicon), under N2 at a 
pressure of 40 psi. Culture medium which had not been exposed to parasites was treated 
in the same way and served as a negative control (medium blank) in proliferation 
experiments using released proteins. Soluble proteins were released from larval bodies by 
sonication (21 kHz at 6.5, um amplitude) for 90s, and partitioned from particulate material 
by centrifugation for 1h at 105,000g, 4'C. nc particulate material was then resuspended 
in RPMI/10 (RPMI containing 10% FCS, penicillin (20OU/ml), streptomycin (100, uglml), 
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2mM L-glutamine and 5x1O-5M 2-mercaptoethanol). Soluble and particulate protein 
fractions and those released by schistosomula during in vitro culture were filter-sterilised 
and the protein content of the soluble fractions determined by the Bradford assay. Both 
soluble and particulate fractions were reconstituted to 1ml with RPMI/10. All fractions 
were stored at -20*C until required. Schistosomula to be used directly in proliferation 
assays, were cultured in M169S for defined times, washed 6 times in RPMI/10 and 
aliquoted into flat-bottomcd 96-wcll microtitrc plates in 100, ul RPMI/10. In experiments 
using live larvae, soluble or particulate fractions, unconcentrated RPMI/10 was used as a 
medium blank (no antigen control). 
3.2.3 Vaccination regimes 
T\vo vaccination regimes were used, pcrcutaneous (p. c. ) and intra-dcrmal (i. d. ). The 
former involved the exposure of anaesthetised mice (Wilson & Coulson, 1986) to 500 
cercariae, attenuated with 20 krad. of gamma radiation from a 6OCo source (Department 
of Radiobiology, Cookridge Hospital, Izeds), via the shaved abdomen. For i. d. 
vaccination, attenuated day 8 parasites were recovered from the lungs of vaccinated mice 
by mincing and incubation (Wilson and Coulson, 1986). Resulting lung-stage 
schistosomula were washed in M169S and samples of 300 were injected in 15PI M169S 
into the dermis of the mouse pinna (Coulson & Mountford, 1989). 
3.2.4 Preparation of responder lymphocytes and antigen presenting cells (APQ 
Responder lymphocytes were obtained by the surgical removal of the axillary lymph 
nodes from p. c. vaccinated mice and the cervical lymph nodes from i. d. vaccinated mice, 
5 days after exposure to parasites. Single cell suspensions were obtained by teasing 
lymph nodes apart with sterile forceps. Cells were washed and resuspended in RPMI/10. 
Irradiated splenocytes were used as a source of APC. T'hese were prepared by removing 
spleens from naive mice and exposing them, whilst on ice, to a 237CS source for 30 min. 
The irradiated spleens were pressed through sterile stainless steel mesh and then washed 
in RPMI/10. The number of lymph node cells and splenocytes was determined, using a 
hacmocytometer, and adjusted to 2x 106/ml for the former and 4x 106/ml for the latter. 
3.2.5 Assay of lymphocyte proliferation 
Responder cells (10'/well) recovered from either p. c. or Ld. vaccinated mice and APC 
(2 x 105/well) were cultured for 5 days (37"C, 6% CO) in either 200PI RPMI/10 alone 
(or the relevant medium blank), or in the presence of live parasites, released proteins 
isolated from live larvae, soluble or particulate parasite proteins. Since the parasite- 
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released proteins were collected in medium containing FCS, a protein estimate could not 
be made. Therefore, in experiments which used released proteins, proliferation was 
expressed per number of parasites from which the material was derived. Additionally, it 
was difficult to obtain an accurate protein estimate for particulate protein and so 
proliferation in response to these samples was also expressed in the same way. 
Each well received 18.5 kBq 3H-tbymidine (specific activity 185 GBq/mmol, 
37MBq/ml; Amersham) for the final 18h of culture, and the incorporation of isotope into 
cellular DNA was measured, after harvesting (cell harvester, MACON), by liquid 
scintillation counting. Results are expressed as mean c. p. m. (+S. E. M. ) for triplicate 
samples. In all experiments, wells containing APC but no responder cells were included 
to control for 3H-thymidine incorporation due to the irradiated splenocytes. Additionally, 
in assays using live schistosomula, cultures which contained live larvae but no responder 
cells or APC were included. In such experiments, values were plotted as total 31-1- 
thymidine incorporation by cells and schistosomula minus the value incorporated by the 
parasites alone. It has been demonstrated previously (James, 1981) that the presence of 
cells does not stimulate uptake of 31-1-thymidine by live larvae. 
Statistical significance of the results was determined using the Student's t-test. 
3.3 Results 
3.3.1 Inhibition of lymphocyte proliferation by a component of M169 
Initially, parasite-released proteins were collected in M169. Unfortunately, a 
constituent of this medium was found to inhibit cell proliferation. Figure 3.2 illustrates 
this fact using a soluble worm antigen preparation (SWAP) as the test antigen. SWAP 
was diluted either in unconcentrated RPMI/10, concentrated RPMI/1 or concentrated 
M169. Cellular proliferation to the antigen preparation was severely inhibited by the 
presence of concentrated M169, but unaffected by RPM1/10 or concentrated RPMI/1. 
Subsequently, all parasite-releascd proteins were collected in RPMI/1. 
3.3.2 Analysis ofproliferative responses of axillary lymph node cells recoveredfiom 
percutaneously vaccinated mice 
The proliferative response of axillary lymph node cells, recovered from p. c. 
vaccinated mice, to soluble protein fractions of schistosomula (1pg/Well) collected at 24h 
intervals over a7 day period is shown in figure 3.3. All samples induced significantly 
higher responses than background proliferation to medium alone (RPMI/10). Ile lowest 
level of proliferation was induced by proteins present in the day 1 soluble fraction, this 
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Fig. 3.3. Proliferative response of axillary lymph node 
cells, recovered from percutaneously vaccinated mice, 
to lpg soluble protein derived from schistosomula and 
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value being significantly lower than all others (P <0.05), but still 13 times greater than the 
medium blank. All other samples induced approximately 2 times greater levels of 
proliferation than the day 1 soluble fraction and up to 30 times greater levels than 
background. 
The pattern of proliferation to the equivalent amount of protein released from 1000 
schistosomula during a 24h period was very different (Fig. 3.4). The highest level of 
proliferation was induced by material released within the first 48b, these values being 
almost 30 times greater than background proliferation to the medium blank (concentrated 
RPMI/1). Thereafter, the proliferative response decreased reaching its lowest level to 
proteins released between day 5 and day 6, a value only 3 times greater than the 
background. 
Axillary lymph node cells responded well to live 5 day old schistosomula (Fig. 3.5), 
all values being higher than background proliferation. When exposed to 400 
schistosomula, the level of proliferation was 11 times greater than background and, the 
response appeared to plateau at this point. However, the degree of proliferation induced 
by sonicated compared to live parasites was greatly enhanced, the highest level occurring 
to 200-400 sonicated parasites, a value 55 times greater than background. When 400 live 
schistosomula of different ages were used directly in lymphocyte blastogencsis assays 
(Fig. 3.6), a pattern of proliferation similar to that in figure 3.4 was observed. Tle highest 
level of proliferation was induced by 1 day old, and the lowest by 11 day old 
schistosomula. 
3.3.3 Analysis ofproliferative responses of cervical lymph node cells recoveredfrom 
intra -dermally vaccinated mice 
The proliferative responses of cervical lymph node cells recovered from i. d. 
vaccinated mice to titrated soluble parasite proteins are shown in figure 3.7. In all cases, 
despite a high background, elevated levels of proliferation occurred to all protein 
samples. The proliferative response appeared to plateau at 10yg per well (Fig. 3.7 inset), 
and the magnitude of the response at this protein concentration was very similar 
whichever fraction was used. However, lyg protein/well was used subsequently to 
conserve scarce samples. Cellular responses to lpg soluble parasite proteins collected 
every 24h over a7 day period are shown in figure 3.8. The lowest level of proliferation 
occurred to proteins present in the day 1 soluble fraction, this value being significantly 
lower than all other samples (P <0.05). After 24h, the magnitude of the response to 
soluble parasite fractions was similar, being almost 3 times greater than the background 
level. 
The pattern of proliferation to the equivalent amount of protein released from 1000 
schistosomula (Fig. 3.9) showed a similar profile to that observed in figure 3.8. A 
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Fig. 3.4. Proliferative response of axillary lymph node 
cells, recovered from percutaneously vaccinated mice, to 
schistosomula-released proteins collected at 24h intervals 
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cells,, recovered from percutaneously vaccinated mice, 
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Fig. 3.7. Proliferative response of cervical lymph node cells, 
recovered from intra-dermally vaccinated mice, to titrated 
soluble protein from 1,3,5 and 7 day old schistosomula. 
Values are expressed as the mean c. p. m. ± S. E. M. from triplicate 
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cells, recovered from intra-dermally vaccinated mice, to 
1pg soluble protein derived from schistosomula and 
collected at 24h intervals over a7 day period. 
Values are expressed as the mean c. p. m. ± S. E. M. f or 
triplicate wells from 3 experiments. 
72 ý 
40 
30 
0 
20 
.2 
10 
0 
ýe TI- c\j CY) qt LO CD r- 
cIIIIIII 
ca c\j m , It U) CD 73 
E 
=3 Culture Period (Days) 
-0 
Fig. 3.9. Proliferative response of cervical lymph node 
cells, recovered from intra-dermally vaccinated mice, to 
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significantly lower response (P< 0.05) was induced by proteins released during the first 
24h of culture than at subsequent times, this value being 3 times greater than background 
levels. Supernatants collected at later time points, induced a higher level of proliferation, 
approximately 5 times greater than background levels. Figure 3.10 illustrates the 
proliferative response of cervical lymph node cells to particulate parasite fractions 
collected every 24h over a7 day period. All fractions gave similarly high responses, each 
being at least 4 times greater than background proliferation. 
3.4 Discussion 
3.4.1 Blastogenesis assay conditions 
Since M169 is a complex medium, it is impossible, without much time-consuming 
work, to identify the component(s) responsible for the inhibition of cellular proliferation. 
However, despite the superior nature of M169 as a parasite culture medium, RPMI/1 was 
capable of supporting a high level of parasite viability, and thus could be used as a 
substitute. 
In all blastogenesis experiments, negative controls were included to account for 3H- 
thymidine incorporation by APC, live larvae, or responder cells in the presence of 
medium alone, whilst SWAP was used as a positive control. In some experiments, lymph 
node cells recovered from naive mice were included to control for any non-specific 
stimulation of proliferation. Ideally, each assay would have included such lymph node 
cell controls; however, test material was often limiting. Also, a concanavalin A control 
would have been useful to allow comparison of cell viability from experiment to 
experiment. 
Blastogenesis experiments used the axillary or cervical lymph nodes excised from 
mice five days after either percutaneous vaccination with optimally-attenuated cercariac, 
or intra-dermal vaccination with day 8 schistosomula respectively. During the period 
between exposure to parasites and excision of lymph nodes, little parasite death occurs 
(Wilson et aL 1986), therefore most T cell responses should be directed towards material 
released by transforming cercariae or by migrating schistosomula. Supportive evidence 
for this inference comes from experiments in which a DTH footpad assay was used to 
probe in vivo cellular responses of mice, 10 or 17 days after vaccination with irradiated 
ccrcariae (Ratcliffe & Wilson, 1992). A much lower response was observed to fixed 
(dead) compared to live lung-stage schistosoinula, suggesting that up to 17 days post- 
vaccination the majority of T cell specificities are towards secretory or released proteins, 
not somatic proteins derived from dead parasites. It has been determined that lymph node 
cells recovered on day 5 yield the highest level of proliferation after in vitro restimulation 
with parasite antigen (Pemberton et A 1991). Presumably, the 5 day exposure period 
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allowed enough time for cells to be primed to parasite material but for few to have left the 
lymph nodes as part of their normal trafficking. 
3.4.2 Proliferative responses of axillary lymph node cells recovered from p. c. 
vaccinated mice 
Since the immune system has a 'lag phase' before a response to antigen is detectable, 
it was likely that cells recovered on day 5 would have a specificity which was biased 
towards proteins released by larvae within the first one to two days after vaccination. It 
may seem surprising therefore that the lowest proliferative response of axillary lymph 
node cells to soluble parasite proteins was to those present in the 24h schistosomula. 
However, two results from chapter 2 may help to explain this. During the first 24h after 
transformation, the schistosomulum synthesises very little protein. However, within this 
time there is a massive release of proteins pre-synthesised in the cercaria. Thus, in terms 
of protein composition, the 24h parasite can be regarded as a cercaria minus the proteins 
released within this period. After 24h, the rate of protein synthesis increases, therefore the 
proportion of total released proteins derived from material synthesised post- 
transformation is also likely to increase. It was possible then, that after the first 24h, more 
proteins to which the mouse had been sensitised were present in the soluble fraction of 
parasites and hence caused the higher degree of proliferation. 
The highest levels of proliferation induced by proteins released in vitro by 1000 
schistosomula occurred to those lost within the first 24h to 48h of culture. It was likely 
that this material constituted the major set of proteins to which the vaccinated mouse had 
been primed. Additionally, during this period, the rate of protein loss is high. Tberefore, 
the enhanced degree of proliferation may also reflect the quantity of antigen used in the 
assay as much as its quality. However this is a reflection of the events which occur during 
a natural infection i. e. a host is exposed to a particular number of parasites not to a 
standard quantity of antigen at all stages. 
The proliferative response of axillary lymph node cells to 400 live schistosomula was 
marginally greater than that induced by isolated released proteins (cf. Fig. 3.4). However, 
it must be remembered that the live parasites were in culture with responder cells for 5 
days. Thus, 400 schistosomula released antigenic material over a period of 120h 
compared with the isolated released proteins which were collected after culture of 1000 
schistosomula for 24h. Although not an accurate comparison, it appears that the presence 
of a live metabolising parasite does not provide a dramatically enhanced antigenic 
stimulus compared to isolated released proteins. This result was in contrast to that 
obtained by James (1981) who demonstrated a highly elevated proliferative response of 
cells to live schistosomula compared to their isolated released proteins. Several factors 
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may account for this discrepancy, firstly James pooled cells from disparate lymph nodes 
of chronically infected mice and as such the results are not directly comparable. 
Secondly, proteins released over 24h or 48h were collected, whereas live schistosomula 
were present in the assay for 62h and therefore had a longer period in which to release 
protein. However, the proliferative response to titrated numbers of live schistosomula 
agreed with those of James (1981), who found that the level of proliferation reached a 
plateau at 400 larvae per well. That sonicated 5 day old schistosomula induced a much 
greater response than intact parasites suggests either the quantity of antigen released from 
viable schistosomula or the number of specific T cells to such released proteins was 
limiting. The latter hypothesis would seem to be correct, since increasing the number of 
live parasites from 400 to 600 did not increase the level of proliferation. The pattern of 
proliferation induced by schistosomula up to 11 days old supported the result obtained 
using isolated released proteins, the lowest level of proliferation occurring to older 
parasites. This indicates that either quantitatively less protein to which the mouse had 
been sensitised was released by later-stage parasites, or that there were qualitative 
differences in the secreted material. 
3.4.3 Proliferative responses of cervical lymph node cells recoveredfrom i. d. vaccinated 
mice 
Initially, i. d. injection of day 8 schistosomula was carried out in FCS-containing 
medium. However, high background levels of proliferation (approximately 20,000 c. p. m. ) 
were obtained, since cervical lymph node cells would proliferate in response to the FCS 
present in RPMI/10. Subsequently, schistosomula were washed and injected into the 
dcrmis of the pinna in M169 containing normal mouse serum. This reduced the 
background proliferation to approximately 5,000 c. p. m.. 
The proliferative response of lymph node cells from Ld. vaccinated mice to titratcd 
soluble protein derived from 1 to 7 day old schistosomula reached a plateau at 
approximately lOpg/well. Tbc magnitude of the response at this antigen concentration 
was similar for all soluble fractions analysed, suggesting either that the isotope or the 
number of antigen-specific T cells was limiting (i. e. antigen was in excess). If the latter 
explanation is correct then the use of limiting quantities of antigen allows smaller 
differences in the number of specific T cells to be detected, in terms of magnitude of 
proliferation. When lpg soluble protein was used per well, the lowest proliferative 
response by lymphocytes was to proteins derived from 1 day old schistosomula. As 
mentioned previously, a parasite of this age can be regarded, in terms of protein 
composition, as a cercaria minus the carly-stage secretions. Following i. d. vaccination of 
mice with 8 day old schistosomula, it was likely that the majority of T cell specificities 
would be to proteins synthesised after transformation, since most proteins synthesiscd 
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prior to transformation have been lost from the schistosomula by day 8 (chapter 2). 
Therefore, it was not surprising that the soluble protein derived from 1 day old 
schistosomula induced the lowest level of proliferation. Subsequent protein fractions 
caused similar levels of proliferation, indicative of the relative homogeneity of this sub- 
set of parasite proteins throughout the first week of development (chapter 2). 
The relatively low response of cervical lymph node cells to proteins released during 
the first 24h after transformation compared with later fractions may be explained by 
qualitative rather than quantitative factors. Although it was likely that quantitatively more 
protein was present in this fraction it would be comprised predominantly of proteins that 
were synthesised prior to transformation. Since 8 day old schistosomula were the 
youngest parasites to which mice in this vaccination regime had been exposed, 
lymphocytes from such animals would not have been primed to stage-spccific proteins 
released during the first 24h. After this time, an increasing proportion of total released 
proteins would be comprised of those synthesised post-transformation. This is likely to 
explain the enhanced proliferative response to proteins released after 24h. 
Particulate parasite fractions were capable of inducing a good, yet fairly uniform 
proliferative response. This is probably because the fraction contains many structural 
proteins which are more likely to be conserved throughout the 7 day period. Any 
fluctuations in proliferation were probably due to inaccuracies in resuspending the pellet, 
resulting in slightly different protein concentrations, rather than real qualitative 
differences. 
3.4.4 Conclusion 
As would be expected, all parasite fractions tested in these assays induced substantial 
levels of proliferation above that caused by medium alone. In terms of fold increase in 
incorporation of 3 H-thymidine above background levels, proteins released from the 
equivalent of 1000 schistosomula were as potent as lpg soluble parasite protein in most 
cases. However, to achieve an accurate comparison it would be essential to compare 1Pg 
released protein with lpg soluble protein. This could be achieved by collecting released 
proteins in scrum-free medium, in which only schistosomula older than 5 days can 
survive sufficiently well. Thus, this investigation would be limited to proteins released by 
older larvae. Such experiments are currently underway in this laboratory. Having 
established that released proteins can stimulate proliferation of T cells recovered from 
protectively vaccinated mice (and were therefore released in vivo in order to prime 
lymphocytes), it would be interesting to determine the type and magnitude of response 
induced i. e. Tbl or M. A good indication of this would be provided by cytokine assays 
performed on culture supernatants taken from T cell proliferation assays. 
For an effective immune response to occur against pathogens, foreign proteins must 
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induce proliferation and therefore clonal expansion of the specific arm of the body's 
defence mechanism. If a high degree of proliferation by lymphocytes is a good indicator 
of the immunogenic and therefore vaccine potential of a group of proteins, then the 
results presented here are encouraging. However, for the purpose of vaccine design 
against schistosomiasis, it is important to define which cellular sub-set is being induced 
to proliferate most by the antigenic fraction. Induction of the 'wrong' sub-set could lead 
to increased pathology rather than cure. Although schistosomula-released proteins 
represent a relatively defined sub-sct of total parasite proteins, their composition is still 
complex. One of the problems of working with crude antigen preparations and trying to 
identify differences in the ability of each to induce proliferation, is the homogeneity 
which exists between fractions. It has been reported previously that lymph node cells 
recovered from mice, 1 week after vaccination, could respond equally well to soluble 
ccrcarial, adult worm and egg antigen preparations, despite the host never having been 
exposed to the latter two life-cycle stages (Mak & Sanderson, 1985). However, at the 
clonal level many differences in reactivity to the various antigenic preparations were 
detected. Tbus, one explanation for the failure of experiments discussed in section 3.1 to 
show a correlation between immune status of the host and ability of lymphocytes to 
proliferate in response to specific antigen maybe the complex nature of the antigen 
mixture used. If more restricted protein mixtures were used, correlations would possibly 
be more obvious. Collection of enough schistosomula-releascd proteins for separation by 
HPEC could potentially help to select candidate vaccine antigens which were capable of 
eliciting strong immune responses of a Thl nature. Alternatively, parasite-rcleased 
proteins could be identified from a gcnc library and the recombinant proteins then tested 
for their ability to induce proliferation of, and cytokine production by, lymph node cells 
recovered from protectively vaccinated mice. Initial steps towards this goal are described 
in chapter 5. 
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CHAPTER FOUR 
Detection of antigenic fractions of Schistosoma mansoni 
using monospecific sera, and sera raised against 
schistosomula-released proteins. 
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4.1 Introduction 
In chapter 1, it was argued that challenge parasites of mice vaccinated once with 
attenuated cercariae were eliminated via aT cell rather than antibody-mediated 
mechanism. Conversely, in multiply-vaccinated mice, the process of elimination is either 
enhanced by, or totally dependent upon antibody-mediated mechanisms. Antibodies 
usually bind to pathogens via accessible epitopes, such as those present on surface- 
exposed proteins. Tbereforc, polypeptides released by schistosomula, unless enriched 
with surface mcmbrane-dcrived macromolecules, are unlikely to be a good source of 
target antigens of protective antibodies. They may nevertheless contain important T cell 
antigens. 
This chapter will describe the characteristics of two antisera, 0-3hS and D4-D8S, 
raised in rabbits against proteins released by schistosomula within the first 3h, and 
between day 4 and day 8 post-transformation, respectively. These sera were produced for 
several reasons. Firstly, analysis of their specificities facilitates investigation of the ability 
of constituents of either 0-3h or D4-D8 released proteins to induce antibody production, 
an indicator of their immunogenicity. However, for the purpose of this work, the most 
important reason was that they could be used to identify proteins expressed from a cDNA 
library; the serum raised against D4-D8 released proteins was produced primarily for this 
purpose. Screening of a larval cDNA library with this serum forms the subject matter of 
the following chapter. 
The 0-3hS was produced for several reasons, but primarily to allow a comparative 
analysis of both 0-3hS and D4-D8S by ELISA and Western blotting experiments against 
their respective homologous antigen preparations or heterologous protein fractions. 
Additionally, 0-3h released proteins were readily available and derived from parasites, 
essentially 100% of which were viable. Furthermore, secretions from newly-transformed 
schistosomula contain stage-spccific proteins, including enzymes involved in skin 
penetration, and as such have a different composition from latcr-stage released 
molecules. In an attempt to compare the relative abundance of a particular protein in an 
antigen preparation and its ability to induce an antibody response in rabbits, molecules 
detected by Western blotting and following Coomassie staining or autoradiography, will 
be described. 
Additionally, monospecific sera and monoclonal antibodies directed against defined 
proteins were used to characterise the soluble and released protein fractions, by Western 
blotting. Finally, sera raised against both early- and later-stage released proteins were 
tested for their ability to confer passive protection to mice, against a Schistosoma 
mansoni challenge infection. 
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4.2 Materials and methods 
4.2.1 Preparation ofparasite material 
Schistosomula were obtained as described in section 3.2.2. For the first 3h, parasites 
were cultured in M169W, the suspension centrifuged at 150g for 60s and the parasite- 
free culture supernatant (0-3h) removed. Schistosomula were resuspended and cultured 
in M169S for a further 4 days after which they were washed 6 times in 10ml M169W, to 
remove serum proteins and dead parasites, then resuspended in M169W containing 1% 
normal rabbit serum (NRS; GIBCO) and cultured for 4 more days. At the end of this 
period, the parasite suspension was centrifuged and the supernatant (day 4- day 8 culture 
supernatant; D4-D8) removed. Several 0-3h or D4-D8 supernatants, collected from 
different parasite cultures, were pooled, concentrated using a stirred ultrafiltration cell 
(Amicon) as described previously (section 3.2.2), and stored at -20*C. Such samples 
were used to raise antiseruin (see section 4.2.2). 
For enzyme linked immunosorbent assays (ELISA) and Westem blotting 
experiments, soluble antigen preparations of ccrcariae (soluble cercarial antigen 
preparation; SCAP), in vitro-cultured lung-stage larvae (soluble larval antigen 
preparation; SIAP) and adult worms (soluble worm antigen preparation; SWAP), 
recovered by portal perfusion of infected mice (Smithers & Terry, 1965), were prepared, 
as detailed in chapter 2. Additionally, 0-3h released proteins were produced as described 
above. However, because protein estimates were required, prior to use of samples in 
ELISA or Western blotting experiments, lung-stage larval secretions had to be collected 
in serum-frec medium. It was noted previously (chapter 2) that within the first 5 to 6 
days after transformation, schistosomula were fragile upon centrifugation and 'sensitive' 
to the absence of serum. If D4-D8 culture supernatants had been collected in scrum-frec 
medium, an unacceptable level of parasite death would have occurred. Previous 
experimental results indicated a strong degree of homology in the proteins released 
between days 4 to 6 and 6 to 8. Since a high level of parasite viability could be 
maintained during in vitro culture from day 6 to day 8 in M169W (which contains no 
serum supplement), proteins released during this time were collected instead of between 
day 4 and day 8. On day 6, schistosomula were washed 6 times in 10ml M169W and then 
cultured for an additional 2 days in M169W. At the end of this period, the culture 
supernatant was recovered and concentrated, whilst the schistosornula were used to yield 
a soluble antigen preparation (SLAP). The protein content of the soluble and released 
fractions was estimated by the Bradford assay (Bio-Rad). 
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4.2.2 Production of antisera 
Antisera to proteins released within the first 3h and between day 4 and day 8 post- 
transformation were raised in New Zealand white rabbits. Prior to the first immunisation, 
a prc-bleed was taken from each animal to serve as a normal rabbit serum (NRS) control 
in subsequent experiments. For the primary inoculation, 500, ul of the appropriate 
concentrated culture supernatant was mixed, by vortexing, with an equal volume of 
Freund's complete adjuvant (SIGMA) and injected sub-cutancously (s. c. ) at 4 or 5 sites 
on the back of the rabbit. Subsequent immunisations were given in Freund's incomplete 
adjuvant (SIGMA) at approximately 4 week intervals. Small test bleeds were taken from 
each rabbit at approximately 2 week intervals to allow changes in the antibody titrcs to be 
monitored by ELISA. Each blood sample was allowed to clot for 1h at room temperature, 
ringed with a mounted needle and allowed to stand for several hours at 4*C. The serum 
was removed, pipetted into eppendorfs and spun at 90OOg for 90s to remove any 
contaminating red blood cells. All sera were stored in small aliquots at -70'C. 
4.2.3 Monoclonal antibodies and monospecific sera 
In an attempt to identify constituents of the soluble and, in particular, released 
parasite proteins by Western blotting, monoclonal antibodies and monospecific sera were 
obtained from research groups around the world. The following samples were kindly 
donated: 
Target antigen M, Specificity Raised in 
(kDa) 
Superoxide dismutase (SOD) 16 
Superoxide dismutase (SOD) 20 
Glutathione S-transferase (Sm26) 26 
Glutathione S-transferase (Sm28) 28 
Triose-phosphate isomerase (TPI) 28 
Haernoglobinase (Sm32) 32 
Calreticulin (Sm58) 58 
Paramyosin (Sm97) 97 
polyclonal rabbits 
monoclonal mice 
polyclonal rabbits 
polyclonal. rabbits 
monoclonal mice 
monoclonal rabbits 
polyclonal rabbits 
monoclonal mice 
4.2.4 Measurement of antigen -specific antibody titre 
Group 
Pierce 
LoVerde 
Pierce 
Pierce 
Ham 
Rotmans 
Picrce 
Pcarcc 
The antibody titrcs of the 0-3h serum (0-3hS) and the D4-D8 serum (D4-D8S) to 
their essentially homologous antigen preparations (0-3h and D6-D8 released proteins 
respectively) or to various other antigcnic fractions of Schistosoma mansoni was 
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determined by ELISA. Microtitre plates (Nunc) were coated with antigen, diluted to 
100, ul with carbonate coating buffer pH 9.6 (15mM Na2 C03,35mM NaHCO), by 
incubation at 4"C overnight in a humid chamber. Subsequently, plates were washed with 
PBS Tween (137mM NaCl, 2.7mM KCI, 8.1mM Na2HP0411.5mM KIHýPO4 containing 
0.3% Twcen 20) and the wells blocked, to inhibit non-spccific binding of antibodies, by 
incubation with blocking buffer (carbonate coating buffer containing 3% normal goat 
serum (NGS)) for 2h at 37*C in a humid chamber. The scra were diluted in blocking 
buffer as required, 100yl of the appropriate sample added to each well and the plates 
incubated in a humid chamber for 2h at room temperature. Plates were washed 3 times 
with PBS T`wcen and, after the addition of 100pl goat anti-rabbit peroxidase conjugate 
(GAR PO conjugate; SIGMA), diluted to 1: 5000 with blocking buffer, incubated in a 
humid chamber for 2h at room temperature. Plates were washed 3 times with PBS Twcen 
and then 100, ul enzyme substrate (10mM Na2HP04.12H20,4.9mM citric acid, containing 
0.05% Tween 20 and, immediately before use 0.2% 0-phenylenediamine and 0.02% 
H20) added to each well. When sufficient colour had developed, the reaction was 
stopped by the addition of 30, ul 8M sulphuric acid and, spectrophometric readings taken 
at 490nm in a Dynatcch MR5000 plate reader. 
4.2.5 SDS Polyacrylamide gel electrophoresis (SDS-PAGE) 
Separation of various protein fractions of Schistosoma mansoni was performed by 
1-D electrophoresis under reducing conditions according to the method of Laemmli 
(1970; see also chapter 2). Known quantities of protein were boiled for 2 min in sample 
buffer (4 volumes sample: 1 volume sample buffer; 10% SDS, 25% glycerol, 0.3125M 
Tris-HCI pH 6.8,0.025% bromophenol blue, 50mM dithiothreitol) and loaded on to gels 
consisting of a running gel (6-16% acrylamide, 0.16-0.43% bis-acrylamide in 0.375M 
Tris-HCI pH 8.8 containing 0.1% SDS) overlaid by a stacking gel (4.5% acrylamide, 
0.12% bis-acrylamide in 0.125M Tris-HCI pH 6.8 containing 0.1% SDS). Molecular 
weight standards (Bio-Rad) were treated in the same way as test antigen fractions, and 
loaded on to the gel. A constant current of 20m. A per gel was applied until the dye front 
reached the running gel, when the current was increased to 30mA per gel. Electrophoresis 
continued until the dye front was approximately 20mm from the base of the gel. Where 
required, gels were fixed in 15% TCA, stained with Coomassie brilliant blue (1.25% 
Coomassie brilliant blue in 40% methanol, 10% acetic acid), destained in a 40% 
methanol, 10% acetic acid mixture and dried onto filter paper. 
4.2.6 Western blotting 
After electrophoretic separation of proteins, gels were sandwiched between an 
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immobilon-P membrane (MILLIPORE), which had been pre-soaked in methanol for 5s 
and then deionised water for 2 min, and filter paper pre-soaked in 0.5% SDS. Blotting of 
proteins took place at 40V for 16h in an LKB "Transphor" apparatus containing transfer 
buffer (25mM Tris, 192mM glycine in 20% methanol) cooled to 4*C by a heat 
exchanger. Upon completion of transfer, the segment of the membrane containing the 
molecular weight markers was sliced off and stained for 5 min with Amido Black (0.1% 
Amido black, 50% methanol, 10% acetic acid), then destained as required in 50% 
methanol, 10% acetic acid. In order to reduce non-specific binding of antibodies, the 
remainder of the membrane was incubated in blocking buffer (PBS containing 0.3% 
T'Ween 20 and 5% NGS) for 2h at room temperature. If required, the membrane was cut 
into strips and then incubated with the test sera, diluted as appropriate in blocking buffer, 
for 2h at room temperature. For each antigen preparation tested, one strip was always 
probed with NRS to serve as a negative control. Strips were washed in 5 changes of PBS 
Tween over 1h and were then incubated in GAR PO conjugate diluted to 1: 20000 in 
blocking buffer or, in experiments where anti-Sm97, anti-TPI or anti-SOD (20 kDa) 
were used, diluted (1: 15000) goat anti-mouse peroxidase conjugate (SIGMA), for 2h at 
room temperature. Strips were washed again for lb in PBS Tween with 5 changes of 
buffer. The sensitive technique of enhanced chemiluminescence (ECL; Amersham) was 
used to detect antigen/antibody complexes as described by the manufacturer. Tle novel 
step utilised by this method is the oxidation of luminol, catalyscd by peroxidase 
conjugated antibodies, which results in the emission of light. Such emissions are detected 
on film (Hyper-film ECL; Amersham) and visualised after incubation in Kodak D19 
developer for approximately 1 min and fixing in Unifix (Kodak; 1 volume Unifix: '21 
volumes water) for 5 min. 
4.2.7 Passive transfer ofserum 
Prior to transfer, the various sera (NRS, 0-3hS and D4-D8S) were heat inactivated 
at 56"C for 30 min to destroy complement activity and then incubated with 2ml packed 
mouse red blood cells for 2h at 37"C to adsorb potentially damaging antibodies directed 
against mouse antigens. Mouse red blood cells were obtained by cardiac puncture using a 
hcpariniscd syringe and needle. Blood was collected into a tube, on ice, containing 1ml 
heparinised saline. The cells were centrifuged at 200g for 10 min at 4*C, the supernatant 
removed and the cells resuspended in hcpariniscd saline. The centrifugation and wash 
steps were repeated, the cells left in suspension for 10 min, centrifuged and the 
supernatant then removed. The cells were then ready to be used for adsorption. 
For all passive transfer experiments, C57BI/6 mice were used, either as recipients of 
NRS, test serum or as challenge controls. Each experimental group contained 5 mice. The 
treatment received by groups of mice in each experiment is displayed in table 4.1. 
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Experiment Bleed Group Treatment 
number number 
1 4 1 Challenge controls 
2 NRS on DO 
3 O-3hS on DO 
4 NRS on D4 and D7 
5 D4-D8S on D4 and D7 
2 7 1 Challenge controls 
2 NRS on D4 and D7 
3 D4-D8S on D4 and D7 
3 7 1 Challenge controls 
2 NRS on DO 
3 O-3hS on DO 
4 O-3hS on D1 
5 O-3hS on D4 and D7 
4 9 1 Challenge controls 
2 NRS on D4 and DT 
3 D4-D8S on DO 
4 D4-D8S on D1 
5 D4-D8S on D4 and D7 
Table 4.1. Experimental design for the passive transfer of 
sera to mice. The experiment number, the bleed from which the 
test serum was derived, and the treatment groups are tabulated. 
Additional experimental details are given in the text. 
86 
In each case, mice were exposed to a mean of either 200 (experiment 1) or 120 
(experiments 2,3 and 4) hand-counted ccrcariae via the tail on day 0. All groups of mice 
which received serum on day 0 were injected several hours prior to challenge infection. 
For each inoculation, 0.5ml serum was administered intravenously. Portal pcrfusion of 
the mice was carried out 5 weeks after challenge infection and the adult worm burden 
determined. Resistance was expressed as the percentage reduction in the number of adult 
worms recovered from mice receiving the test serum compared to that of challenge 
control mice or mice receiving NRS, and was calculated from the formula 
R= (C - T)/C x 100 
where T is the mean number of worms recovered from the test group, C is the mean 
number of worms recovered from the control group and R is the level of resistance. 
Differences in worm burdens were tested for statistical significance using the Student's t 
test. 
4.3 Results 
4.3.1 SDS-PAGE analysis ofsoluble and released proteins of Schistosoma mansoni 
A Coomassie-stained gel of the protein fractions used in subsequent ELISA or 
Western blot experiments is displayed in figure 4.1. Each sample was loaded at 
25pg/lane. Ile soluble cercarial antigen preparation contained two dominant proteins of 
molecular weight (M) 31 and 28 kDa, the latter being a major component of both 0-3h 
and D6-D8 released proteins. Two polypcptides of M, 61 and 20 kDa present in SCAP 
were barely visible in SLAP and could not be detected in SWAP. Constituents of the 
lung-stage soluble preparation more closely resembled SWAP than SCAP but contained 
a dominant, and possibly unique, protein at approximately 45 kDa. Ile dominant doublet 
in SCAP at 31 and 28 kDa became a triplet in SLAP and SWAP, the additional protein 
occurring at 32 kDa. The latter two preparations contained several minor polypeptides at 
approximately 90 kDa which could not be detected in SCAP or either of the released 
protein fractions. 
Approximately 12 polypeptides could be detected in the 0-3h released material; of 
the two most dominant, the moiety at 61 kDa could not be detected in D6-D8 released 
proteins whilst the 28 kDa antigen remained prominent. In the D6-D8 released fraction 
approximately 15-20 proteins were detectable, ranging in M, from 70 kDa to <10 kDa. 
The most dominant protein occurred at 28 kDa whilst a polypeptide at approximately 20 
kDa was also prominent. Thus, the early- and later-stage released proteins were not 
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Fig. 4.1. Coomassie-stained gel of soluble preparations of cercariae 
(SCAP), lung-stage larvae (SLAP) and adult worms (SWAP) and 
early-stage (0-3h) and later-stage (D6-D8) released proteins of 
Schistosoma mansoni. The molecular weights (kDa) of the 
standards are illustrated. 
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identical in composition. Additionally, in comparison to either SCAP or SLAP, the 0-3h 
and D6-D8 released proteins, which are likely to be sub-scts of these cruder soluble 
parasite preparations, showed both quantitative and qualitative differences in their 
composition. Some constituents of the soluble preparations appeared to be released in 
relatively large quantities whilst others did not seem to be released at all. However, using 
1-D SDS-PAGE, it was not possible to state unequivocally that proteins of identical M,, 
present in both soluble and released protein fractions, were indeed the same molecule. 
4.3.2 Production of antisera and vaccination schedule 
The vaccination schedule for each rabbit, inoculated with either 0-3h or D4-D8 
released proteins, and the resulting antibody titre determined by ELISA against their 
homologous antigen preparation (0.025pg/well), is shown in figure 4.2. In these 
experiments, the 0-3hS was used at a dilution of 1: 12800 and the D4-D8S at 1: 800. The 
antigen-specific antibody titre of the rabbit immunised with 0-3h released proteins 
reached a plateau after 2 boosts (Fig. 4.2A). Approximately 2 weeks after the third boost, 
whilst the antibody titre was high, this rabbit was terminally bled (bleed 7). In contrast, 
the antibody titre of the rabbit immunised with proteins released by schistosomula 
between days 4 and 8, increased dramatically after the second boost (Fig. 4.213) and was 
still rising after the third boost. Between weeks 17 and 37 after the primary inoculation, 
the titre fell very little. The rabbit received one more boost at week 37 and was then 
terminally bled 2 weeks later (bleed 9). 
4.3.3 Analysis of serum reactivity by ELISA 
In order to identify the appropriate antibody and antigen dilutions to be used in 
subsequent ELISA experiments, a matrix was set up in which the sera (bleed 7) were 
diluted down the plate and the antigen concentration across the plate. 'Me D4-DSS gave 
a good optical density reading, which fell on the linear part of the dilution curve (data not 
shown), at a serum dilution of 1: 800 and using D6-D8 released proteins at a 
concentration of 0.025pg/Well. The 0-3hS was many times more potent than the D4-D8S 
and could be used at a dilution of 1: 12800 when plates were coated with 0-3h released 
proteins at 0.025, ug/well. However, most experiments incorporated an antibody dilution 
curve which commenced at 1: 800 and an antigen concentration of 0.025pg/wcll. 
Ile reactivity of each serum (bleed 7) to its homologous and heterologous antigen 
fraction determined by ELISA is illustrated in figure 4.3. Tlie 0-3hS reacted very 
strongly to its homologous antigen preparation but much less so to the hetcrologous 
D6-D8 released protein fraction. In contrast, the D4-D8S reacted more strongly to 
proteins released within the first 3h post-transformation than it did to its essentially 
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Fig. 4.2. Vaccination schedule and antibody titre, determined 
by ELISA, of serum recovered from rabbits immunised with 
proteins released by schistosomula during the first 3h (A) or 
between day 4 and day 8 (B) post-transformation. 
Plates were coated with the homologous antigen (0-3h 
or D6-D8 released proteins) at 0.025pg/well. Numbers 
indicate times at which blood samples were taken. 
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Fig. 4.3. Titration of 0-3hS and D4-D8S in an ELISA against 
their homologous and heterologous antigen preparations. 
The graph represents the reactivity of the 0-3hS 
(squares) against 0-3h (1: 1) or D6-D8 W released proteins 
and D4-D8S (triangles) against 0-3h (A) or D6-D8 
(A) released proteins. Both antigen preparations were used 
at 0.025pg/well. All values are expressed as the mean O. D. 
S. E.. 
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homologous fraction (D6-D8 released proteins). The reactivity of the two sera against 
their homologous antigen fraction (0-3h or D6-D8 released proteins) and soluble 
cercarial or lung-stage larval preparations (data not shown) was compared by ELISA. 
This experiment demonstrated that the sera reacted more strongly to their homologous 
antigens than to the soluble preparations. 
The reactivity of the sera in an ELISA, using plates coated with soluble preparations 
of either cercariac, lung-stage schistosomula or adult worms is shown in figure 4.4. T'he 
0-3hS reacted strongly to SCAP yet relatively poorly to both SLAP and SWAP. 
Similarly, the D4-D8S gave a high O. D. against SCAP but much lower levels to SLAP 
or SWAP. The pattern of reactivity of the two sera is depicted more clearly in the inset of 
figure 4.4. The 0-3hS reacted more strongly to SCAP than did the D4-D8S. However, 
antibodies from the two sera showed an equal affinity for proteins present in SIAP whilst 
the D4-D8S reacted more strongly than the 0-3hS to proteins present in SWAP. In a 
further experiment which used different cercarial, lung-stage larval and adult worm 
antigen preparations, the pattern of reactivity was similar (data not shown). However, 
antibodies from the 0-3hS showed a slightly higher affinity for SLAP than the D4-D8S, 
whilst the reactivities to SWAP were almost identical. 
4.3.4 Analysis of serum specificity by Western blotting 
Tbc specificity of both sera to antigens present in 0-3h or D6-D8 released protein 
fractions (loaded at 2.5yg/cm in a 3cm trough lane) detected by Western blotting is 
shown in figure 4.5. Since the 0-3hS and D4-D8S reacted less strongly to D6-D8 than 
to 0-3h released proteins, the sera had to be used at higher concentrations (commencing 
at 1: 250 instead of 1: 1000) to allow their antibody specificities against this preparation to 
be defined. The 0-3hS recogniscd at least 7 distinct moieties in its homologous antigen 
preparation, with four of Mr 70,45,20 and 12 kDa being particularly prominent. At the 
serum concentrations used, the D4-D8S recognised a smaller number of antigens but, as 
for the 0-3hS, proteins of 20 and 12 kDa were dominant. Both 0-3hS and D4-D8S 
detected a similar set of antigens in the D6-D8 released proteins. However, a minor 
protein of <20 kDa (arrowed) was only recognised by the 0-3hS whilst a 47 kDa antigen 
(affowcd) was only identified by the D4-D8S. Unlike the pattern of reactivity against the 
0-3h released proteins, neither serum recognised any antigen particularly strongly, 
perhaps the most prominent being of M. 28 and 20 kDa. 
When the two sera were used to probe Western blots of three soluble parasite 
fractions (SCAP, SLAP and SWAP), the intensity of staining mirrored the result obtained 
by ELISA (data not shown). However, by using the same range of serum dilutions 
for all three antigen preparations, few proteins could be detected in either SLAP or 
SWAP. T'herefore, subsequent experiments used higher serum concentrations for SIAP 
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Fig. 4.4. Titration of 0-3hS and D4-DBS in an ELISA 
against soluble preparations of cercariae (solid lines), 
lung-stage schistosomula (dashed lines) or adult 
worms (dotted lines). 
The reactivities of the 0-3h serum (0) and D4-D8 
serum (A) against each preparation is expressed as the 
mean O. D. ± S. E.. The inset figure shows an enlarged 
segment of the graph (see text for details). 
93 
800 1600 3200 6400 12800 25600 51200 104000 
Reciprocal serum dilution 
M 
(x 10 
200 - 
116 
97 
66 
45 
0-3h D6-D8 
31 
a 
'W . 
11 111tI 
000000 
0oo000 Lo 00 Lf) 00 
oo00o 
0-3hS D4-D8S NRS 0-3hS D4-D8S 
Fig. 4.5. Western blot analysis of 0-3h and D6-D8 
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0-3hS, D4-D8S and NRS at the serum dilutions 
indicated underneath the brackets. 
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and SWAP to allow the specificity of the sera to be determined (Fig. 4.6). A broad array 
of proteins was identified by both 0-3hS and D4-D8S in SCAP, ranging in M, from 
>200 kDa to <10 kDa. When the 0-3hS was used to probe blots of SCAP, antigens of 45, 
20 and 12 kDa were particularly prominent, whilst only the latter two were recognised 
strongly by the D4-D8S. Both sera rccognised a diverse range, but more restricted 
number of proteins in SLAP and SWAP. The D4-D8S detected several high M, antigens 
which were unique to SLAP and SWAP, especially one at approximately 97 kDa. This 
protein was recognised by the 0-3hS in SLAP but not in SWAP. Additionally, the 
dominant protein at 12 kDa in SCAP which was identified by both sera, could not be 
detected in either SLAP or SWAP. Furthermore, the 45 kDa protein was only identified 
by the 0-3hS in SCAP but not in SIAP or SWAP, whilst the dominant 20 kDa protein 
which was detected by both sera could only be visualised at the highest serum 
concentration in SLAP and SWAP. No proteins were identified by antibodies from NRS 
in any of the soluble parasite preparations tested. 
4.3.5 Identification ofparasite proteins with monospecific sera or monoclonal 
antibodies 
Monospecific sera or monoclonal antibodies were used in an attempt to identify 
constituents of soluble and released protein fractions derived from schistosomula. The 
dilutions used for each monospecific sera varied. Suitable dilutions were arrived at by 
using the suggested working concentration and testing it on Western blots of SWAP. If 
the staining was either too strong or too weak, the dilution was altered accordingly. 
Figure 4.7 shows the pattern of antigcn/antibody staining using the defined sera, against 
SCAP, SLAP and SWAP loaded at identical antigen concentrations (10pg/cm of a 3CM 
trough lane). It was possible to detect superoxide dismutase (Sm16), both glutathione S- 
transferases (Sm26 and Sm28), haernoglobinase (Sm32), calreticulin (Sm58) and 
paramyosin (Sm97) in most antigen preparations, but not superoxide dismutase (20 kDa) 
or triose-phosphate isomerase. Of the proteins detected, superoxide dismutase (16 kDa), 
calreticulin and paramyosin appeared to constitute a higher percentage of the total soluble 
protein in later- compared to earlier-stage parasites. In contrast, both GSTs showed a 
similar staining intensity throughout the three lifc-cyclc stages. Haemoglobinasc could 
be detected in both SIAP and SWAP but not in SCAR 
The 0-3h and D6-D8 released proteins were analysed in a similar manner (Fig. 4.8). 
However, due to the scarcity of the latter, both preparations were used at a lower antigen 
concentration (2.5pg/cm of a 3cm trough lane). In such experiments, the serum 
concentrations were increased, which allowed the detection of Sm26 and Sm28 in both 
the 0-3h and D6-D8 released proteins. Additionally, SOD (16 kDa) and calrcticulin 
could be detected in proteins released between day 6 and day 8. 
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Fig. 4.6. Western blot analysis of soluble preparations of 
cercariae (SCAP), lung-stage larvae (SLAP) and adult 
worms (SWAP) of Schistosoma mansoni. 
Antigen preparations (loaded at IlOpg/cm per 3cm trough 
lane) were probed with 0-3hS, D4-D8S or NRS at the 
serum dilutions indicated underneath the brackets. 
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Fig. 4.7. Western blot analysis of soluble preparations of cercariae 
(SCAP),, lung-stage larvae (SLAP) and adult worms (SWAP) of 
Schistosoma mansoni. Parasite proteins were detected with 
monospecific sera or monoclonal antibodies against paramyosin 
(Sm97), superoxide dismutase (Sm16), glutathione S-transferases 
(Sm26 and Sm28), calreticulin (Sm58) or haemoglobinase (Sm32). 
All antigens were loaded at 10pg/cm. 
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Fig. 4.8. Western blot analysis of 0-3h and D6-D8 released 
proteins of Schistosoma mansoni. 
Parasite proteins were detected with monospecific sera or 
monoclonal antibodies against superoxide dismutase (Sm16), 
glutathione S-transferases (Sm26 and Sm28) and calreticulin 
(Sm58). All antigens were loaded at 10; jg/cm per 3cm 
trough lane. 
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4.3.6 Passive transfer of O-AS and D4-D8S to mice 
Both 0-3hS and D4-D8S were tested for their ability to provide passive protection 
to mice challenged with cercariae of Schistosoma mansoni. The scra were transferred on 
various days to assess the importance of skin- and lung-stage parasites as targets of 
immune elimination by each serum. The mean worm burdens, and calculated resistance 
values compared to the NRS control group, from 4 individual experiments arc displayed 
in table 4.2. In experiment 1, mice receiving 0-3hS (bleed 4) intravenously (i. v. ) on day 0 
or D4-D8S (bleed 4) i. v. on days 4 and 7 showed reductions in worm burdens of 25% 
and 25.7% respectively. However, the results were not statistically significant. Likewise, 
experiment 2 in which mice received either NRS or D4-D8S (bleed 7) on days 4 and 7, a 
reduction in worm burden of 22% was achieved which was not statistically significant. In 
experiment 3 where mice received 0-3hS (bleed 7) on day 0, day 1 or days 4 and 7, 
statistically significant reductions in adult worm burdens of 29.3%, 47% and 50.5% 
respectively were achieved compared with the single control group which received NRS 
on day 0. However, when compared to the challenge control group, reductions of 
-0.05%, 24.7% and 29.6% were recorded, none of which attained statistical significance. 
In experiment 4, in which mice received D4-D8S on day 0, day 1 or days 4 and 7, none 
of the resistance values were statistically significant compared to the mean worm burden 
of mice from the NRS control group. 
4.4 Discussion 
4.4.1 A comparative analysis ofsoluble and released proteins of Schistosoma mansoni, 
detected by Coomassie staining and autoradiography 
Soluble and released proteins derived from radio-labelled larvae of Schistosoma 
mansoni have been identified previously by autoradiography (chapter 2). At the time, 
limitations on parasite material, imposed by the size of the snail colony, prevented the 
detection of released proteins by conventional staining methods. Therefore, only proteins 
released from parasites radio-labclled with 35S-methionine either prior to, or post- 
transformation could be detected. Expansion of the snail colony allowed more parasites to 
be obtained and therefore enough released proteins to be collected for detection by 
Coomassie staining, following electrophoretic separation, irrespective of time of 
synthesis. The gel displayed in figure 4.1 showed many similarities to the proteins 
detected by autoradiography, described in chapter 2. 
As expected, there was a degree of antigcnic conservation in the soluble protein 
fractions from cercariae to schistosomula through to adult worms; however there were 
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Experiment Treatment Mean worm Resistance cf. NRS 
number burden ± S. E. control group 
1 Challenge controls 66.8 4.5 
(131 ead 4) NRS on DO 69.6 7.7 
O-3hS on DO 52.2 5.6 25% (P>0.05) 
NRS on D4 + D7 69.5 14.0 
D4-D8S on D4 + D7 51.6 9.1 26% (P>0.05) 
2 Challenge controls 28.2 1.1 
(Bleed 7) NRS on D4 + D7 35.4 2.2 
D4-D8S on D4 + D7 27.6 2.8 22% (P>0.05) 
3 Challenge controls 36.4 4.9 
(Bleed 7) NRS on DO 51.7 4.1 
0-3hS on DO 36.6 2.7 29% (P<0.05) 
0-3hS on D1 27.4 2.1 47% (P<0.01) 
0-3hS on D4 + D7 25.6 3.7 51% (P<0.01) 
4 Challenge controls 39.2 2.1 
(Bleed 9) NRS on D4 + D7 36.2 3.7 
D4-D8S on DO 25.8 + 3.4 29% (P>0.05) 
4-138S on D1 26.5 2.3 27% (P>0.05) 
D4-D8S on D4 + D7 1 29.5 3.7 19% (P>0.05) 
Table 4.2. Protection data achieved with 0-3hS and 
D4-D8S upon passive transfer to mice on either day 
0,1, or days 4 and 7. The mean worm burden ± S. E. 
from each group is shown. All resistance values 
were calculated as detailed in section 4.2.7 using 
the mean worm burden of mice receiving NRS -alone 
as the control group. 
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also both qualitative and quantitative differences. By separating sonicatcd extracts of 
cercariae, schistosomula and adult worms using 2-D SDS-PAGE, Miller, Rckosh & 
LoVcrde (1989) calculated that adult worms shared 60% of the polypcptides of 
schistosomula. However, they found no differences between proteins of the ccrcarial 
extract and those of 1,3,5 and 6h schistosomula. Presumably, this was because only a 
low level of protein synthesis occurs within the first 6h post-transformation (Nagai et aL 
1977; Yuckenburg, Poupin & Mansour, 1987; Blanton & Licate, 1992) and stage- 
specific proteins, associated with skin invasion and the transformation process, may still 
persist. It was also interesting to note, from the same study, that a protein of 20 kDa was 
identified in extracts of schistosomula but not adult worms. In this study, a protein (or 
proteins) at approximately 20 kDa could be detected in SCAP but not SWAP. The 
dominant protein present in SLAP was of 45 kDa. A protein of the same M, was detected 
after autoradiography of labelled soluble parasite proteins (chapter 2). This 
macromolecule was barely detectable in the 24h soluble schistosomula preparation, but 
became one of the prominent proteins in 7 day old schistosomula. 
The two most dominant released proteins detected by radio-labelling of parasites, 
were of M, 61 and 20 kDa. Following Coomassie staining, the former was prominent in 
the 0-3h but not the D6-D8 released proteins. Ile latter could be detected in the 0-3h 
released proteins but did not stain strongly, whereas, in the D6-D8 released fraction, only 
a protein of marginally higher M. could be seen. Thus, it appeared that two 
macromolecules of slightly differing M,, occurring at approximately 20 kDa, were 
present in parasite-released proteins, an hypothesis which was also suggested in chapter 
two on the basis of the presence or absence of protcase activity. The strong intensity of 
this protein (or proteins) on autoradiographs compared to Coomassie-staincd gels 
suggests that it either has a relatively high proportion of methionine residues or is 
synthesised and released at a high rate during the labelling period. Likewise, a protein at 
45 kDa, released by labelled schistosomula during in vitro culture, was prominent on 
autoradiographs yet was barely detectable by Coomassie staining. Conversely, the 
dominant moiety at 28 kDa in both 0-3h and D6-D8 released proteins on Coomassic- 
stained gels was not prominent on autoradiographs of similar fractions. 17his suggests that 
the protein either has a low methionine content or a low rate of synthesis and release 
during the labelling period. A comparison of the proteins released by schistosomula, and 
those present in soluble preparations of cercariae, schistosomula and adult worms, 
showed that there were both quantitative and qualitative differences in their composition. 
This provided further evidence that the released proteins were derived from viable 
parasites and not artefacts from dead or dying schistosomula. 
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4.4.2 Analysis of serum reactivity by ELISA 
Since much more protein is released by schistosomula during the first 3h after 
transformation than at later stages (Harrop, unpublished observations), the higher titre of 
the 0-3hS compared with the D4-D8S may simply reflect the quantity of proteins used to 
inoculate the rabbits, rather than their antigcnicity. A recommended vaccination dose for 
rabbits ranges from 50yg to 10OOpg antigen per inoculation (Harlow & Lane, 1988). The 
rabbit immunised with 0-3h released proteins received at least 50pg for each dose 
whereas the recipient of D4-D8 released molecules was inoculated with approximately 
10yg. This may provide one explanation for the higher titrc of the 0-3hS. However, 
antibodies present in the D4-D8S bound more strongly to material released during the 
first 3h post-transformation than to D6-D8 released protcins. 'Ibis suggests that moietics 
common to both 0-3h and 134-138 released proteins are more immunogenic, in terms of 
antibody production, than those unique to the latter. A further potential explanation which 
would affect interpretation of the titre of the 134-138S, was that an inaccurate estimate of 
the quantity of parasite protein used in ELISA experiments was made. Tle D6-D8 
released proteins were obtained by culturing schistosomula in medium containing FCS 
for the first 6 days, washing thoroughly and then culturing in scrum-free medium for the 
final 2 days. It was possible that the washing step was not sufficient to prevent some 
contamination of parasite-derivcd material with FCS, which would yield an incorrect 
estimate of the amount of parasitc-derived protein. Hence, if less parasite-released 
proteins were used to coat wells of plates used in ELISA experiments than calculated, an 
underestimate of the antigen-specific antibody titrc would be made. Subsequently, this 
potential problem has been overcome by applying the 6 day old schistosomula to a 
Percoll gradient, centrifuging and then washing thoroughly. 
As expected, the 0-3hS bound more strongly to its homologous antigen preparation, 
than to a hetcrologous fraction. However, this serum was more reactive against D6-D8 
released proteins in ELISA experiments than the D4-D8S. The higher titrc of the 0-3hS 
compared to the D4-D8S may provide a simple explanation for this result. Ideally, the 
D4-D8S would be tested in ELISA experiments against D4-D8 released proteins. 
However, for the reason stated in section 4.2.1, this was not possible. 
Both sera reacted much more strongly to SCAP than to SLAP or SWAP in ELISA 
experiments indicating that the released proteins to which they were raised constituted a 
greater proportion of the soluble preparation of cercariac than later-stage parasites. Since 
the biosynthctic labelling of parasites gave no quantitative feel for the proportion of 
released proteins derived from either cercariae or schistosomula, this was an interesting 
observation. Both sera reacted equally well to SIAP, and there was an indication that 
antibodies present in the D4-D8S bound more strongly, than those from 0-3hS to 
SWAP. The very low reactivity of both sera to SWAP could suggest that the 0-3h and 
102 
D4-D8 released proteins represent a much smaller percentage of SWAP compared to 
SCAP. Alternatively, it is possible that some of the released proteins may not be present 
at all in SWAP, indicative of stage-specific expression of such released molecules at 
prc-adult phases of the life-cycle. 
4.4.3 Detection of antigenic fractions of Schistosoma mansoni with antibodies present 
in O-AS and D4-D8S 
In all Western blots of released proteins, using either conventional diaminobcnzidine 
staining (data not shown) or ECL, a high background reactivity was observed, even with 
the strong blocking step used to prevent non-spccific binding of antibodies to the 
membrane. A possible explanation for this, was provided by observations of Coomassie- 
stained gels. Soluble preparations of Schistosoma mansoni yielded sharp bands with a 
low background staining, whereas many gels of released proteins showed more diffuse 
bands and a higher background throughout much of the lane. This background appeared 
to be amplified in Western blotting experiments, especially when 0-3h released proteins 
were used, where the staining extended into the stacking gel. Within the first 3h post- 
transformation, much of the cercarial glycocalyx is lost; indeed during in vitro culture of 
transforming radiolabellcd cercariae, Caulfield et al. (1987) detected 70% of the labelled 
glycocalyx in the culture medium. The glycocalyx is highly antigenic and is composed 
predominantly of carbohydrate residues of high M, (Caulfield et al. 1987). Glycoproteins 
and carbohydrates are known to separate less readily into discrete bands by SDS-PAGE 
than proteins. Complexes may form between carbohydrates and proteins which may 
prevent entry into the gel or poor resolution (Hames & Rickwood, 1990). Tlius, the high 
background staining may be caused by antibodies binding to immunogenic carbohydrate 
residues or glycoproteins derived from the glycocalyx which, due to their poor resolution 
by SDS-PAGE, result in a broad smear. 
Of the discrete proteins detected by antibodies present in the 0-3hS on blots of 0-3h 
released proteins, an antigen at approximately 20 kDa was dominant. A protein of 
identical M, has been described previously (chapter 2) and was the most intense band 
detected following autoradiography, but not Coomassie staining, in both 0-3h and later- 
stage released proteins. The two most prominent proteins on Coomassic-stained gels of 
0-3h released proteins, at 31 and 28 kDa, were not rccognised strongly by the 0-3hS, 
suggesting that they were not very immunogenic in terms of antibody production. A 
comparative analysis of the antibody specificities of 0-3hS and D4-D8S was difficult to 
determine because of the differences in their titre. However, the D4-D8S rccogniscd the 
4 most dominant immunogcns (M, 70,45,20 and 12 kDa) detected by the 0-3hS. Both 
sera recognised additional antigens in the D6-D8 released proteins which, in most cases, 
were of identical M,,. A protein of 28 kDa was rccognised more strongly by both sera in 
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this fraction than in 0-3h released proteins. Again, a protein of 20 kDa was identified by 
both sera. 
Why the 0-3hS recognised proteins in the D6-DS, but not the 0-3h released proteins 
to which it was raised was puzzling. For example, proteins of approximate M, 55 and 38 
kDa were recognised by the 0-3hS in D6-D8, but not in 0-3h, released proteins. There 
are two possible explanations for this result. Firstly, variations in antigen preparations 
may have affected the result. Secondly, it was possible that antibodies present in the 
serum were binding to glycosylated regions of proteins shared by several molecules. 
Indeed, Zodda & Phillips (1982) described a monoclonal antibody reactive against two 
proteins of 160 and 130 kDa, whereas Kelly et aL (1986) showed it to bind to antigens of 
200,38,20 and 17 kDa. This poly-specific recognition was due to a common 
carbohydrate epitope. Similarly, the 0-3hS recognised a few antigens (38 kDa and <14 
kDa) in the D6-D8 released proteins that the D4-D8S did not. 71is could be explained 
by the fact that antibody responses vary significantly from rabbit to rabbit (Hammcrl, 
Hard, & Thalhamer, 1993). Tlerefore, one antigen may produce a good antibody 
response in one rabbit but a poor response in another. This potential problem will be 
remedied in future by raising antisera in more than one rabbit and/or by using different 
species e. g. mice and rats. 
The range of antibody specificities of 0-3hS and D4-D8S against soluble 
preparations of Schistosoma mansoni was also complex. Both sera recogniscd a protein 
of 20 kDa very strongly in SCAP, but only weakly at the highest serum concentrations in 
SLAP or SWAP. Thus, this immunologically dominant protein appears to be highly 
enriched in cercariae compared with schistosomula or adult worms. A broad smear at 
approximately 97 kDa was present on blots of SLAP and SWAP probed with D4-D8S. A 
protein of this M, has been charactcrised previously and found to be paramyosin (Lanar et 
A 1986), which will be referred to later (section 4.4.4). In general, there was a moderate 
level of homology between the banding patterns seen on Coomassie stained gels of 
soluble and released proteins and those detected by antibodies, from either serum, on 
Western blots of the same samples. Thus, it would appear that even if a protein is well 
represented in a preparation, it does not guarantee that it will induce a good antibody 
response in an animal. However, the validity of using only one animal to raise each 
serum, and variations which may occur in the preparation of antigens, arc factors which 
must be considered when drawing such conclusions. 
4.4-4. Identification ofparasite proteins with monospecific sera or monoclonal 
antibodies 
In an attempt to identify some of the proteins present in the complex antigenic 
mixtures used in this study, monospecific sera or monoclonal antibodies were used to 
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probe Western blots. As would be expected, most of the target antigens of the antibodies 
were detected in soluble preparations of Schistosoma mansoni. However, neither SOD 
(20 kDa) nor T`PI could be detected. There are several possible explanations for this 
failure. Either such proteins were absent, or only present in minute quantities, in the 
fractions tested or that the antibodies were denatured upon transport. The latter 
explanation was more likely for the monoclonal antibody directed against TPI, since this 
enzyme is universal in cells performing glycolysis and has previously been 
immunoprecipitated from all stages of the parasite life-cycle (Ham et al. 1985). 
The proteins detectable in this study included the antioxidant enzymes SOD (16 kDa) 
and GST which arc important in protecting parasites from potentially lethal molecules 
generated by the exposure of leukocytcs to appropriate stimuli. The sensitivity of 
Schistosoma mansoni from different life-cycle stages to 11ý02 and oxygen-frec radicals 
has been described previously (Narc, Smith & Prichard, 1990). It was found that newly- 
transformed schistosomula, lung-stage and 2 week old larvae were much more 
susceptible to the presence of '_I202 or oxygcn-free radicals than were 4 and 8 week old 
worms. Concurrently, the level of activity of some antioxidant enzymes was elevated in 
the older parasites. In particular, the GST activity increased dramatically from newly- 
transformed schistosomula through to 8 week old worms. SOD showed a small but not 
statistically significant increase in activity. Nare et al. (1990), postulated that the lower 
level of antioxidant activity in juvenile worms could account for their greater 
susceptibility to immune elimination compared to more mature parasites. Obviously, this 
hypothesis does not hold true in the rat model of schistosomiasis, in which the majority of 
parasites arc eliminated 4-6 weeks after primary infection (Stirewalt et al. 1951; 
Smithers & Terry, 1964). In the work described in this chapter, no attempt was made to 
measure enzyme activity. However, in terms of the quantity of protein, SOD (16 kDa) 
showed a significant increase in the soluble sub-set of proteins from ccrcariac through to 
the adult worm stage. Hacmoglobinase, the acid-thiol protcinase responsible for the 
breakdown of bacmoglobin from which the parasite obtains much of its source of amino 
acids, could be detected in SIAP and SWAP but not SCAR This supports the findings of 
Dresden, Payne & Basch (1982) who could not detect hacmoglobinasc activity in 
ccrcariae but could in 12 day old worms. Since schistosomula do not begin feeding avidly 
on red blood cells until after arrival in the liver, such stage-specific expression of the 
enzyme would seem logical. However, recently Gotz & Klinkert (1993) cast doubt on the 
identity of Sm32 as the 'haemoglobinase' of Schistosoma mansoni. Instead, evidence was 
presented which suggested that Sm31 was the enzyme responsible for the breakdown of 
hacmoglobin. If this result proves to be correct, then the work described here would need 
to be repeated with a monospecific serum or monoclonal antibodies directed against 
Sm3l. 
Although it has becn surmiscd that Sm28 was an cxcretory/secretory mctabolite of 
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the parasite (Capron et A 1987), as far as I am aware the identification of either Sm28, 
Sm26, SOD or calreticulin as proteins released from cultured schistosomula has not been 
described previously. However, two forms of SOD were found to be actively secreted by 
adult stages of the human parasite Onchocerca volvulus (Henkle et aL 1991). In view of 
the protective function of superoxide dismutases in inhibiting killing mechanisms based 
on the production of oxygen-free radicals, it was suggested by Cordciro da Silva et A 
(1992) that schistosome SODs may be involved in parasite defence against the host 
immune response. Thus, the observation that the 16 kDa SOD could be detected in 
proteins released by schistosomula between day 6 and day 8 lends weight to this 
suggestion. It was interesting to note that the promising vaccine candidate Sm28 was 
detected in proteins released both immediately after transformation and 6-8 days later. 
Whether the protein is lost during the turnover of the outer bilayer of the tegument, or is 
actively secreted, is not known. 'ne detection of calrcticulin in proteins released by 
schistosomula during in vitro culture was not expected. However, little is known about 
either the function or location of this molecule in Schistosoma mansoni (Khalife et A 
1993). 
4.4.5 Passive transfer of sera 
The protection provided to mice against a cercarial challenge by transfer of 0-3hS or 
D4-D8S was not very successful. The D4-D8S showed little difference in ability to 
confer protection when transferred on day 0,1 or days 4 and 7. None of the results 
attained statistical significance at the 95% level when compared to the mean worm 
burdens of either NRS or challenge control groups. Ile most encouraging results were 
obtained with the 0-3hS when transferred on day 0, day 1 or days 4 and 7. These results 
were comparable to those obtained by Bickle et aL (1985) and Mangold & Dean (1992). 
Bickle et aL (1985) used serum from rabbits vaccinated up to 16 times with optimally- 
attenuated cercariae and achieved between 34% and 69% protection (mean=43%) when 
serum was transferred to mice on the day of challenge and 31% to 56% (mean=41%) 
when given 5-6 days post-challenge. Mangold & Dean (1992) used purified IgG, from 
serum raised in rabbits which had been vaccinated 3 times with 50 krad. irradiated 
ccrcariae, in passive transfer experiments. When transferred to mice on days 4 and 7 
post-challenge, 43%-61% reductions in the adult worm burdens were achieved. It was 
found that the level of resistance induced was very much dependent on the quantity of 
IgG administered. Resistance was calculated compared to the worm burdens of mice 
receiving NRS alone. In an attempt to use fewer mice, only one NRS control group was 
included in the experiments described in this chapter. This group received NRS on day 0, 
therefore there were no NRS controls for 0-3hS transferred on day 1 or days 4 and 7, and 
as such the statistical significance of these results cannot be corroborated. Furthermore, 
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NRS increased the mean worm burden of this group compared to the challenge controls. 
It is possible that by increasing the volume of fluid in the vascular system, the diameter of 
capillaries could be widened slightly, allowing parasites to pass through sites, such as the 
pulmonary capillaries more easily. However, if this were true, an even greater difference 
in the worm burdens should have been detected between the group of mice which 
received 0.5ml NRS on two days and the challenge control group. None of the results 
from this experiment attained statistical significance when compared to the mean worm 
burden of the challenge control group. Therefore, it depended upon which control group 
was used for comparison, whether or not the results were statistically significant. 
The mechanism by which the serum reduced the worm burden is not known. The 
elimination of pathogens by antibodies is usually brought about by binding to cpitopcs 
exposed on the surface of the foreign body. Several methods of elimination can occur 
thereafter, which include: reccptor-mediated phagocytosis (an unlikely effector 
mechanism against a large multicellular pathogen), antibody-depcndcnt complement 
activation, ADCC and possibly even inhibition of important enzymes which are 
expressed, at least transiently, on the parasite surface, for example GST or 7? 1. Mangold 
& Dean (1992) found that removal of the Fc fragment of IgG antibodies by pepsin 
treatment prior to passive transfer to mice, completely abrogated immunity. 11iis 
suggested that an effector mechanism which involved host components bearing Fc 
receptors was required for immune elimination. 
Thus, antibody-mediated elimination mechanisms usually act directly on the surface 
of the target. Since the sera used in these experiments were raised against parasite- 
released proteins it is perhaps not surprising that they did not confer high levels of 
protection. Tbcre are several possible explanations for the relative success of the 0-3hS 
compared to the D4-D8S at transferring resistance. Firstly, the 0-3hS had a much greater 
antibody titre than the D4-D8S. Since the injection of serum Lv. results in its widespread 
distribution throughout the tissues of the recipient, it is important that along the route of 
parasite migration there is a high antibody concentration. If the concentration were too 
low, an insufficient number of antibodies would bind to the target to facilitate the 
induction of effector mechanisms. Secondly, during the first 3h the glycocalyx is shed, 
and may be accompanied by underlying material derived from the tegument. 11us, the 0- 
3hS could contain more antibodies capable of binding to proteins exposed on the parasite 
surface, than the D4-D8S. Although the rate of turnover of the outer bilayer of the 
tegument is not known for schistosomula, in adult worms the process occurs relatively 
slowly, with a 61 of approximately 5 days (Saunders, Wilson & Coulson, 1987). If a 
similar turnover rate occurs in schistosomula, the D4-D8S is unlikely to contain many 
antibodies with specificities towards proteins of tegumental origin. However, Miller et aL 
(1989) showed that a monospecific serum against a 12.5 kDa antigen was capable of 
mediating a high degree of parasite killing in an in vitro assay using cosinophils or 
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complement despite the proteins internal location in flame cells of the parasite excretory 
system. 
Although the most successful serum at conferring passive protection to mice was 
raised against early-stage released proteins, there was an indication that it acted most 
efficiently when administered on days 4 and 7 post-challenge. This corresponds to the 
time during which challenge schistosomula would be resident in the lungs. However, it 
must be borne in mind that this group of mice received twice as much serum as other 
experimental groups and therefore effectively had double the antibody titre. Mangold & 
Dean (1986; 1992) found that the most consistent level of resistance achieved with serum 
from multiply vaccinated mice was obtained when transferred at a time coincident with 
parasite migration to the lungs. Additionally, Gregoire et al. (1987) found that their 
protective IgM monoclonal antibody transferred significant resistance to mice when 
administered on the day of challenge or 8 days, but not 15 days, later. Ford et al. (1984) 
showed that serum from infected or vaccinated rats was equally as protective when 
transferred to recipient rats on the day of challenge or 5-7 days later. Tlius, it has been 
shown that either sera or monoclonal antibodies can effectively cause a reduction in 
worm burden of mice or rats, when administered at a time coincident with challenge 
parasite residence in the lungs. Since the 0-3hS was effective against schistosomula older 
than 4 days, suggests that there is a degree of antigenic conservation between cercariae 
and lung-stage parasites, an hypothesis that was confirmed by the results described 
previously (chapter 2 and section 4.3.4) and by others (Atkinson & Atkinson, 1982; 
Miller et al. 1989). 
In conclusion, sera raised against early (0-3h) and latcr-stagc (D4-D8) 
schistosomula-rcleased proteins recognised a complex pattern of antigens in both soluble 
and released protein fractions. It is likely that some of these molecules correspond to 
proteins detected by autoradiography (chapter 2) or by Coornassie staining (this chapter). 
Proteins of 45,20 and 12 kDa were detected by antibodies on blots of various antigen 
fractions. In particular, the 20 kDa antigen(s), although not particularly prominent on 
Coomassie-staincd gels, was dominant on autoradiographs (chapter 2) and could be 
detected by both sera on Western blots of all parasite protein fractions used in this study. 
As such, this protein (or proteins) warrants further investigation. 
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CHAPTER FIVE 
Identification of recombinant proteins expressed from a larval 
Schistosoma mansoni cDNA library. 
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5.1 Introduction 
In the previous chapters, the proteins released by schistosomula during in vitro 
culture (chapter 2), their ability to stimulate proliferation of lymph node cells recovered 
from vaccinated mice (chapter 3) and the properties of sera raised against sub-scts of 
these proteins (chapter 4) were described. Further work was impeded by the small 
quantities of schistosomula-released proteins which could be obtained from parasite 
cultures (approximately 15, ug per culture). While this amount was sufficient to analyse T 
cell responsiveness (chapter 4) and possibly allow small-scale vaccination experiments 
with mice, it could not provide a source for purification of individual constituents. 
Antibody screening of schistosomc cDNA libraries, the majority of which have been 
generated from adult worm mRNA, has identified and facilitated further characterisation 
of several potential vaccine candidates including GST, TPI and paramyosin. It is 
important that candidate vaccine antigen(s) are available in recombinant form for several 
reasons. Firstly, the cDNA coding for the recombinant protein can be sequenced and its 
homology to any other cloned protein determined. The existence of homologies could 
provide an insight to the function of the molecule in the host. Secondly, by using high 
level expression systems, large amounts of the protein can be obtained. Since it is 
unlikely that sufficient quantities of the purified protein(s) could be obtained from 
parasites to vaccinate the population at risk from the disease, this is an important factor. 
Additionally, a plentiful supply of the protein enables more experiments to be undertaken 
to investigate the nature of the molecule. For example, the amino acid sequence of the 
protein can be determined. Furthermore, if the protein is suspected to be an enzyme, it 
can be used in functional assays e. g. GST. 
From the amino acid sequence, it is possible to predict potential B and T cell 
epitopes. This can be achieved by using computer programmes or, by using synthetic 
peptides in assays of T cell proliferation or in ELISA experiments as described by 
Reynolds, Shoemaker & Ham (1992). Synthetic peptidcs containing the appropriate B 
and/or T cell cpitopes, derived from candidate antigens have several advantages as 
potential vaccines, which were detailed by Taylor, Cordingley & Butterworth (1984). 
Such moieties would be cheap to manufacture, an important consideration for a vaccine 
destined for use in developing countries. Furthermore, quality control would be easy to 
maintain and the possibility of undesirable side-effects should be greatly reduced 
compared to use of complex antigenic mixtures. As described in section 1.9.4, Capron 
and colleagues have identified peptides, derived from GST, which when used to 
vaccinate animals, not only caused a reduction in the worm burden but also decreased 
female worm fecundity. 
With these considerations in mind, it was decided that a cDNA library would be 
constructed and screened in order to identify, and subsequently obtain sufficient 
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quantities of, schistosomula-released proteins. It is not known whether the protective 
antigen(s) which mediate lung phase immunity arc stagc-spccific or common to other 
life-cycle stages. Therefore, to maximise the chances that mRNA species coding for the 
relevant released proteins were present, a cDNA library in the lambda Zap 11 expression 
vector was constructed using mRNA extracted from 4 to 8 day old in vitro-culturcd 
schistosomula. Larvae in this age range have a high rate of protein synthesis (chapter 2) 
and therefore should contain greater quantities of mRNA compared to earlier stages. The 
elevated level of synthesis during this period was due to the expression of a broad array 
of proteins rather than a restricted few. Thus, a diverse range of mRNA species should 
also be present. Furthermore, by using such parasite material, mRNA coding for 
cercaria-spccific proteins, which are not important to immunity against schistosomiasis 
(section 1.7.5), would be absent. As described in the previous chapter, an antiserurn 
raised against proteins released by in vitro-cultured schistosomula between day 4 and 
day 8 has been characterised. Antibodies present in the serum bound to parasite proteins 
on Western blots indicating that it would be suitable for screening a gene library, since 
recombinant antigens immobilised on nitrocellulose filters arc also likely to be in a 
denatured form. This chapter describes initial results aimed at identifying parasite- 
released proteins expressed from a larval cDNA library using serum raised against such 
molecules. 
5.2 Materials and Methods 
5.2.1 Collection ofparasite material 
Schistosomula were obtained from snails with patent S. mansoni infections, as 
described previously in section 3.2.2, and cultured in M169 + FCS (1%). Cultures were 
terminated on either day 4,5,6,7 or 8, the schistosomula pelleted by centrifugation and 
then stored at -80*C until required. 
5.2.2 Isolation of total RAIA ftom schistosomula 
In order to prevent degradation by contaminating RNase activity, all procedures used 
in the isolation of RNA were carried out using Diethyl pyrocarbonate (DEPQ treated 
reagents, autoclaved glassware, sterile plasticwarc and RNasc-free reagents. 
RNA was recovered from schistosomula using the method described by Sambrook, 
Fritsch & Maniatis (1989). Briefly, frozen 4 to 8 day old schistosomula were resuspended 
and homogenised in guanidine isothiocyanate homogenisation buffer (4M guanidine 
isothiocyanate (GIBCO), OAM Tris-HCI pH 7.5,1% 2-mcrcaptoethanol) using an Ystral 
shearer (Fryma Ltd., Hemel Hempstead, U. K. ). Sodium lauryl sarcosinatc (BDH) was 
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then added to a final concentration of 0.5% and the mixture centrifuged at 5000g for 10 
min at room temperature. The resulting supernatant was layered onto a cushion of 53M 
caesium chloride (CsCI), 0.01M EDTA pH 7.5 and centrifuged in an SW41 swing-out 
rotor at 32,000 rpm for 24h, 20*C. The majority of the supernatant above the resulting 
RNA pellet was removed with a pasteur pipette and the bottom of the centrifuge tube, 
containing the RNA, detached using a red-hot razor blade. The RNA pellet was washed 
once in 70% ethanol and then left to dissolve in TES (10mM Tris-HCI pH 7.5,1mM 
EDTA pH 8.0,0.1% SDS) overnight at 4C on a shaking platform. Subsequently, the 
RNA solution was extracted once with phenol: chloroform: isoamylalcohoI (25: 24: 1) and 
twice with chloroform: isoamylalcohol (24: 1), followed by overnight sodium 
acetate: ethanol (1/10th volume 3M sodium acetate pH 5.2: 3 volumes ice cold 100% 
ethanol) precipitation at O"C. This solution was then centrifuged for 20 min at 9000g, 
4'C, the supernatant removed carefully and discarded. The pellet was washed in icc-cold 
70% ethanol and centrifuged again for 15 min after which the supernatant was removed. 
The pellet was resuspended in 100pl DEPC-treated water and the RNA yield determined 
spectrophometrically at 260run. The integrity and quality of the preparation was assessed 
by agarose gel electrophorcsis (1% agarose in 1x TBE; from a 5x stock of 0.45M Tris, 
0.44M boric acid, 0.01M EDTA). To an appropriate volume of the sample, IUl loading 
buffer (0.25% bromophenol blue, 0.25% xylcne cyanol, 15% Ficoll 400) was added and 
the mixture made up to 81il with 1x TBE. The gel tank was filled with 1x TBE and the 
sample loaded into wells of the gel. Electrophoresis took place at 10OV. At the end of the 
run, gels were soaked in a solution of 0.005% ethidiurn bromide for approximately 10 
min, washed briefly in distilled water and the RNA visualised on a UN. transilluminator. 
5.2.3 Generation and screening of a larval cDNA library 
A larval cDNA library in the lambda Zap II expression vector was constructed by 
Clontech laboratories (Palo Alto, California, USA) using total RNA isolated from in 
vitro-culturcd schistosomula. The procedure used to manufacture the library included the 
purification of mRNA from total RNA, denaturation of any secondary structures by 
methylmercuric hydroxide treatment and, following second strand synthesis by reverse 
transcriptase, the quantity of DNA amplified by PCR. Low molecular weight (<400 base 
pairs) cDNAs were removed, whilst those remaining were cloned into a unique EcoRI 
site in the lambda Zap 11 vector using EcoRI linkers. Ilie library was amplified once. 
Clontech reported that the unamplified library had a complexity of 2x 106 plaque 
forming units/ml (pfu/ml) and that 96% of the amplified library, which had a titre of 
approximately 1011 pfu/ml, contained cDNA inserts which ranged in size from 1.0 kb to 
5.0 kb. 
Prior to screening of the library, plating cells were produced by inoculating 10ml 
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Luria-Bertani media (LB media; 1% Tryptone, 0.5% yeast extract, 0.17M NaCl, pH 7.0) 
containing 0.2% maltose, with a bacterial colony (strain BB4; see appendix 2), and 
incubated overnight at 37*C on a shaking platform (250 rpm). Ile cells were pelleted by 
centrifugation at 30OOg for 10 min and then resuspended in 4ml 10MM MgS04* The 
library was diluted in SM buffer (100mM NaCI, 50mM Tris pH7.5,5mM MgSO4,0.01% 
gelatin) to yield approximately 70,000 pfu per 400CM2plate. An appropriate volume of 
plating cells was added to the diluted bacteriophage and the mixture incubated in a water 
bath for 20 min at 37T. Moltcn top agar (LB media containing 0.7% bacto agar) was 
added to the mixture which was then carefully poured on to the top of 1-2 day old LB 
Agar plates (LB media containing 1.5% bacto agar). Once solidified, the plates were 
incubated in an inverted position at 42T. 
An estimate of the proportion of bacteriophage which contained no cDNA insert was 
made by utilising the ability of lambda Zap, containing an intact P-galactosidasc gene, to 
convert X-gal (5-bromo-4-chloro-3-indolyi-p-D-galactopyranosidc), a lactose 
analogue, to a product that is coloured deep blue. Bactcriophage which contain a cDNA 
insert have a disrupted lac Z' gene and are unable to synthesisc: a functional fl- 
galactosidase enzyme. Tlereforc, resultant plaques arc clear. 'Me addition of 40, ul X-gal 
(20mg/ml in dimethylformamidc) plus an inducer of the lac T gene, such as isopropyl 
D-thiogalactopyranosidc (IPTG; 4pl from a 1M stock) to the LB agar on which the 
library was plated out, following incubation at 42*C for approximately 4h, allowed non- 
recombinant colonies to be distinguished from those containing cDNA inserts. Several of 
these 'blue' plaques were picked and purified to homogeneity. 
The library was screened essentially as described by Huynh, Young & Davis (1986) 
with antiscrum, raised against proteins released by schistosomula during in vitro culture 
between days 4 and 8 post-transformation (D4-D8S). Briefly, LB plates were seeded 
with bacteria infected with bactcriophage as described previously, and incubated at 42*C 
until small plaques were visible. Nitrocellulose filters (Millipore) which had been pre- 
soaked in 10mM IPTG and allowed to air dry, were carefully placed onto the plates and 
incubated at 37*C for a further 4h. Before removal of the filters, small pin pricks were 
made through to the agar support, to allow correct orientation at a later time. Filters were 
washed briefly in blot wash buffer (see section 4.2.6) and incubated in blocking buffer 
(blot wash buffer containing 5% NGS) overnight at 4*C. Dilution of the primary serum to 
1: 1000 yielded a good positive signal, using diaminobcnzidine staining, against released 
proteins spotted onto nitrocellulose filters and a low background against bacterial lysates 
(data not shown), and was therefore used in all screening procedures. Filters were 
incubated for 2h in D4-D8S, diluted to 1: 1000 in blocking buffer, washed for 3x 20 min 
with blot wash buffer and then incubated for 2h with goat anti-rabbit pcroxidase 
conjugate diluted to 1: 1000 in blocking buffer. The filters were washed again and then 
incubated with peroxidase substrate solution (0.17M ammonium acctatc, 2.9 mM citric 
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acid warmed to 40T plus 0.01% diaminobenzidine and 0.0003% H202 added 
immediately prior to use). The reaction was terminated by washing filters in water. Any 
clone expressing a protein which was detected by the serum stained more strongly than 
remaining clones. Such 'positive' clones were isolated from the test plate and purified to 
homogeneity by several rounds of re-scrcening. 
5.2.4 Excision ofplasmids firom Lambda Zap 
From the bacteriophage DNA of isolated plaques, pBluescript containing the inserted 
cDNA was excised through the use of a helper phagc. To perform this, 100PI plating cells 
(strain XL1-blue; see appendix 2), 200, ul of the isolated clone (approximately 1010 
pfu/nil) and 20pl R408 helper phage (106_107 pfU/Ml) were added to an eppendorf tube 
and incubated for 15-20 min at 37*C. This mixture was added to 5ml LB media in a 
small conical flask, incubated at 37*C for 2-6h on a shaking platforin and then heated at 
70"C for 20 min to kill bacteria and inactivate the parent phagc. Cell debris was removed 
by centrifugation (5000g) for 5 min and the supernatant, containing packaged filamentous 
phage particles (phagemid), decanted into sterile eppendorf tubes and stored at 4"C until 
required. 
To obtain single colonies, 200, ul of the phagcmid and 100#1 plating cells were added 
to an eppendorf tube, the mixture incubated at 37*C for 15 min and then the suspension 
streaked out on ampicillin-containing (50, ug/ml) LB agar plates and incubated at 37"C 
overnight. XL1-blue host cells infected with phagemid gave ampicillin-resistant 
colonies, whereas cells infected with helper phage did not form colonies. The plates were 
stored at 4*C. 
5.2.5 Plasmid mini preparations 
Plasmid preparations were prepared essentially as described by Birnboim & Doly 
(1979). Single colonies, obtained from the procedure described above (section 5.2.4), 
were picked and used to inoculate 5ml LB medium containing ampicillin (50P&Iffil) 
which was then incubated overnight at 37*C on a shaking platform. The culture was 
centrifuged (100OOg for 10 min), the supernatant discarded and the pellet resuspended in 
100, ul solution 1 (50mM glucose, 25mM Tris-HCI pH 8.0,10 mM EDTA). To this, 200PI 
ice cold, freshly prepared solution 11 (0.2M NaOH, 1% SDS) was added, the suspension 
mixed gently by inverting and then left on ice for 5 min. Subsequently, 150, UI ice cold 
solution 111 (60% 5M potassium acetate, 11.5% glacial acetic acid) was added, the 
mixture vortexed, left on ice for 5 min and then centrifuged at 90OOg for 5 min. The 
supernatant was transferred to a new tube and then extracted once with phenol and once 
with chloroform: isoamylalcohol. To the recovered aqueous phase, 250pl isopropanol was 
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added, left for 5 min at room temperature and then centrifuged at 90OOg for 10 min. The 
supernatant was removed and the pellet washed carefully with 70% ethanol. Once dry, 
the pellet was resuspended in 50pl TE (10mM Tris-HCl pH 7.5,1mM EDTA pH 8-0). 
5.2.6 Restriction digestion ofplasmids and estimation of the cDNA insert size 
Since cDNA was cloned into the unique EcoRl site of lambda Zap, the insert could 
be excised by EcoRl digestion. Plasmid preparations were digested to completion with 
EcoRl (Pharmacia) in EcoRI buffer following incubation at 37"C as described by the 
manufacturer. Subsequently, 1pl RNase A (10mg/ml) was added and the mixture 
incubated for a further hour at 37"C. At the end of this period, the reaction was 
terminated by incubation of the mixture for 10 min at 65*C. The sample was stored at 
-20"C until required for analysis by gel clectrophoresis. The insert size was calculated by 
running the restriction digest, on a1% agarose gel alongside an EcoRIIHindlIl digest of 
lambda DNA. The gel was stained with cthidium bromide and the DNA visualised on a 
U. V. transilluminator. 
5.2.7 DNA isolation 
Adult worms of Schistosoma mansoni were recovered by portal perfusion of infected 
mice (Smithers & Terry, 1965), and then DNA isolated from the parasites as described by 
Jeffs & Simpson (1993). Briefly, adult worms were ground to a powder in the presence of 
a small amount of liquid nitrogen in a mortar and pestle. The powder was thawed in an 
equal volume of extraction buffer (5OmM Tris-HCI pH 8.0,5OmM EDTA pH 8.0, 
100mM NaCl) at 37"C. Subsequently, an equal volume of extraction buffer containing 
1% SDS and 100, uglml proteinase K was added, the mixture incubated for approximately 
2h at 37*C and then spun at 30OOg for 3 min to remove any cell debris. The supernatant 
was transferred to a sterile eppendorf tube and extracted twice with 
phenol: chIorofonn: isoamylalcohoI (25: 24: 1) and twice with chlorofonn: isoamylalcohol. 
The resulting aqueous layer was removed to a fresh tube, RNase A (10OP&Iml) added, 
and the solution incubated for 1h at 37*C. Ile mixture was then extracted again as 
described above. To the aqueous layer, 1/10th volume 3M sodium acetate pH 5.2 and 2.5 
volumes ice cold 100% ethanol was added, mixed gently, placed on ice for approximately 
30 min to precipitate and then centrifuged at 90OOg for 15 min at 4C. Ile supernatant 
was removed carefully, discarded and the pellet washed with ice cold 70% ethanol, the 
centrifugation step repeated and the supernatant discarded. The pellet was gently 
resuspended in TE buffer, pH 8.0 and then stored at -20*C. 
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5.2.8 Random primed labelling 
Owing to the initial difficulties in obtaining DNA labelled to a high specific activity, 
the DNA was cleaned using a GENECLEAN kit (BIO 101 Inc. La Jolla, California, 
U. S. A. ), prior to the labelling step. To prevent possible stcric inhibition during 
subsequent labelling, the DNA (50-100ng) was digested for 3h at 37*C with an EcoRl, 
Pst, Hindill mixture in one phor-all buffer (Pharmacia). Digestion was terminated by 
heating to 65*C for 10 min and was followed by a single extraction with phenol and then 
chloroform: isoamylalcohol. The DNA was precipitated by adding 4, ul 3M sodium acetate 
and 80pl 100% ethanol and leaving on ice for 15 min followed by centrifugation for 15 
min at 9000g, 4*C. The supernatant was removed and the pellet washed with ice cold 
70% ethanol. Once dry, the pellet was resuspended in 10, ul TE. 
Prior to random primed labelling (described by Feinberg & Vogelstein, 1983), the 
DNA was denatured by heating for 10 min at 100*C and then rapidly cooled on ice. To an 
eppendorf tube, 25ng of denatured DNA, 3pl dNTP mixture (IPI dAT?, dGTP and dTTP 
from 0.5mM stocks), 2yl 10x hcxanucleotide mixture (Boehringcr Mannheim) and 5pl 
[a32P] dCrP (NEN DuPont, Stevenagc, U. K.; 3000Ci/mmol) were added. Ilis mixture 
was made up to 191il with sterile water and lyl (approximately 2U) Klenow enzyme 
(Bochringer Mannheim) then added. The mixture was incubated for 30 min at 37*C and 
the reaction terminated by adding 2yl 0.2M EDTA pH 8.0 and by heating to 65*C for 10 
min. Unincorporated [a 32P] dCTP was removed by spun column chromatography. A 
Sephadex G50 column (Pharmacia) was equilibrated with STE (10mM Tris-HCI pH 8.0, 
1mM EDTA pH 8.0,100mM sodium chloride) and the labelling mixture applied to the 
top of the column which was then centrifuged at 1600g for 4 min. The solution which 
passed through the column was collected and the degree of labelling measured by liquid 
scintillation counting. 
5.2.9 Filter hybridisation 
Approximately equal quantities of previously denatured plasmid preparations derived 
from isolated clones, were spotted onto nitrocellulose filters in 1pl drops. As controls, 
denatured adult worm DNA served as the positive and a plasmid preparation isolated 
from a non-recombinant colony as the negative. In addition a filter which had been 
applied to LB agar containing the larval cDNA library plated at low density was used as 
another test. The DNA was baked onto the filters by incubation in a vacuum oven at 80T 
for 30 min. The filters were placed into bybridisation bottles and 20ml pre-hybridisation 
buffer (4x STE, 10x Denhardt's solution (2% BSA, 2% Ficoll, 2% polyvinylpyrrolidone, 
0.1% SDS, 0.1% sodium pyrophosphate)) containing denatured fragmented herring 
sperm DNA (100pg/ml) added and incubated for 4h at 68"C. This buffer was poured off 
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and replaced with pre-hybridisation buffer containing the labelled DNA (3-5 X 106 
cpm/mI pre-hybridisation buffer) which had previously been denatured. Ibc mixture was 
incubated overnight at 68*C. After the hybridisation step, the filters were washed to a 
high stringency with 2x SSC (from a 20x stock of 3M sodium chloride, 0.3M sodium 
citrate, pH 7.0), 0.1% SDS at room temperature for 5 min. Ibis was followed by 2x 20 
min washes with 1x SSC, 0.1% SDS at 68*C and 2x 20 min washes with 0.2x SSC, 0.1% 
SDS at 68"C. The filters were dried, wrapped in cellophane and exposed to Hyperfilm 
MP (Amersham) in the presence of intensifying screens and placed up for 
autoradiography at -70"C. After an exposure time of 24h, the film was developed as 
described in section 4.2.6. 
5.3 Results 
Collection of approximately 150,000 4 to 8 day old schistosomula, enabled the 
recovery of 10, ug total RNA. This provided enough material for a CDNA library to be 
generated by Clontech laboratories. By plating out the library on the bacterial strain 
XL1-blue in the presence of IPTG and X-gal, approximately 15% of the resulting 
plaques were blue suggesting that 85% of bacteriophagc contained a cDNA insert. This 
compares to 96% recombinants reported by Clontech. Twenty randomly-picked 'clear' 
plaques were purified to homogeneity and the bacteriophage DNA converted into the 
plasmid form. Restriction digests with EcoRI of the purified plasmids followed by 
electrophoretic separation on 1% agarose gels, enabled the average cDNA insert size of 
the library to be calculated. A value of 1.3 kb was obtained which compared to 1.6 kb 
reported by Clontech who used PCR amplification of the inserts from 6 randomly picked 
clones followed by agarose gel elcctrophorcsis, to determine the average insert size. 
After screening approximately 1X 106 plaques with the D4-D8S, only 5 positive 
clones were identified on separate plates. Figure 5.1 shows these 5, alongside a non- 
recombinant clone, after they had been plaque purified. The positive clones were not 
recognised by NRS nor by sera raised against proteins released by newly-transformcd 
schistosomula in vitro (0-3hS) or those released by adult worms in vivo (data not shown). 
Monospecific sera and monoclonal antibodies to proteins, which have been cloned in 
other laboratories, were obtained (see section 4.2.3). These were used to ascertain 
whether the positive clones identified in this study expressed proteins which were 
recognised by any of the antibodies. Two clones (18 and 39) expressed proteins which 
were recognised by an anti-Sm97 monoclonal antibody (Fig. 5.2). None of the positive 
clones expressed proteins which were detected by antibodies directed against calrcticulin, 
26 or 28 kDa glutathione S-transferases, triosc phosphate-isomcrase or superoxide 
dismutasc (data not shown). 
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Fig. 5.1. Screening of filters of isolated positive clones 
(10,17,18,39 and 40) and a non-recombinant clone (N. R. ) 
with serum raised against parasite-released proteins (D4-D8S). 
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Fig. 5.2. Screening of positive clones with a 
monoclonal antibody against paramyosin (Sm97). 
Numbers represent the corresponding pos it ive 
clone whereas N. R. is an isolated non- 
recombinant clone. 
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DNA from all of the positive clones was converted to the plasmid form and, aftcr 
restriction digestion, their cDNA insert size determined on agarose gels (Fig. 5.3). T'he 
insert sizes were approximately 1.3 kb (clone 10), 1.2 kb (clone 17), 1.3 kb (clone 18), 
0.75 kb (clone 39) and 1.2 kb (clone 40). Clones 10 and 18 gave two bands on gels 
suggesting that they had an internal EcoRI cleavage site in their cDNA insert. 
Ile low frequency of identification of positive clones raised doubts about the quality 
the schistosome library. In order to ensure that the library was of schistosomc origin and 
did not contain a high proportion of contaminating DNA, schistosome DNA was labelled 
with 32P and used to probe filtcr-bound DNA derived from the lambda Zap library. High 
stringency washes were used to minimise non-spccific binding of the complex labelled 
genomic DNA. A photograph of the resulting autoradiograph is shown in figure 5.4. 
Binding of the DNA to the bluescript vector containing no insert (negative control) was 
hardly visible wbilst binding to the immobiliscd genomic DNA (positive control) was 
very strong. All of the plasmid preparations derived from positive clones (10,17,18,39 
and 40) or randomly-picked plaques (A-F) gave a good signal although the intensity 
varied from clone to clone. The nitrocellulose filter containing plaques derived from the 
library also bound the labelled DNA (data not shown) although not as strongly as the 
plasmid preparations as judged by the intensity of the signal. 
5.4 Discussion 
Both the number of recombinant bacteriophage and the average insert size of the 
library compared favourably to the results reported by Clontcch. 
Since the serum used for screening (D4-D8S) was capable of recognising parasite 
antigens by Western blotting (chapter 4), and the library appeared to be of good quality, 
the relatively low frequency of identification of positive clones was disappointing. The 
use of hybridisation to check that the bacteriophage contained cDNA inserts of 
Schistosoma mansoni origin confirmed that they did. Additional supportive evidence for 
the origin of the library is provided by the recognition of two of the positive clones by an 
anti-Sm97 (paramyosin) monoclonal antibody. Despite the fact that this protein is 
universal in invertebrates and is probably well conserved, the result is unlikely to be 
coincidental. 
There are several possible explanations for the low yield of positive clones. Firstly, 
the mRNA which encodes released proteins may represent only a tiny proportion of othcr 
mRNA species and would thus be relatively rare in the library. Secondly, the antibodies 
may rccognise predominantly glycosylated regions of proteins, which would not be 
available for binding during the screening procedure. Thirdly, it was shown (section 
4.3.3) that the D4-D8S had a higher affinity for proteins present in soluble preparations 
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Fig. 5.3. Analysis of EcoRl restriction digests 
of purified plasmid preparations of non- 
recombinant and 'positive' clones (10,17,18, 
39 and 40). Samples were separated on 1% 
agarose gels alongside an EcoRl/Hindlll lambda DNA 
digest, the fragment sizes of which are indicated 
at the side of the photograph, in kilobases. 
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Fig. 5.4. Filter hybridisation of labelled total 
genomic DNA to either homologous genomic 
DNA M or purified plasmids of non-recombinant 
phage H, positive clones (10,17,18,39 
and 40) and randomly picked clones (A, B, 
Cy Do E and F). 
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of cercariae rather than schistosomula. This indicated that the immunogenic proteins 
which were released at the lung-stage of development were highly enriched in soluble 
preparations of cercariae compared to schistosomula. As such, a cDNA library generated 
from ccrcarial mRNA may be more appropriate for the detection of recombinants using 
the D4-D8S. A further consideration to bear in mind is the validity of raising serum in a 
single animal; such serum may not be representative since it might only contain 
antibodies directed against a limited number of potential antigens present in the released 
proteins. In the near future it is hoped that anti-serum can be raised in mice, rats and 
rabbits to schistosomula-released proteins. 
Of the 5 positive clones identified, none expressed proteins which were rccogniscd 
by serum raised against 0-3h released proteins or those released by adult worms. 
Tberefore, it is possible that the clones code for molecules which are only released during 
a short period of parasite development. It was of interest to note that of the five positive 
clones identified, two were recognised by an anti-paramyosin monoclonal antibody. One 
of the clones recognised by this antibody appeared to have an internal EcoRI site. 
Although the D4-D8S detected a protein of 97 kDa in soluble preparations of 
schistosomula and adult worms (section 4.3.4), it did not do so in D6-D8 released protein 
preparations. Additionally, the anti-Sm97 monoclonal antibody did not react with any of 
the D6-D8 released proteins. Unless paramyosin was only released between days 4 and 
6, it is difficult to explain why the D4-D8S contained antibodies directed against 
paramyosin. Since there is a large body of information available about this protein, it is 
unlikely that characterisation of the two 'paramyosin' clones will be taken much further. 
Although the anti-Sm97 monoclonal antibody did not bind to proteins expressed by the 3 
remaining positive clones, the possibility remains that they may still code for paramyosin. 
In order to resolve this question, antibodies bound to proteins expressed by the 3 clones 
could be clutcd from nitrocellulose filters and used to probe a blot of purified 
paramyosin. 
Future work will be described in the concluding discussion. 
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CHAPTER SIX 
Concluding discussion 
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Throughout the course of studying proteins released by schistosomula during in vitro 
culture, significant differences in the surface morphology of normal and attenuated larvae 
were consistently observed. After 8 days in culture, schistosomula derived from normal 
cercariac exhibited the characteristics of parasites recovered from the lungs (Crabtree & 
Wilson, 1986a). Although 20 krad. -irradiated schistosomula had lost their mid-body 
spines, an indication that development had proceeded normally, they exhibited random 
muscular constrictions along the length of their body. Additionally, the alternating 
extensions and contractions of the body, which are characteristic of lung-stage 
schistosomula, occurred more slowly and the maximum extension was less in irradiated, 
compared to normal parasites. It was suggested that these abnormalities could account for 
the persistence of attenuated larvae in the skin-draining lymph nodes and lungs, two 
events which are essential for the induction of protective immunity in this vaccine model. 
Despite the large body of information which is available on many aspects of the 
irradiated cercaria vaccine model, there is still little known about the antigens which 
mediate immunity. In a recent review Sher et aL (1989) stated that four basic strategies 
have been employed in the identification of potential vaccine candidates against 
schistosomiasis. The first, and most widely used approach, has been the generation of 
monoclonal antibodies, followed by the identification and synthesis of the relevant target 
cpitopes (the identification of TPI represents an example of this approach). The second, is 
to identify antigens seen uniquely by naturally resistant hosts. The third approach is to 
induce resistance in a host by immunisation with a crude antigen preparation, and then 
analyse the immune response induced subsequently. This procedure led to the 
identification of paramyosin. The final approach is to identify an "Achilles heel" in the 
life-cycle of the parasite, i. e. a component which is functionally essential to parasite 
survival (the ccrcarial proteases probably fall into this category). None of these 
approaches was followed directly to identify the antigens which mediate lung-phase 
immunity in the irradiated cercaria vaccine model. Instead, based on the detailed 
information available on the induction and effector phases of immunity in this model, it 
was hypothesised that proteins released from schistosomula would provide a source of 
potential vaccine candidates. 
Biosynthctic labelling with "S-methionine either prior to, or post-cercarial 
transformation, facilitated analysis of the kinetics of protein synthesis and release by 
schistosomula during in vitro culture. Over an 11 day period, approximately four 
different phases of protein synthesis could be identified, which may relate to the 
developmental processes undergone by schistosomula in vivo. Furthermore, the proteins 
released by larvae during development to the lung-stage, were characteriscd. 
Schistosomula labelled prior to transformation released two dominant proteins of M, 61 
and 20 kDa whilst parasites labelled post-transformation released three dominant 
molecules of 61,45 and 20 kDa. 
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To assign a function to any of these molecules would, at the moment, be speculation. 
Nevertheless, there are several potential sources from which such proteins could be 
derived. The acetabular glands are likely to make a large contribution to material released 
within the first few hours post-transformation. However, such structures have completely 
disappeared before the lung-stage is reached. Conversely, the head gland does persist to 
this stage; its secretions have been postulated to facilitate parasite entry into the blood 
vessels of the dcrmis (Crabtree & Wilson, 1985). The tegument of the lung 
schistosomulum also contains a novel secrctory vesicle, the homogeneous body (Crabtree 
& Wilson, 1986a), the products of which may act as a lubricant to aid progress along a 
capillary. Additionally, the embryonic gut becomes active at the lung-stagc, and the 
nephridial system enlarges; both could act as sources of secretions to trigger the 
pulmonary effector response. Whilst the possibility remains that in vivo, schistosomula 
release qualitatively or quantitatively different proteins than those cultured in vitro, the 
high level of parasite viability maintained during in vitro culture and their ability to 
mature when surgically transferred to naive mice suggests that the molecules detected 
are, at worst, a good representation of those released in vivo. Although much of the work 
in this thesis was based on the irradiated ccrcaria vaccine model, the analysis of parasitc- 
released proteins is not constrained by this model. If the proteins released by parasites 
cultured in vitro or in vivo arc indeed identical, then the charactcrisation of such 
molecules is equally as relevant to human schistosomiasis as it is to the mousc model. 
Parasite-released proteins are unlikely to be a good source of vaccine candidates for 
immune elimination mechanisms such as ADCC, which are dependent upon opsonisation 
by antibodies. However, they may be a good source of T cell immunogcns. James (1987) 
suggested that "a vaccine based on T cell-mediated immunity offers certain theoretical 
advantages over a vaccine dependent on antibody. For example, virtually any antigen, 
whether surface, internal, or secreted, against which the host is immunised in a way that 
specifically sensitizes the correct T cell subset and to which the host is rcexposed upon 
challenge infection could, theoretically, be of protective value in inducing lymphokinc 
production. " "... Since cell-mediated immunity is antigen specific in the induction phase, 
but can operate non-spccifically in the effector phase, the cytotoxic reactivity of 
lymphokine activated macrophage effector cells need not be directed toward specific 
surface epitopes on the target. This offers the distinct advantage of overcoming the 
parasite's immune evasion strategies of antigen masking or shedding and antibody 
cleavage. Finally, the cpitopcs triggering T cell responses are more likely to be protein 
than carbohydrate in nature and less likely to depend on conformation possibilities, that 
would expc"dite vaccine production. " However, despite such statements, the relevance of 
T cell-mediated effector mechanisms in human schistosomiasis is not clear. 
Antibody-mediatcd killing of Schistosoma mansoni has been well documented in 
experimental systems (Capron & Capron, 1986; Capron et aL 1987; Shcr et aL 1989) and 
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also in sera of patients with schistosomiasis (Butterworth et al. 1985; Butterworth et al. 
1987; Dessein et al. 1988). Although cellular immune responses have been studied in 
experimental systems (Sher et al. 1982; Constant et al. 1990; Pemberton et al. 1991; 
Ratcliffe & Wilson, 1991; Constant & Wilson, 1992; Richter, Reynolds & Ham, 1993) 
and infected subjects (Colley et al. 1977; Vieira et al. 1987), very little is known about 
the relationship between the specific cellular immune response to Schistosoma mansoni 
antigens and the degree of infection. Recent studies on infected patients in Brazil have 
addressed these issues. Gazzinelli et al. (1992) identified a group of individuals who lived 
in endemic areas and had continued contact with 'contaminated' water but were 
repeatedly stool negative; these people were termed endemic normals. It was found that 
peripheral blood mononuclear cells (PBMC) taken from this group of people were highly 
responsive to schistosome antigen preparations, particularly soluble egg antigens. 
Furthermore, upon stimulation, the cells produced significantly higher levels of IFNg 
than equivalent cells from infected patients. More recently, Ribeiro de Jesus et al. (1993) 
identified 50 subjects, living in an endemic area of schistosomiasis, who had the same 
degree of exposure to cercariae. Despite this, the degree of infection, assessed by eggs per 
gram of facces (cpg faeces) was variable (0-5604). It was found that the proliferative 
response of PBMC to schistosomula and adult worm antigens was higher in individuals 
with a low degree of infection (<400 epg faeccs) than the response by heavily infected 
individuals (>400 epg faeccs; P<0.001). An inverse correlation between the proliferative 
response to Schistosoma mansoni antigens and the degree of re-infection was also 
observed (P=0.02). It was suggested that cellular immune mechanisms could be involved 
in human resistance to Schistosoma mansoni infection. 
The work described in this thesis used an assay of lymph node cell blastogenesis as 
an indicator of the potency of various antigen preparations as T cell immunogcns. Ilie 
results from such experiments demonstrated that schistosomula-rcleased proteins were 
capable of inducing a strong proliferative response by lymph node cells recovered from 
protectively vaccinated mice. This proves that cells from such mice have been sensitiscd 
to some, or all, of these macromolecules previously, and that released proteins provide a 
good source of T cell immunogens. Additionally, live schistosomula induced a strong 
proliferative response. Fractionation of the parasite-released proteins into samples of 
limited antigenic composition, prior to use in blastogenesis assays would provide an 
indication as to which specific moleculc(s) may serve as candidate vaccine antigens. 
Unfortunately, due to the limited quantity of material available, this was not a feasible 
option. 71berefore, further characterisation of the proteins is required before any particular 
antigen can be regarded as a vaccine candidate. However, the released protein or proteins 
at approximately 20 kDa perhaps deserve special attention. As suggested in chapters two 
and four, it appears that more than one molecule is represented at this molecular weight. 
Such molecules were dominant on autoradiographs of released proteins derived from 
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schistosomula labelled either prior to, or post-transformation. In addition, antibodies 
from serum raised against released macromolecules bound to protcin(s) at 20 kDa very 
strongly. Although neither of these facts guarantee that this protein would be a potent 
stimulator of Th cells, if such a result was obtained, it would be of great interest. A 
protein of similar molecular weight has been identified by Dunne et aL (1992). In this 
study, a group of infected Kenyan patients were treated with chemotherapeutic drugs and 
then the intensities of reinfection followed over the next two years. It was found that their 
IgE responses against an adult worm antigen preparation correlated negatively with 
intensities of reinfection. By Western blot analysis, a dominant 22 kDa antigen was 
recogniscd by IgE antibodies from most, but not all, high IgE responders. This antigen 
was found to be located in the tegument of the adult worm, and of lung and liver worms, 
but not in skin-stage schistosomula. 
Since further characterisation of the released proteins described in this thesis was 
impeded by their low availability, recombinant DNA technology was utiliscd. Initial 
attempts made to screen a larval cDNA library with serum raised against schistosomula- 
released proteins, resulted in the identification of 5 positive clones. Of these, two 
expressed proteins which were recognised by a monoclonal antibody directed against 
paramyosin. It is hoped that further screening of the library will lead to the identification 
of the dominant 20 kDa antigen(s) described in this study, and other schistosomula- 
released proteins. Initially, it should be possible to obtain microgram quantities of the 
fusion proteins which could be purified by affinity chromatography or eluted from 
electrophoretic gels. After concentration, such molecules can be used in T cell 
blastogencsis assays, and their ability to induce proliferation of, and cytokinc production 
by, such cells tested. Results obtained from such experiments should allow the selection 
of a small number of potential vaccine antigens. By using high level expression systems, 
large quantities of the selected molecules should eventually be obtained. This would 
facilitate further characterisation of such moieties. 
In summary, the work described in this thesis has provided a firm foundation for the 
hypothesis that schistosomula-released proteins are an important source of candidate T 
cell vaccine antigens. It is hoped that the further characterisation of one, or more, of the 
released proteins described in this study, will eventually progress to the stage at which 
trial vaccination experiments in mice can be implemented. 
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APPENDIX ONE 
Irradiation of Schistosoma mansoni cercariae impairs 
neuromuscular function in developing schistosomula. 
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Irradiation of Schistosoma mansoni Cercariae Impairs 
Neuromuscular Function in Developing Schistosomula 
Richard Harrop and R. Alan Wilson, Department of Biology, University of York, Heslington. York, United Kingdom 
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ABsTRAcr Optimally attenuated larvae of Schisto- 
soma mansoni (20 krad) are incapable of migrating 
farther than the lungs, and they induce high levels of 
resistance in mice to a subsequent challenge infection. 
The effect of gamma radiation on the parasite is de- 
scribed and related to the migratory pattern of atten- 
uated larvae. Scanning electron microscopy revealed 
marked morphological differences between normal and 
irradiated larvae at Ihe lung stage of development. The 
latter exhibited random constrictions, probably re- 
sulting from contraction of circular muscle fibers, at 
intervals along the length of the body and showed sub- 
tle differences in motility. We suggest these abnor- 
malities account for persistence of attenuated larvae in 
the skin-draining lymph nodes and lungs, 2 events that 
are instrumental to the induction of protective im- 
munity in this vaccine model. 
A single exposure of C57131/6 strain mice to 
500 gamma-irradiated cercariae of Schistosoma 
mansoni induces up to 70% protection against a 
challenge with normal parasites (Dean, 1983). 
The optimal radiation dose has been defined as 
20 krad in our experimental system, but other 
investigators use up to 56 krad. Recently, Reyn- 
olds and Ham (1992) compared 15- and 50-krad 
doses of gamma radiation and found the former 
induced higher levels ofprotective immunity. An 
exposure regime involving normal parasites but 
precluding pathological changes in the liver (e. g., 
single sex, or drug-terminated infections) elicits 
only low levels ofprotection. Gamma irradiation 
of cercariae appears to have no effect on the sub- 
sequent surface antigenicity of schistosomula 
(Simpson et al., 1985), their ultrastructure (Mas- 
tin et al., 1985), or their ability to stimulate pro- 
liferation of human mononuclear cells (Vicira et 
al., 1987). Recently, it has been demonstrated 
that protein synthesis is inhibited, relative to 
normal larvae, in the first 24 hr after irradiation 
but nevertheless recovers by 72 hr (Wales et al., 
1992). However, the major diffierence between 
irradiated and normal larvae that has been high- 
lighted is in the pattern of migration through the 
mammalian host. Optimally irradiated larvae 
show a retarded exit from the skin. Some enter 
and persist in lymph nodes draining the exposure 
site, whereas others reach the lungs but appar- 
ently travel no farther (Mountford et al., 1988). 
The migration of hyperirradiated parasites, which 
induce little or no resistance, is even more ab- 
breviated, none actually reaching the lungs (Con- 
stant et al., 1990). 
The altered pattern of migration shown by op- 
timally irradiated larvae has been proposed to 
be the key factor responsible for the induction 
of protection (Mountford et al., 1988). There is 
a greater, more prolonged proliferation of T cells 
in lymph nodes draining the skin and lungs after 
exposure to irradiated than to normal parasites 
(Constant and Wilson, 1992). Additionally, the 
antigen-stimulated production of cytokines, par- 
ticularly interferon gamma and interleukin 3, is 
more persistent (Pemberton et al., 1991). The 
attenuated schistosomula that reich the lungs are 
also an important component in vaccination suc- 
cess. They stimulate the recruitment of schisto- 
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some-specific CD4' T cells to the pulmonary pa- 
renchyma and airways (Aitken et al., 1988). This 
persistent population ofT lymphocytes may serve 
to arm the lungs against the arrival of challenge 
parasites, providing the organ with the capacity 
for a rapid memory response on secondary ex- 
posure to antigen. However, the question of how 
irradiation modifies parasites, causing them to 
stimulate the more intense immune response, 
remains unanswered. In tae course of studying 
larval excretory-secretory antigens, we consis- 
tently observed significant differences in surface 
structure between attenuated and normal larvae 
that may provide an explanation. 
Cercariae of a Puerto Rican strain of S. man- 
soni were shed from Biomphalaria glabrata snails 
and one-half was exposed to 20 krad of gamma 
radiation from a 60CO source (Department of Ra- 
diobiology, Cookridge Hospital, Leeds, U. K. ). 
Bodies were sheared from normal and irradiated 
cercariae in 5% glucose (Ramalho-Pinto et al., 
1974) and recovered after separation from tails 
on a discontinuous Percoll gradient (Lazdins et 
al., 1982). The bodies were cultured in 24-well 
plates at 37 C in a 5% CO,: 95% air mixture, in 
Medium 169 (Basch, 198 1) lacking erythrocytes 
and with 1% fetal calf serum replacing human 
serum. The absence of erythrocytes in the me- 
dium prevents transformation of schistosomula 
to the liver stage (Clegg and Smithers, 1972). 
After some days in culture, gross morphological 
differences between normal and irradiated larvae 
were detectable by light microscopy. To char- 
acterize these, schistosomula were fixed, pre- 
pared for scanning electron microscopy (Crab- 
tree and Wilson, 1980) and examined in an ISI 
(International Scientific Instruments, Harpur Hill, 
Derbyshire, England. U. K. ) 100A microscope. 
After 8 days in culture, schistosomula derived 
from normal cercariae (Fig. IA) exhibited the 
characteristics of schistosomula recovered from 
the lungs (Crabtree and Wilson, 1986). The body 
was elongate and lacked spines apart from the 
extreme anterior and posterior regions. The dis- 
appearance of midbody spines is an indication 
that development had proceeded normally in 
vitro. Schistosomula derived from irradiated 
cercariae (Fig. I B) showed a similar pattern of 
spination, but differed in appearance in I marked 
respect. They showed a series of tight constric- 
tions (between I and 10) distributed randomly 
along the length of the body- These were not 
shrinkage artifacts resulting from specimen prep- 
aration. The constrictions were first apparent by 
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I-IGURE 1. Scanning election micrographs of'schis- 
tosomula cultured for 8 days in vitro. Scale bar = 10 
gm. A. Normal schistosomulum showing the smooth 
outline of the body and characteristic loss of midbody 
spines but presence of anterior (a) and posterior (p) 
spines. B. Schistosomulum derived from an irradiated 
cercaria showing constrictions of the body at random 
points along its length (arrows), and presence of an 
terior (a) and posterior (p) spines. 
light microscopy on day 5 of culture and only 
prominent by day 6-7ý they were a consistent 
feature of all cultures of attenuated larvae. Sim- 
ilar constrictions were present on attenuated lar- 
vae recovered from the lungs of vaccinated mice 
on day 8. Subtle differences in motility between 
normal and attenuated larvae could also be ob- 
served. The alternating extensions and contrac- 
tions of the body, which are characteristic of lung 
schistosomula, occurred more slowly and the 
maximum extension was less in the irradiated 
parasites. Both sets of larvae remained indefi- 
nitely in an arrested state of development with 
more than 50% surviving for at least 6 wk, the 
irradiated larvae retaining constrictions through- 
out. 
The musculature of the schistosomulum is an 
arrangement of inner longitudinal and outer cir- 
cular fibers, lying immediately below the tegu- 
ment and external to the parenchyma and other 
cells of the body. These internal tissues serve as 
a hydrostatic skeleton on which the muscles act 
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in a concerted manner to achieve the alterations 
in body form involved in the process of intra- 
vascular migration (Crabtree and Wilson, 1986). 
Thus, extension of the body occurs by the si- 
multaneous contraction of the circular and re- 
laxation of the longitudinal fibers, and vice versa 
for contraction. The function of the anterior and 
posterior spines is to provide purchase against 
the vessel wall and to facilitate movement along 
the lumen (Crabtree and Wilson, 1980). 
We suggest that each random constriction in 
the body wall is produced by the overcontraction 
of I or 2 circular muscle fibers to their maximum 
extent, whereas other circular muscle fibers re- 
main in balance with the extended longitudinal 
fibers. Thus, gamma radiation exerts a delayed 
effect on the neuromuscular coordination of the 
parasite without causing its death. This inter- 
pretation of the altered structure provides one 
possible explanation of the truncated migration 
pattern of attenuated schistosomula. The differ- 
ences in surface structure and motility only be- 
come apparent after 5 days in culture, a fact con- 
sistent with the observation that larvae are able 
to commence their migration from the skin be- 
fore becoming sequestered in a lymph node or 
the lungs (the t,, 2 for the migration of normal 
parasites out of mouse skin is approximately 4 
days [Miller and Wilson, 1978]). 
We conclude that the optimal dose of gamma 
radiation exerts an effect on the parasite at a 
crucial stage in its development 5-7 days after 
exposure. This effect is manifest as a progressive 
disruption of neuromuscular coordination that 
impairs parasite motility. The result is to trap 
attenuated larvae in the draining lymph nodes 
and lungs, where they are likely to release larger 
quantities of antigen due to the prolonged period 
of residence, thus stimulating the immune re- 
sponse and generating the protective state. A high 
radiation dose (80 krad) presumably acts earlier, 
preventing parasite migration from the skin, 
whereas a low dose (5 krad) permits a relatively 
normal migration; in both extreme situations the 
attenuated larvae fail to induce a high level of 
immunity (Constant et al., 1990; Coulson and 
Wilson, unpubl. data). 
The authors thank Peter Crosby for perform- 
ing the electron microscopy. R. H. was the recip- 
ient of an S. E. R. C. studentship award. 
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Ultrastructural Determination of Cystogenesis by Various 
Toxoplasma gondY Isolates in Cell Culture 
David S. Lindsay, Maria A. Toivio-Kinnucan, and Byron L Blagburn, Department of Pathobiology, College of Veterinary Medicine, Auburn University, Alabama 36840,5519 
ABSIRACr. The tissue cyst stage of Toxoplasmagondii is important in relapsing disease seen in toxoplasmic 
encephalitis and retinochoroiditis. An in vitro culture 
system to examine the developmental biology of the 
tissue cyst stage would greatly aid in our understanding 
of this stage of the parasite's life cycle. We used trans- 
mission electron microscopy (TEM) and acid-pepsin digestion of infected cell cultures to determine the ca- 
pability of 21 isolates of T. gondil to produce tissue 
cysts in cell cultures. All 21 of the isolates had acid- 
pepsin-resistant stages present, and tissue cysts could be demonstrated in 19 using TEM. The present study demonstrates that tissue cyst formation in vitro is a 
common phenomenon for T. gondii isolates. 
TOXOPlasma gondii is a ubiquitous protozoan 
parasite that infects human beings and most oth- 
er warm-blooded animals (Dubey and Beattie, 
1988). Its facultatively heteroxenous life cycle 
consists of the following polymorphic stages: 
sporozoites within sporulated oocysts; tachy- 
zoites, the rapidly dividing stages that occur early in infections and are the stages that are trans- 
placentally transmitted; and bradyzoites, the 
slowly dividing stages that are present in tissue 
cysts. Biological and antigenic diffierences exist 
among the 3 stages of the parasite (Frenkel et al., 1970; Dubey and Frenkel, 1976; Freyre et al., 1989; Kasper, 1989). 
Toxoplasma gondii infections in immuno- 
competent adu! t animals usually are asympto- 
matic, whereas serious disease can occur in 
transplacentally infected, young or immunocom- 
promised animals. Toxoplasmic encephalitis now is recognized as a serious, often fatal, manifes- 
tation of the infection in many patients with the 
acquired immunodeficiency syndrome (Luft and 
Remington, 1988,1992; Strittmatter et al., 1992). 
Toxoplasmic encephalitis and retinochoroiditis 
probably are caused by reactivation or rupture 
of latent tissue cyst stages (Frenkel and Escaja- 
dillo, 1987). 
Cell culture systems for examining the devel- 
opmental biology of bradyzoites and tissue cysts 
would aid in our knowledge of these important 
stages of the parasite's life cycle. Certain isolates 
of T. gondii produce tissue cysts in cell cultures 
(Hogan et al., 1960; Matsubayashi and Akao, 
1963; Kambara et al., 197 1; Shimada et al., 1974; 
Hoff et al., 1977; Jones et al., 1986; Lindsay et 
al., 1991). Two of these studies (Hogan et al., 
1960; Shimada et al., 1974) examined the RH 
isolate of T. gondd, whereas different isolates 
were used in the other studies. 
The present study was conducted to determine 
the ability of various isolates of T. gondil to pro- 
duce tissue cysts in cell cultures. 
Four commonly used laboratory isolates, RH. 
TS-4, ME-49, and OT-1, and 17 isolates from 
various wild mammals and birds were examined 
for the ability to produce tissue cysts in cell cul- 
tures (Table 1). The GT- I isolate was used as a 
positive control because it previously has been 
shown to produce tissue cysts in cell culture 
(Lindsay et al., 199 1). All T. gondil isolates, ex- 
cept RH and TS-4, were maintained as chronic 
infections in female ICR mice prior to use in cell 
culture studies. Most isolates were used after only 
I passage in mice; none had been passaged in 
mice more than 3 times. The RH and TS-4 iso- 
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Strain 
BB4 
XL1-Blue 
Genotypc 
supF58 supE44 hsdR514 
gaIK2 gaI722 trpR55 
metBI tonA AlacU169F 
[proAB+IaclqlacZAM15 
TnlO(tetD] 
supE44 hsdRl7 recAl 
endAl gyrA46 thi relAl 
lac- 
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